

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Mobilized peripheral blood: an updated perspective | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/8-2125/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/8-2125" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Mobilized peripheral blood: an updated perspective" />
    
            <meta name="og:title" content="F1000Research Article: Mobilized peripheral blood: an updated perspective.">
            <meta name="og:description" content="Read the latest article version by Darja Karpova, Michael P. Rettig, John F. DiPersio, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="23258">
            <meta name="article-id" content="21129">
            <meta name="dc.title" content="Mobilized peripheral blood: an updated perspective">
            <meta name="dc.description" content="Enforced egress of hematopoietic stem cells (HSCs) out of the bone marrow (BM) into the peripheral circulation, termed mobilization, has come a long way since its discovery over four decades ago. Mobilization research continues to be driven by the need to optimize the regimen currently available in the clinic with regard to pharmacokinetic and pharmacodynamic profile, costs, and donor convenience. In this review, we describe the most recent findings in the field and how we anticipate them to affect the development of mobilization strategies in the future. Furthermore, the significance of mobilization beyond HSC collection, i.e. for chemosensitization, conditioning, and gene therapy as well as a means to study the interactions between HSCs and their BM microenvironment, is reviewed. Open questions, controversies, and the potential impact of recent technical progress on mobilization research are also highlighted.">
            <meta name="dc.subject" content="Mobilization, Hematopoietic stem and progenitor cells, G-CSF, CXCR4, VLA4, CXCR2, BM niche, Chemosensitization, Conditioning, Gene therapy">
            <meta name="dc.creator" content="Karpova, Darja">
            <meta name="dc.creator" content="Rettig, Michael P.">
            <meta name="dc.creator" content="DiPersio, John F.">
            <meta name="dc.date" content="2019/12/20">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.21129.1">
            <meta name="dc.source" content="F1000Research 2019 8:2125">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="Mobilization">
            <meta name="prism.keyword" content="Hematopoietic stem and progenitor cells">
            <meta name="prism.keyword" content="G-CSF">
            <meta name="prism.keyword" content="CXCR4">
            <meta name="prism.keyword" content="VLA4">
            <meta name="prism.keyword" content="CXCR2">
            <meta name="prism.keyword" content="BM niche">
            <meta name="prism.keyword" content="Chemosensitization">
            <meta name="prism.keyword" content="Conditioning">
            <meta name="prism.keyword" content="Gene therapy">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2019/12/20">
            <meta name="prism.volume" content="8">
            <meta name="prism.number" content="2125">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.21129.1">
            <meta name="prism.url" content="https://f1000research.com/articles/8-2125">
            <meta name="citation_title" content="Mobilized peripheral blood: an updated perspective">
            <meta name="citation_abstract" content="Enforced egress of hematopoietic stem cells (HSCs) out of the bone marrow (BM) into the peripheral circulation, termed mobilization, has come a long way since its discovery over four decades ago. Mobilization research continues to be driven by the need to optimize the regimen currently available in the clinic with regard to pharmacokinetic and pharmacodynamic profile, costs, and donor convenience. In this review, we describe the most recent findings in the field and how we anticipate them to affect the development of mobilization strategies in the future. Furthermore, the significance of mobilization beyond HSC collection, i.e. for chemosensitization, conditioning, and gene therapy as well as a means to study the interactions between HSCs and their BM microenvironment, is reviewed. Open questions, controversies, and the potential impact of recent technical progress on mobilization research are also highlighted.">
            <meta name="citation_description" content="Enforced egress of hematopoietic stem cells (HSCs) out of the bone marrow (BM) into the peripheral circulation, termed mobilization, has come a long way since its discovery over four decades ago. Mobilization research continues to be driven by the need to optimize the regimen currently available in the clinic with regard to pharmacokinetic and pharmacodynamic profile, costs, and donor convenience. In this review, we describe the most recent findings in the field and how we anticipate them to affect the development of mobilization strategies in the future. Furthermore, the significance of mobilization beyond HSC collection, i.e. for chemosensitization, conditioning, and gene therapy as well as a means to study the interactions between HSCs and their BM microenvironment, is reviewed. Open questions, controversies, and the potential impact of recent technical progress on mobilization research are also highlighted.">
            <meta name="citation_keywords" content="Mobilization, Hematopoietic stem and progenitor cells, G-CSF, CXCR4, VLA4, CXCR2, BM niche, Chemosensitization, Conditioning, Gene therapy">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Darja Karpova">
            <meta name="citation_author_institution" content="Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, 69120, Germany">
            <meta name="citation_author" content="Michael P. Rettig">
            <meta name="citation_author_institution" content="Division of Oncology, Department of Medicine, Washington University School of Medicine,, St. Louis, Missouri, 63110, USA">
            <meta name="citation_author" content="John F. DiPersio">
            <meta name="citation_author_institution" content="Division of Oncology, Department of Medicine, Washington University School of Medicine,, St. Louis, Missouri, 63110, USA">
            <meta name="citation_publication_date" content="2019/12/20">
            <meta name="citation_volume" content="8">
            <meta name="citation_publication_number" content="2125">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.21129.1">
            <meta name="citation_firstpage" content="2125">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/8-2125/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/8-2125.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=23258 /> <input type=hidden id=articleId name=articleId value=21129 /> <input type=hidden id=xmlUrl value="/articles/8-2125/v1/xml"/> <input type=hidden id=xmlFileName value="-8-2125-v1.xml"> <input type=hidden id=article_uuid value=6d2c0418-1961-4ed8-ab5a-919f02f46244 /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Mobilized peripheral blood: an updated perspective"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.21129.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.21129.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/8-2125"
  },
  "headline": "Mobilized peripheral blood: an updated perspective",
  "datePublished": "2019-12-20T09:27:10",
  "dateModified": "2019-12-20T09:27:10",
  "author": [
    {
      "@type": "Person",
      "name": "Darja Karpova"
    },    {
      "@type": "Person",
      "name": "Michael P. Rettig"
    },    {
      "@type": "Person",
      "name": "John F. DiPersio"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Enforced egress of hematopoietic stem cells (HSCs) out of the bone marrow (BM) into the peripheral circulation, termed mobilization, has come a long way since its discovery over four decades ago. Mobilization research continues to be driven by the need to optimize the regimen currently available in the clinic with regard to pharmacokinetic and pharmacodynamic profile, costs, and donor convenience. In this review, we describe the most recent findings in the field and how we anticipate them to affect the development of mobilization strategies in the future. Furthermore, the significance of mobilization beyond HSC collection, i.e. for chemosensitization, conditioning, and gene therapy as well as a means to study the interactions between HSCs and their BM microenvironment, is reviewed. Open questions, controversies, and the potential impact of recent technical progress on mobilization research are also highlighted."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/8-2125.html",
            "name": "Mobilized peripheral blood: an updated perspective"
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Mobilized peripheral blood: an updated perspective </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=23258 data-id=21129 data-downloads="" data-views="" data-scholar="10.12688/f1000research.21129.1" data-recommended="" data-doi="10.12688/f1000research.21129.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/8-2125/v1/pdf?article_uuid=6d2c0418-1961-4ed8-ab5a-919f02f46244" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-21129-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-21129-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-21129-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Karpova D, Rettig MP and DiPersio JF. Mobilized peripheral blood: an updated perspective [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2019, <b>8</b>(F1000 Faculty Rev):2125 (<a class=new-orange href="https://doi.org/10.12688/f1000research.21129.1" target=_blank>https://doi.org/10.12688/f1000research.21129.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-21129-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=21129 id=track-article-signin-21129 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/21129?target=/articles/8-2125.html">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=23258 /> <input name=articleId type=hidden value=21129 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Mobilized peripheral blood: an updated perspective</h1><span class=other-info> [version 1; peer review: 2 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class="">Darja Karpova<a href="https://orcid.org/0000-0003-0695-1854" target=_blank id=author-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0003-0695-1854</div><sup>1</sup>,&nbsp;</span><span class="">Michael P. Rettig<sup>2</sup>,&nbsp;</span><span class=""><a href="mailto:jdipersi@DOM.wustl.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>John F. DiPersio</span></a><sup>2</sup></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class="">Darja Karpova<a href="http://orcid.org/0000-0003-0695-1854" target=_blank id=mauthor-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0003-0695-1854</div><sup>1</sup>,&nbsp;</span><span class="">Michael P. Rettig<sup>2</sup>,&nbsp;</span><span class=""><a href="mailto:jdipersi@DOM.wustl.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>John F. DiPersio</span></a><sup>2</sup></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 20 Dec 2019 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.21129.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, 69120, Germany<br/> <sup>2</sup> Division of Oncology, Department of Medicine, Washington University School of Medicine,, St. Louis, Missouri, 63110, USA<br/> <p> <div class=margin-bottom> Darja Karpova <br/> <span>Roles: </span> Conceptualization, Writing – Original Draft Preparation </div> <div class=margin-bottom> Michael P. Rettig <br/> <span>Roles: </span> Supervision, Writing – Review & Editing </div> <div class=margin-bottom> John F. DiPersio <br/> <span>Roles: </span> Supervision, Writing – Review & Editing </div> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=58984-57776></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=61520-57777></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Enforced egress of hematopoietic stem cells (HSCs) out of the bone marrow (BM) into the peripheral circulation, termed mobilization, has come a long way since its discovery over four decades ago. Mobilization research continues to be driven by the need to optimize the regimen currently available in the clinic with regard to pharmacokinetic and pharmacodynamic profile, costs, and donor convenience. In this review, we describe the most recent findings in the field and how we anticipate them to affect the development of mobilization strategies in the future. Furthermore, the significance of mobilization beyond HSC collection, i.e. for chemosensitization, conditioning, and gene therapy as well as a means to study the interactions between HSCs and their BM microenvironment, is reviewed. Open questions, controversies, and the potential impact of recent technical progress on mobilization research are also highlighted. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> Mobilization, Hematopoietic stem and progenitor cells, G-CSF, CXCR4, VLA4, CXCR2, BM niche, Chemosensitization, Conditioning, Gene therapy </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> John F. DiPersio (<a href="mailto:jdipersi@DOM.wustl.edu">jdipersi@DOM.wustl.edu</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> John F. DiPersio </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> DK and JFD have a patent application (PCT/US2017/059770). MPR and JFD have pending patent applications (PCT/US2017/059777). JFD is founder and advisor for Magenta Therapeutics Inc. and WUGEN Inc. He receives income from RiverVest Venture Partners and Magenta Therapeutics Inc., he receives research funding from Amphivena Therapeutics, NeoimmuneTech Inc., Macrogenics Inc., Incyte Corp., BiolineRx, Altiris, and WUGEN Inc., and he is an Advisory Board Member for Cellworks Group, RiverVest Venture Partners, and Arch Oncology. MPR serves as a consultant for RiverVest Venture Partners and has received research funding from Amphivena Therapeutics, Novimmmune, and Cantex. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> MPR acknowledges funding from the National Institutes of Health, National Cancer Institute (R50 CA211466), and the Alvin J. Siteman Cancer Center, Siteman Investment Program award, supported by The Foundation for Barnes-Jewish Hospital Cancer Frontier Fund, the Barnard Trust, and a National Cancer Institute Cancer Center support grant (P30 CA091842). JFD is supported by grants from the National Institutes of Health (P50 CA171963, Project 4 Leader) and NIH/National Cancer Institute (R35 CA210084). <br/> <i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</i> </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp; © 2019 Karpova D <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Karpova D, Rettig MP and DiPersio JF. Mobilized peripheral blood: an updated perspective [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2019, <b>8</b>(F1000 Faculty Rev):2125 (<a href="https://doi.org/10.12688/f1000research.21129.1" target=_blank>https://doi.org/10.12688/f1000research.21129.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 20 Dec 2019, <b>8</b>(F1000 Faculty Rev):2125 (<a href="https://doi.org/10.12688/f1000research.21129.1" target=_blank>https://doi.org/10.12688/f1000research.21129.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 20 Dec 2019, <b>8</b>(F1000 Faculty Rev):2125 (<a href="https://doi.org/10.12688/f1000research.21129.1" target=_blank>https://doi.org/10.12688/f1000research.21129.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d28331e174>Introduction</h2><p class="" id=d28331e177>Discovered by pure chance in patients recovering from chemotherapy almost 45 years ago<sup><a href="#ref-1">1</a></sup>, the phenomenon of hematopoietic stem cell (HSC) mobilization has transformed the clinical practice of HSC transplantation<sup><a href="#ref-2">2</a></sup>. It has further extended to indications beyond HSC collection, including mobilization-based chemosensitization, conditioning, and gene therapeutic approaches, which are areas of intensive research. Better understanding of the pathways governing HSC trafficking can provide important insights into how stem cell localization within the bone marrow (BM) is regulated, which explains a continued need for basic research on mobilization to define the underlying molecular and cellular mechanisms.</p><p class="" id=d28331e188>In mammals, the first definitive HSCs arise in several intra and extraembryonic tissues from which they first migrate into the fetal liver<sup><a href="#ref-3">3</a>,<a href="#ref-4">4</a></sup>. Following expansion in the fetal liver, HSCs continue their journey towards the BM, where the overwhelming majority of adult HSCs are subsequently found in their unique, specialized environments, the BM niches<sup><a href="#ref-5">5</a>,<a href="#ref-6">6</a></sup>. Interestingly, despite the dramatically reduced migratory activity upon BM colonization, a small fraction of adult HSCs can be found in the peripheral circulation at any given time<sup><a href="#ref-7">7</a>–<a href="#ref-9">9</a></sup>. Even though random leakiness of BM retention pathways cannot be excluded as a cause, the regularity of this physiological HSC egress<sup><a href="#ref-10">10</a>–<a href="#ref-12">12</a></sup> implies a biological function. The number of HSCs in the circulation at steady state can be substantially augmented by a wide variety of endogenous and exogenous stimuli such as growth factors<sup><a href="#ref-13">13</a>–<a href="#ref-20">20</a></sup>, chemotherapy<sup><a href="#ref-1">1</a>,<a href="#ref-21">21</a>–<a href="#ref-23">23</a></sup>, chemokines<sup><a href="#ref-24">24</a>–<a href="#ref-27">27</a></sup>, chemokine and integrin receptor agonists and antagonists<sup><a href="#ref-28">28</a>–<a href="#ref-31">31</a></sup>, bioactive lipids<sup><a href="#ref-32">32</a>,<a href="#ref-33">33</a></sup>, exercise<sup><a href="#ref-34">34</a>,<a href="#ref-35">35</a></sup>, infection, and inflammation<sup><a href="#ref-36">36</a>,<a href="#ref-37">37</a></sup> (<a href="#f1">Figure 1</a>). This enforced egress of HSCs into peripheral blood is called mobilization. While the function of homeostatically circulating HSCs remains enigmatic, pharmacologically induced HSC egress is increasingly used as the preferred strategy to generate grafts for HSC transplantation (HSCT), the only curative therapeutic option for many hematopoietic malignancies as well as non-malignant pathologies. HSCT requires the intravenous infusion of a minimum of 2×10<sup>6</sup> CD34<sup>+</sup> stem cells/kg recipient body weight; however, a dose of 5×10<sup>6</sup> CD34<sup>+</sup> cells/kg is considered preferable for early, consistent, and long-term multilineage engraftment<sup><a href="#ref-116">116</a>–<a href="#ref-118">118</a></sup>. Each failure or delay to collect sufficient hematopoietic stem/progenitor cells (HSPCs) to proceed to transplantation extends the time of high-dose chemotherapy and increases the risk of disease progression in cancer patients.</p><a name=f1 class=n-a></a><div class="fig panel clearfix"><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/23258/cf4cbc74-bbfe-41af-9412-6843bf2adcd1_figure1.gif"><img alt="cf4cbc74-bbfe-41af-9412-6843bf2adcd1_figure1.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/23258/cf4cbc74-bbfe-41af-9412-6843bf2adcd1_figure1.gif"></a><div class=caption><h3>Figure 1. Mobilization stimuli.</h3><p id=d28331e305>A wide variety of stimuli that lead to increased numbers of circulating hematopoietic stem cells (HSCs) have been identified, including but not limited to growth factors (cytokines<sup><a href="#ref-17">17</a></sup>, granulocyte colony-stimulating factor [G-CSF]<sup><a href="#ref-19">19</a>,<a href="#ref-38">38</a></sup>, granulocyte-macrophage colony-stimulating factor [GM-CSF]<sup><a href="#ref-20">20</a></sup>, stem cell factor [SCF]<sup><a href="#ref-18">18</a>,<a href="#ref-39">39</a>,<a href="#ref-40">40</a></sup>, FLT3 ligand [FLT3L]<sup><a href="#ref-40">40</a>–<a href="#ref-42">42</a></sup>, thrombopoietin [TPO]<sup><a href="#ref-15">15</a>,<a href="#ref-16">16</a>,<a href="#ref-40">40</a></sup>, angiopoietin [Angpt]<sup><a href="#ref-43">43</a>,<a href="#ref-44">44</a></sup>, vascular endothelial growth factor [VEGF]<sup><a href="#ref-43">43</a>–<a href="#ref-45">45</a></sup>, and interleukins [ILs] -1<sup><a href="#ref-46">46</a></sup>, -3<sup><a href="#ref-47">47</a>,<a href="#ref-48">48</a></sup>, -6<sup><a href="#ref-49">49</a></sup>, -7<sup><a href="#ref-50">50</a></sup>, -12<sup><a href="#ref-51">51</a></sup>, -17<sup><a href="#ref-52">52</a></sup>, and -33<sup><a href="#ref-53">53</a>,<a href="#ref-54">54</a></sup>), chemotherapy-induced myeloid rebound<sup><a href="#ref-1">1</a>,<a href="#ref-23">23</a>,<a href="#ref-55">55</a></sup>, chemokines (CXCL12 and analogs<sup><a href="#ref-27">27</a>,<a href="#ref-56">56</a></sup>, Gro-α<sup><a href="#ref-57">57</a></sup>, -β<sup><a href="#ref-26">26</a>,<a href="#ref-58">58</a>,<a href="#ref-57">57</a>,<a href="#ref-59">59</a></sup>, and -γ<sup><a href="#ref-57">57</a></sup>, and IL-8<sup><a href="#ref-24">24</a>,<a href="#ref-25">25</a>,<a href="#ref-60">60</a></sup>), chemokine receptor antagonists (CXCR4 antagonists<sup><a href="#ref-61">61</a>,<a href="#ref-62">62</a>,<a href="#ref-63">63</a></sup> and inhibitors of the intracellular mediator of CXCR4 signaling, the small Rho GTPase Rac1<sup><a href="#ref-64">64</a>,<a href="#ref-65">65</a></sup>), bioactive lipids (sphingosine-1 phosphate [S1P]<sup><a href="#ref-66">66</a>,<a href="#ref-67">67</a></sup> and ceramide-1 phosphate [C1P]<sup><a href="#ref-66">66</a>,<a href="#ref-67">67</a></sup>) and bacterial toxins<sup><a href="#ref-36">36</a>,<a href="#ref-68">68</a>,<a href="#ref-69">69</a></sup> (lipopolysaccharide [LPS]<sup><a href="#ref-37">37</a>,<a href="#ref-70">70</a></sup> and pertussis toxin [PTX]<sup><a href="#ref-71">71</a>–<a href="#ref-74">74</a></sup>), proteases (trypsin<sup><a href="#ref-75">75</a></sup>, matrix metalloprotease 9 [MMP9]<sup><a href="#ref-58">58</a>,<a href="#ref-76">76</a></sup>, CD26<sup><a href="#ref-77">77</a>,<a href="#ref-78">78</a></sup>, cathepsin G<sup><a href="#ref-79">79</a></sup>, and neutrophil elastase<sup><a href="#ref-79">79</a></sup>) and adenosine receptor agonists (defibrotide)<sup><a href="#ref-80">80</a>,<a href="#ref-81">81</a></sup>, inhibitors of adhesive cell interactions<sup><a href="#ref-82">82</a></sup> (VLA4<sup><a href="#ref-28">28</a>,<a href="#ref-29">29</a>,<a href="#ref-83">83</a></sup> and VLA4/VLA9<sup><a href="#ref-84">84</a></sup> inhibitors, VCAM1<sup><a href="#ref-85">85</a></sup>, and CD44<sup><a href="#ref-86">86</a>,<a href="#ref-87">87</a></sup> blockers) and ephrin A3 receptor antagonists<sup><a href="#ref-88">88</a></sup>, polymeric sugar molecules (dextran<sup><a href="#ref-89">89</a></sup>, fucoidan<sup><a href="#ref-89">89</a>,<a href="#ref-90">90</a></sup>, Betafectin PGG-Glucan<sup><a href="#ref-91">91</a></sup>, and glycosaminoglycan [GAG] mimetics<sup><a href="#ref-92">92</a></sup>), and prostaglandin inhibitors<sup><a href="#ref-93">93</a></sup>. For the majority of the listed stimuli, a direct or indirect targeting of CXCR4 (green) or VLA4 (blue) signaling or both (red) has been documented. On the systemic level, the time of day<sup><a href="#ref-10">10</a>,<a href="#ref-11">11</a>,<a href="#ref-94">94</a></sup>, stress<sup><a href="#ref-95">95</a>,<a href="#ref-96">96</a></sup> and exercise<sup><a href="#ref-97">97</a>–<a href="#ref-100">100</a></sup>, trauma and tissue damage<sup><a href="#ref-101">101</a>–<a href="#ref-103">103</a></sup>, infection<sup><a href="#ref-104">104</a></sup> and inflammation<sup><a href="#ref-105">105</a>,<a href="#ref-106">106</a></sup>, coagulation<sup><a href="#ref-107">107</a>–<a href="#ref-109">109</a></sup> and complement<sup><a href="#ref-110">110</a>–<a href="#ref-113">113</a></sup> cascade along with cortisol<sup><a href="#ref-94">94</a>,<a href="#ref-114">114</a></sup> and the central<sup><a href="#ref-114">114</a></sup> as well as the sympathetic nervous system (SNS)<sup><a href="#ref-115">115</a></sup> have been shown to affect HSC egress out of the bone marrow (BM) into the peripheral blood. In sharp contrast to the diversity of mobilizing agents discovered and tested in preclinical models, only G-CSF alone (healthy donors) or in conjunction with chemotherapy and plerixafor (patients) is being used in the clinic. CNS, central nervous system.</p></div></div><p class="" id=d28331e674>The need to optimize mobilization regimens with regard to their stem cell yield, side effects and risk profile, cost-effectiveness, and availability for different groups of patients, as well as the need to better understand the communication between HSCs and their niche, continues to drive mobilization research. In this review, we discuss how deciphering the events induced by the most commonly used mobilizing agent, granulocyte colony-stimulating factor (G-CSF), led to the development of new mobilization strategies. We highlight the most recent findings and how we envision the newly discovered mobilization approaches will impact mobilization in the clinic. Alternative applications for mobilization are also reviewed. Lastly, we identify open questions and controversies, prospective directions, and how recent technical advances can be implemented within mobilization research.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d28331e680>Current mobilization regimens</h2><p class="" id=d28331e683>G-CSF-mobilized blood is the preferred graft source for virtually all autologous and an increasing majority of allogeneic HSCTs owing to its generally higher stem cell content, reduced rates of graft failure, and better overall survival as compared to the BM<sup><a href="#ref-2">2</a>,<a href="#ref-119">119</a>,<a href="#ref-120">120</a></sup>. After 4–5 days of treatment with G-CSF, circulating HSPCs increase an average of 50–100-fold<sup><a href="#ref-121">121</a>,<a href="#ref-122">122</a></sup> as a result of HSPC pool expansion followed by mobilization. The latter is achieved through targeting the two major pathways involved in stem cell retention: chemokine receptor CXCR4- and integrin VLA4-mediated signaling<sup><a href="#ref-79">79</a>,<a href="#ref-123">123</a>,<a href="#ref-124">124</a></sup>. Attenuation of these pathways is achieved on the level of gene expression as well as through proteolytic cleavage<sup><a href="#ref-79">79</a>,<a href="#ref-123">123</a>–<a href="#ref-127">127</a></sup>. While the role of specific proteases involved in the latter, such as neutrophil elastase, cathepsin G, and MMP9, remains controversial<sup><a href="#ref-128">128</a>,<a href="#ref-129">129</a></sup>, the cell surface protease dipeptidyl peptidase 4 (DPP-4, CD26), which cleaves and inactivates the CXCR4 ligand CXCL12, has indeed been shown to be essential for G-CSF-induced mobilization<sup><a href="#ref-77">77</a>,<a href="#ref-78">78</a></sup>.</p><p class="" id=d28331e738>Shortcomings of G-CSF such as the slow mode of action<sup><a href="#ref-17">17</a>,<a href="#ref-130">130</a></sup>, side effects, and contraindications<sup><a href="#ref-131">131</a>,<a href="#ref-132">132</a></sup> as well as significant heterogeneity in the mobilization response<sup><a href="#ref-121">121</a></sup> explain the quest for alternative mobilizing agents<sup><a href="#ref-133">133</a></sup>. Plerixafor (AMD3100), a small molecule bicyclam CXCR4 antagonist, is FDA approved for autologous stem cell mobilization in non-Hodgkin’s lymphoma and multiple myeloma (MM)<sup><a href="#ref-134">134</a>,<a href="#ref-135">135</a></sup>. When combined with G-CSF, plerixafor increases CD34<sup>+</sup> concentration 2–3-fold compared to G-CSF alone<sup><a href="#ref-134">134</a>,<a href="#ref-135">135</a></sup>. However, a significant disadvantage of plerixafor is its cost, adding $25,567 per patient compared to G-CSF alone<sup><a href="#ref-136">136</a></sup>. Furthermore, up to 24% of patients undergoing autologous stem cell transplantation for lymphoma receiving plerixafor and G-CSF still fail to collect ≥2×10<sup>6</sup> CD34<sup>+</sup> cells/kg in 4 days of apheresis<sup><a href="#ref-134">134</a>,<a href="#ref-135">135</a></sup>. A recent economic analysis determined that reducing apheresis by 1 day can potentially decrease medical costs by $6,600<sup><a href="#ref-137">137</a></sup>. Thus improved/alternative mobilizing agents and strategies are needed.</p><p class="" id=d28331e803>The long-standing view has been that both HSPC expansion and mobilization are necessary for clinically relevant mobilization. In line with this view, mobilization with CXCR4 or VLA4 antagonists alone fails to achieve numbers that would allow their use without G-CSF, despite promising potential in preclinical models<sup><a href="#ref-29">29</a>,<a href="#ref-61">61</a>,<a href="#ref-83">83</a>,<a href="#ref-138">138</a>–<a href="#ref-140">140</a></sup>. Very recent findings by our group and others challenge this notion and suggest that efficient recruitment of long-term, serially repopulating HSCs can be accomplished within minutes<sup><a href="#ref-57">57</a>,<a href="#ref-58">58</a></sup>. Indeed, CXCR4 or VLA4 blockade, when combined with the stimulation of a different chemokine receptor, CXCR2, results in extremely rapid and potent HSC mobilization in mice with a repopulating capacity similar or even superior to G-CSF-recruited HSCs<sup><a href="#ref-57">57</a>,<a href="#ref-58">58</a></sup>. These observations show that major changes in cellular composition or localization are not required for efficient mobilization. They further highlight the existence of different HSC species that, upon disruption of certain adhesive tethers, can egress from the BM very rapidly with kinetics that appear incompatible with a prior requirement for changes in gene expression.</p><p class="" id=d28331e836>The key role of the stromal compartment in G-CSF-induced mobilization has long been appreciated<sup><a href="#ref-124">124</a>,<a href="#ref-129">129</a>,<a href="#ref-141">141</a></sup>. Following activation of their G-CSF receptor, BM monocytes/macrophages, the most prominent hematopoietic component of the BM stroma<sup><a href="#ref-142">142</a>–<a href="#ref-144">144</a></sup>, downregulate several retention molecules, including the major CXCR4 ligand, CXCL12, and several VLA4 ligands by non-hematopoietic stroma, resulting in HSPC egress<sup><a href="#ref-143">143</a>,<a href="#ref-145">145</a>–<a href="#ref-147">147</a></sup>. Absence of the G-CSF receptor on monocytes/macrophages abrogates the G-CSF-induced mobilization response<sup><a href="#ref-143">143</a></sup>, whereas the cytokine oncostatin M is thought to mediate communication between monocytes and non-hematopoietic stroma<sup><a href="#ref-145">145</a>,<a href="#ref-148">148</a></sup>. Interestingly, rapid mobilizing agents in general, and chemokines and chemokine receptor antagonists in particular, are assumed to act on hematopoietic cells directly. Our recent findings challenge this view and suggest a critical contribution of stromal (endothelial) CXCR2 targeting upon rapid HSC mobilization by the combination of the CXCR2 ligand truncated Gro-beta (tGro-β) and a VLA4 antagonist<sup><a href="#ref-57">57</a></sup>. Since CXCR2 is absent from the HSPC surface<sup><a href="#ref-25">25</a>,<a href="#ref-26">26</a></sup>, CXCR2-expressing neutrophils have long been assumed to be the responding cell. Upon stimulation with CXCR2 agonists, neutrophils release proteases that cut adhesive interactions between HSPCs and their niche<sup><a href="#ref-60">60</a>,<a href="#ref-76">76</a>,<a href="#ref-149">149</a>,<a href="#ref-150">150</a></sup>. Yet CXCR2 within stroma was sufficient to induce mobilization with tGro-β and a VLA4 antagonist<sup><a href="#ref-57">57</a></sup>, pointing towards changes in endothelial layer permeability<sup><a href="#ref-151">151</a></sup> as well as crosstalk between endothelia and neutrophils as the “priming” events triggered by CXCR2 activation that boost VLA4 antagonist-induced HSPC egress (<a href="#f2">Figure 2</a>).</p><a name=f2 class=n-a></a><div class="fig panel clearfix"><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/23258/cf4cbc74-bbfe-41af-9412-6843bf2adcd1_figure2.gif"><img alt="cf4cbc74-bbfe-41af-9412-6843bf2adcd1_figure2.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/23258/cf4cbc74-bbfe-41af-9412-6843bf2adcd1_figure2.gif"></a><div class=caption><h3>Figure 2. Mobilization priming effects of CXCR2 stimulation.</h3><p id=d28331e924>Upon activation of the CXCR2 receptor on the surface of neutrophils (NE) and/or endothelial cells (EC), a reciprocal stimulation of the cells occurs that is critical for the subsequent boost of mobilization with a VLA4 or CXCR4 antagonist. Augmented mobilization appears to be a result of increased permeability of the endothelial layer together with other cell contact mediated or soluble factors derived from CXCR2-stimulated cells that reduce hematopoietic stem/progenitor cell (HSPC) retention. Additional inhibition of the VLA4 or CXCR4 receptor results in efficient targeting of the very primitive, serially repopulating HSPCs retained in the bone marrow (BM) primarily via VLA4 or CXCR4 signaling, respectively. The rapid kinetics of CXCR2 agonist + VLA4 or CXCR4 antagonist-induced mobilization preclude major molecular or cellular changes prior to the BM egress and rather suggest a close proximity of the primitive HSPC fraction to the BM sinusoids.</p></div></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d28331e934>Development of alternative HSPC mobilization regimens and grafts</h2><p class="" id=d28331e937>As we continue to learn about the events and mechanisms regulating HSPC egress, we approach the ultimate goal of developing an “optimal” mobilization strategy to collect sufficient numbers of primitive stem cells with superior properties within a day or two. In contrast to the days when clinical observations determined the applicability of a mobilization approach, educated and targeted designs are becoming the basis for the clinical development of mobilizing agents. In addition to the quantity and fitness of the HSPCs, as reflected in their engraftment capacity, the immunogenic properties of the graft (i.e. the graft-versus-host disease [GvHD] profile) are an important feature requiring optimization, potentially at the cost of stem cell numbers. For example, a substantially reduced incidence of GvHD is observed upon transplantation of CXCR4 antagonist-mobilized grafts, possibly due to co-mobilization of a specific population of dendritic cells (DCs) with immunomodulatory properties, plasmacytoid DCs<sup><a href="#ref-140">140</a>,<a href="#ref-152">152</a>,<a href="#ref-153">153</a></sup>. Along the same lines, grafts mobilized with pegylated G-CSF were superior to standard G-CSF in that they were associated with less GvHD<sup><a href="#ref-154">154</a>,<a href="#ref-155">155</a></sup> while graft-versus-leukemia (GvL) effects were improved through mobilization of invariant natural killer T (iNKT) cells<sup><a href="#ref-155">155</a></sup>. Susceptibility of the mobilized HSPCs to further molecular manipulation, e.g. using gene therapy, is another important criterion when defining the “optimal” mobilization strategy. Lastly, if proven to be suitable for mobilized HSPCs, recently described methods for <i>ex vivo</i> expansion of HSCs<sup><a href="#ref-156">156</a></sup> are expected to shift the emphasis on HSPC quality over quantity even further.</p><p class="" id=d28331e968>Studies with CXCR4 and VLA4 antagonists, tested in VLA4 and CXCR4 knockout mice, respectively, implied an independence between the two axes<sup><a href="#ref-139">139</a>,<a href="#ref-157">157</a>,<a href="#ref-158">158</a></sup>. This suggests that subsets of HSPCs are being retained in the BM by either CXCR4 or VLA4. Combined with the knowledge of the complexity and multiplicity of events induced in the course of G-CSF mobilization<sup><a href="#ref-129">129</a>,<a href="#ref-133">133</a></sup>, co-existence of these (and possibly other) functionally distinct HSPC populations suggests combinatorial mobilization approaches as the best alternatives to G-CSF. Thus, the small molecule Me6TREN reportedly inhibits CXCR4 and VLA4 signaling simultaneously, possibly through upregulation of the protease MMP9<sup><a href="#ref-159">159</a></sup>. However, given the controversy regarding the role of MMP9 for mobilization<sup><a href="#ref-128">128</a></sup>, other approaches should be explored. In addition to cell-intrinsic HSPC retention pathways, disruption of endothelial layer integrity, along with the endothelial cell activation and subsequent crosstalk between endothelial and mature hematopoietic cells, should be included in designing “optimal” mobilization. Recent data suggest that Viagra (sildenafil citrate), a phosphodiesterase type 5 (PDE5) inhibitor which blocks the degradation of cyclic GMP in the smooth muscle cells lining blood vessels, resulting in vasodilation, can synergize with plerixafor to rapidly mobilize stem cells in mice<sup><a href="#ref-160">160</a></sup>.</p><p class="" id=d28331e1000>Various techniques for <i>ex vivo</i> graft manipulation (e.g. T cell depletion and CD34 enrichment<sup><a href="#ref-161">161</a>–<a href="#ref-164">164</a></sup>) have been developed that entail extended periods during which the HSPCs stay outside of their natural environment and therefore, unsurprisingly, exhibit reduced stem cell capacity<sup><a href="#ref-165">165</a>,<a href="#ref-166">166</a></sup>. From further in-depth analyses of differentially mobilized blood (see below), we expect to learn not only how to target specific HSPC populations but also how to mobilize HSPCs without a concurrent mobilization of mature cells, T-cells in particular. In general, <i>a priori</i> cell type-specific targeting remains challenging because of the high conservation of migratory and retention pathways between different hematopoietic cell types. Nevertheless, selective HSPC mobilization represents an intriguing goal that would help reduce additional graft manipulation.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d28331e1026>Mobilization beyond stem cell collection</h2><div class=section><a name=d28331e1029 class=n-a></a><h3 class=section-title>Chemosensitization</h3><p class="" id=d28331e1034>In addition to supplying HSPCs with the factors required for their normal development, the BM microenvironment is also a refuge for malignant cells, allowing them to escape cytotoxic therapies and cause disease relapse<sup><a href="#ref-167">167</a>,<a href="#ref-168">168</a></sup>. This provides a rationale for targeting the interactions between tumor cells and the BM, with the goal of sensitizing them to therapy. Pathways responsible for the anchorage and survival of malignant cells and resistance to chemotherapy largely overlap with those of normal HSPCs<sup><a href="#ref-168">168</a>,<a href="#ref-169">169</a></sup>. Accordingly, blockade of CXCR4 and VLA4 signaling and/or G-CSF was tested in conjunction with chemotherapy in pre-clinical models of acute myeloid leukemia (AML<sup><a href="#ref-170">170</a>–<a href="#ref-173">173</a></sup>), acute<sup><a href="#ref-174">174</a>,<a href="#ref-175">175</a></sup> and chronic<sup><a href="#ref-176">176</a></sup> lymphoid leukemia, and MM<sup><a href="#ref-177">177</a></sup>. Moreover, the FDA-approved CXCR4 antagonist plerixafor has been tested as a chemosensitizing agent alone and in combination with G-CSF in patients with relapsed AML<sup><a href="#ref-178">178</a>,<a href="#ref-179">179</a></sup>. While the mobilizing capacity varied substantially, an overall benefit from adding mobilizing agent(s) to chemotherapy has been reported, prolonging survival and decreasing tumor burden<sup><a href="#ref-170">170</a>,<a href="#ref-172">172</a>,<a href="#ref-177">177</a>,<a href="#ref-180">180</a></sup> or even eradicating disease<sup><a href="#ref-175">175</a></sup>. The benefits of this approach in AML and other hematologic malignancies, in spite of these preclinical as well as early clinical studies, remain both unclear and controversial.</p></div><div class=section><a name=d28331e1099 class=n-a></a><h3 class=section-title>Conditioning</h3><p class="" id=d28331e1104>As HSPCs are pharmacologically driven from the BM into circulation, the temporarily unoccupied spaces (niches) in theory become available to new cells, e.g. the HSPCs introduced into a mobilized recipient during transplantation. The utility of mobilization for non-cytotoxic and on-target conditioning prior to HSCT is supported by the fact that mobilized cells return to the BM after spending some time in peripheral circulation, as shown in studies of parabiotic mice<sup><a href="#ref-181">181</a></sup>. Yet virtually all attempts at mobilization alone for conditioning of an adult host before HSCT have been unsuccessful (Karpova and Rettig, unpublished data). It is unclear whether the reason is that the cells introduced exogenously are inherently disadvantaged (less fit?) compared with endogenously circulating HSPCs or whether the mobilizing agent interferes with the repopulating capacity of the transplanted cells. An intriguing alternative explanation is that owing to targeting/recruitment of a specific population during the mobilization process, and by extension because of emptying of very specific niches, only HSPCs mobilized with the same mobilizing regimen are able to engraft BM niches that become available. Interestingly, since BM- or fetal liver-derived HSPCs have been used to engraft mobilized recipients (Karpova and Rettig, unpublished data), the possibility that a qualitative rather than quantitative approach might lead to successful, persistent engraftment is untested. Given recent reports of successful conditioning using antibody–drug conjugates targeting the pan leukocyte marker CD45<sup><a href="#ref-182">182</a></sup> and the CD117-targeting antibodies<sup><a href="#ref-183">183</a>–<a href="#ref-185">185</a></sup>, or a cocktail of monoclonal antibodies depleting CD47-expressing cells along with T cells, NK cells, and HSPCs<sup><a href="#ref-186">186</a></sup>, mobilization-based conditioning may not be a promising approach in postnatal recipients. However, fetal HSPC mobilization with a VLA4 antagonist followed by <i>in utero</i> HSCT results in increased donor HSC homing to the fetal liver and enhanced long-term allogeneic engraftment in mice<sup><a href="#ref-187">187</a></sup>. Therefore, mobilization-based conditioning regimens might be applicable for <i>in utero</i> HSCT.</p></div><div class=section><a name=d28331e1138 class=n-a></a><h3 class=section-title>Gene therapy</h3><p class="" id=d28331e1143>Manipulating HSCs to correct mutations that cause inherited diseases of the hematopoietic system such as sickle cell anemia and beta-thalassemia represents a potential cure, with recent advances in gene therapeutic approaches (CRISPR-Cas9, TALEN, and ZFN)<sup><a href="#ref-188">188</a>–<a href="#ref-193">193</a></sup> allowing sustainable correction of the genetic defects. Autologous HSCT is the method of choice in this setting, whereby instead of extracting HSCs for subsequent <i>ex vivo</i> manipulation, stem cells are mobilized into the circulation and subjected to gene therapy <i>in situ</i><sup><a href="#ref-194">194</a>–<a href="#ref-196">196</a></sup>. As discussed above, HSC collection and <i>ex vivo</i> editing inevitably leads to a diminished stem cell capacity, which can be avoided by editing the cells in the peripheral blood. Proof of principle for mobilization-based gene therapy was reported following mobilization with G-CSF plus a CXCR4 antagonist, with sustained expression of the introduced transgene over a period of 5 months<sup><a href="#ref-196">196</a></sup>. We believe this approach should be developed further, e.g. by using it in combination with mobilization strategies to preferentially recruit stem cells with superior repopulating capacity into the circulation. In addition, these cells may be more susceptible to therapeutic gene editing. Apart from its obvious therapeutic benefit, this approach might become useful for studying functional differences between HSCs that have been mobilized into the circulation and returned to the BM and HSCs that remain in the BM niche.</p></div><div class=section><a name=d28331e1173 class=n-a></a><h3 class=section-title>Biology of the hematopoietic niche</h3><p class="" id=d28331e1178>The discovery of compounds and pathways that enable HSPC displacement from the niche has provided important insights into the regulation of HSPC trafficking and maintenance. For example, detailed analysis of the mechanisms underlying G-CSF-induced mobilization was indispensable for establishing monocytes/macrophages as crucial components of the BM niche and understanding their crosstalk with the non-hematopoietic stroma<sup><a href="#ref-143">143</a>,<a href="#ref-145">145</a>–<a href="#ref-147">147</a></sup>. More recent studies demonstrated that bone marrow dendritic cells regulate endothelial cell function in part through CXCR2 signaling, resulting in HSPC mobilization and loss of bone marrow macrophages<sup><a href="#ref-151">151</a></sup>. Similarly, studies with the CXCR2 ligand tGro-β disclosed the role of another mature leukocyte population, neutrophils, in HSPC trafficking<sup><a href="#ref-57">57</a>,<a href="#ref-58">58</a>,<a href="#ref-76">76</a></sup>. Together with the observation that the circadian release of HSPCs into the circulation is synchronized by daily return of aged neutrophils from the circulation into the BM<sup><a href="#ref-197">197</a></sup>, these findings implicate neutrophils as critical mediators of HSPC localization at steady state and upon enforced egress. On the molecular level, the recognition that all physiological, pathological, and pharmacological mobilization stimuli described to date interfere with VLA4 or CXCR4 signaling or both (<a href="#f1">Figure 1</a>) highlights the key roles of these two pathways in HSPC trafficking.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d28331e1216>Open questions and future directions</h2><div class=section><a name=d28331e1219 class=n-a></a><h3 class=section-title>Homeostatic HSPC trafficking</h3><p class="" id=d28331e1224>The physiological function and regulation of daily HSPC egress remain elusive. We know that, similar to their mature counterparts, the release of HSPCs from the BM follows a circadian rhythm<sup><a href="#ref-11">11</a>,<a href="#ref-94">94</a>,<a href="#ref-198">198</a></sup>, with sympathetic nervous system-derived adrenergic signals acting through beta(3)-adrenergic receptors on BM stroma to downregulate CXCL12 signaling (and therefore retention<sup><a href="#ref-10">10</a>,<a href="#ref-11">11</a></sup>). While we understand the purpose of migration of more differentiated hematopoietic cells out of the BM to undergo maturation, encounter antigens, proliferate, etc., the role(s) of HSPCs found in blood and other peripheral tissues is speculative. Exchange between different parts of the hematopoietic system has been suggested to be mediated by homeostatic HSPC migration<sup><a href="#ref-7">7</a>,<a href="#ref-133">133</a></sup> and is supported by observations from parabiotic<sup><a href="#ref-9">9</a>,<a href="#ref-199">199</a>,<a href="#ref-200">200</a></sup> as well as partially irradiated<sup><a href="#ref-201">201</a>,<a href="#ref-202">202</a></sup> mice. An alternative explanation implies a possible immune surveillance function of HSPCs that have also been found in the lymphoid system<sup><a href="#ref-203">203</a></sup> and non-hematopoietic tissues with crucial immune functions such as the intestine<sup><a href="#ref-204">204</a></sup>. Furthermore, expression of MHC class II molecules, otherwise restricted to professional antigen-presenting cells, has been detected in HSPCs<sup><a href="#ref-205">205</a>,<a href="#ref-206">206</a></sup>.</p></div><div class=section><a name=d28331e1285 class=n-a></a><h3 class=section-title>Prediction of HSPC mobilization success and failure</h3><p class="" id=d28331e1290>With regard to inadequate HSPC mobilization, one must distinguish between disease- and/or treatment-associated failure and failure of G-CSF mobilization in healthy donors. Of note, less than 1% of “healthy allogeneic donors” fail to collect an optimal (5×10<sup>6</sup> CD34/kg) or minimal (2×10<sup>6</sup> CD34/kg) amount of CD34<sup>+</sup> cells after a standard 4–5-day regimen of G-CSF mobilization<sup><a href="#ref-133">133</a></sup>. This relatively uncommon event may represent the extreme heterogeneity of HSPC mobilization seen among the general population with no known medical conditions or prior exposure to chemotherapy or radiation. Thus, CD34 counts between 5 and 500 cells per µl blood have been reported<sup><a href="#ref-121">121</a></sup>. The general consensus, derived from studies of poor- and well-mobilizing mouse strains<sup><a href="#ref-207">207</a>,<a href="#ref-208">208</a></sup>, as well as repetitive mobilization of healthy donors<sup><a href="#ref-121">121</a>,<a href="#ref-209">209</a></sup>, is that genetic factors determine the mobilization response in healthy individuals. However, single nucleotide polymorphisms in any of the obvious candidate genes (including CXCL12<sup><a href="#ref-210">210</a></sup>, VCAM1<sup><a href="#ref-211">211</a>,<a href="#ref-212">212</a></sup>, and CD44<sup><a href="#ref-212">212</a>,<a href="#ref-213">213</a></sup>) do not correlate with mobilization efficacy in response to G-CSF or plerixafor in larger population studies<sup><a href="#ref-133">133</a>,<a href="#ref-214">214</a>,<a href="#ref-215">215</a></sup>. Knowledge of high or low HSPC mobilization potential could be translated into donor screening prior to mobilization to help predict response and potentially to guide the best mobilization strategy.</p><p class="" id=d28331e1353>The probability of mobilization failure in patients directly correlates with the amount and extent of prior cytotoxic exposure<sup><a href="#ref-216">216</a>–<a href="#ref-218">218</a></sup>. Other clinical and demographic features of normal donors and patients undergoing autologous stem cell mobilization that predict poor mobilization include age<sup><a href="#ref-217">217</a>,<a href="#ref-219">219</a></sup>, resting platelet counts<sup><a href="#ref-217">217</a>,<a href="#ref-220">220</a></sup>, and a history of diabetes mellitus<sup><a href="#ref-221">221</a></sup>. Failure rates have decreased since the CXCR4 antagonist plerixafor was approved for the mobilization of HSPCs for MM and non-Hodgkin lymphoma patients when given in conjunction with G-CSF<sup><a href="#ref-133">133</a>–<a href="#ref-135">135</a></sup>. However, given that the diminished mobilization response results from the substantially reduced HSPC pool in these patients<sup><a href="#ref-222">222</a></sup>, approaches that both potently expand HSPCs and induce their egress into the circulation are needed. We recently reported that the administration of CXCR4 antagonists to mice by subcutaneous continuous infusion for 1–4 weeks induces a robust mobilization response that significantly exceeds the mobilization achieved with bolus drug injections and was 25–50-fold greater than a 5-day course of G-CSF<sup><a href="#ref-158">158</a></sup>. Moreover, continuous infusion of CXCR4 inhibitors leads to a two- to four-fold expansion of the HSPC pool in the bone marrow that exhibits a distinct repopulating advantage when tested in serial competitive transplantation experiments. Similarly, others have shown that the FMS-like tyrosine kinase 3 ligand (Flt3L) stimulates the expansion and mobilization of HSPCs in animals and humans<sup><a href="#ref-223">223</a>–<a href="#ref-225">225</a></sup>.</p></div><div class=section><a name=d28331e1405 class=n-a></a><h3 class=section-title>Profiling of differentially mobilized blood</h3><p class="" id=d28331e1410>Gene expression profiling of the HSPC populations mobilized with different agents has been performed, mostly using microarrays<sup><a href="#ref-57">57</a>,<a href="#ref-226">226</a></sup>. Not unexpectedly, increased relative expression of genes involved in lymphoid development were detected in grafts mobilized with a CXCR4 antagonist alone and in conjunction with G-CSF as compared to G-CSF alone<sup><a href="#ref-226">226</a></sup>. A closer similarity between BM-resident and CXCR4 antagonist-mobilized HPSCs as compared to BM-resident versus G-CSF-mobilized HSPCs had been proposed to be due to the fast kinetics of CXCR4 antagonist-induced mobilization. However, the opposite was detected when comparing the three, with BM-resident HSPCs showing a profile much closer to that of G-CSF-mobilized HSPCs<sup><a href="#ref-57">57</a></sup>. It would appear from these studies that CXCR4 disruption recruits a specific rather than representative fraction of the BM HSPCs. By contrast, VLA4 antagonist + tGro-β-mobilized HSPCs have a profile very similar to that of BM-resident as well as G-CSF-mobilized HSPCs, indicating that rapid kinetics of mobilization can indeed be associated with an HSPC profile closely related to BM-resident HSPCs<sup><a href="#ref-57">57</a></sup>.</p><p class="" id=d28331e1432>Single cell RNA sequencing (scRNA-seq) is currently revolutionizing the field of hematopoietic cancer research by defining the heterogeneity of malignant cells and the supporting network of non-malignant cells<sup><a href="#ref-227">227</a>–<a href="#ref-230">230</a></sup>. Naturally, scRNA-seq analysis and comparison of differentially mobilized HSPCs will provide key insights and may strengthen the notion that they are comprised of different HSPC subsets rather than representing a homogenous population with an overall altered expression profile depending on the agent used. Moreover, we anticipate that concurrent analysis of peripheral blood and BM HSPC compartments will shed new light on the unique identity and specific origin of mobilized cells that respond to specific mobilizing agents. In general, single cell characterization of mobilized blood/HSPCs is expected to be particularly informative with rapid-mobilizing agents, where the kinetics of the cell recruitment would not allow for major changes of the cell identity or localization prior to BM egress.</p><p class="" id=d28331e1442>Interestingly, despite the more elaborate isolation process for non-hematopoietic as opposed to hematopoietic cells, a detailed characterization of the stromal populations using single cell approaches has been published already<sup><a href="#ref-231">231</a>–<a href="#ref-233">233</a></sup>. However, the contribution of the newly identified populations to HSPC retention remains unexplored. Ultimately, simultaneous analysis of stroma and HSPCs based on their proximity using spatial transcriptomics promises to reveal potentially unique relationships between certain stromal and hematopoietic cell types and thereby define the biological roles of the long-argued diversity within the hematopoietic niche.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d28331e1457>Summary</h2><p class="" id=d28331e1460>Pharmacologically induced egress of HSPCs from the BM has become an indispensable tool in HSCT with all autologous and over 80% of allogeneic transplants performed with mobilized blood. Mechanistic insights gained from studying the complex chain of events induced during mobilization with G-CSF have paved the way for the rational design of alternative mobilization approaches without the inherent shortcomings of G-CSF such as slow mode of action and side effects. Similar to the recruitment of healthy HSPCs into the circulation, targeting of various BM retention pathways has been explored as a means to sensitize leukemic cells and thereby improve the efficacy of chemotherapy. Moreover, mobilization of HSPCs as a non-cytotoxic conditioning strategy as well as for gene therapy represents two other applications of mobilization beyond mere collection of a stem cell graft. Understanding the physiological function of homeostatic HSPC trafficking and identifying the genetic determinants of mobilization efficiency, along with characterizing the differentially mobilized HSPC populations on a single cell level, represent some of the directions of future mobilization research.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d28331e1467 class=n-a></a><h2 class=main-title id=d28331e1469>Acknowledgements</h2><p class="" id=d28331e1472>We kindly thank Joel Eissenberg (St Louis University School of Medicine) and Elisa Donato (German Cancer Research Center [DKFZ] and DKFZ-ZMBH Alliance) for critical revision of the manuscript, helpful comments, and discussion. DK is a past scholar of the German Academic Exchange Service (postdoctoral fellowship ID: 57054578, 2014–2016).</p></div><div class=back-section><a name=d28331e1476 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d29776>References</h2><div class="section ref-list"><a name=d28331e1476 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d28331e1483 class=n-a></a>Richman CM, Weiner RS, Yankee RA: Increase in circulating stem cells following chemotherapy in man. <i>Blood.</i> 1976; <b>47</b>(6): 1031–9. <a target=xrefwindow id=d28331e1491 href="http://www.ncbi.nlm.nih.gov/pubmed/1276467">PubMed Abstract </a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d28331e1500 class=n-a></a>Henig I, Zuckerman T: Hematopoietic stem cell transplantation-50 years of evolution and future perspectives. <i>Rambam Maimonides Med J.</i> 2014; <b>5</b>(4): e0028. <a target=xrefwindow id=d28331e1508 href="http://www.ncbi.nlm.nih.gov/pubmed/25386344">PubMed Abstract </a> | <a target=xrefwindow id=d28331e1511 href="https://doi.org/10.5041/RMMJ.10162">Publisher Full Text </a> | <a target=xrefwindow id=d28331e1514 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4222417">Free Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d28331e1523 class=n-a></a>Burns CE, Zon LI: Homing sweet homing: odyssey of hematopoietic stem cells. <i>Immunity.</i> 2006; <b>25</b>(6): 859–62. <a target=xrefwindow id=d28331e1531 href="http://www.ncbi.nlm.nih.gov/pubmed/17174927">PubMed Abstract </a> | <a target=xrefwindow id=d28331e1534 href="https://doi.org/10.1016/j.immuni.2006.11.006">Publisher Full Text </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d28331e1543 class=n-a></a>Medvinsky A, Rybtsov S, Taoudi S: Embryonic origin of the adult hematopoietic system: advances and questions. <i>Development.</i> 2011; <b>138</b>(6): 1017–31. <a target=xrefwindow id=d28331e1551 href="http://www.ncbi.nlm.nih.gov/pubmed/21343360">PubMed Abstract </a> | <a target=xrefwindow id=d28331e1554 href="https://doi.org/10.1242/dev.040998">Publisher Full Text </a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d28331e1563 class=n-a></a>Lo Celso C, Scadden DT: The haematopoietic stem cell niche at a glance. <i>J Cell Sci.</i> 2011; <b>124</b>(Pt 21): 3529–35. <a target=xrefwindow id=d28331e1571 href="http://www.ncbi.nlm.nih.gov/pubmed/22083139">PubMed Abstract </a> | <a target=xrefwindow id=d28331e1574 href="https://doi.org/10.1242/jcs.074112">Publisher Full Text </a> | <a target=xrefwindow id=d28331e1577 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3215569">Free Full Text </a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d28331e1587 class=n-a></a>Schofield R: The relationship between the spleen colony-forming cell and the haemopoietic stem cell. <i>Blood Cells.</i> 1978; <b>4</b>(1–2): 7–25. <a target=xrefwindow id=d28331e1595 href="http://www.ncbi.nlm.nih.gov/pubmed/747780">PubMed Abstract </a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d28331e1604 class=n-a></a>Wright DE, Wagers AJ, Gulati AP, <i> et al.</i>: Physiological migration of hematopoietic stem and progenitor cells. <i>Science.</i> 2001; <b>294</b>(5548): 1933–6. <a target=xrefwindow id=d28331e1615 href="http://www.ncbi.nlm.nih.gov/pubmed/11729320">PubMed Abstract </a> | <a target=xrefwindow id=d28331e1618 href="https://doi.org/10.1126/science.1064081">Publisher Full Text </a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d28331e1627 class=n-a></a>Goodman JW, Hodgson GS: Evidence for stem cells in the peripheral blood of mice. <i>Blood.</i> 1962; <b>19</b>(6): 702–14. <a target=xrefwindow id=d28331e1635 href="http://www.ncbi.nlm.nih.gov/pubmed/13900318">PubMed Abstract </a> | <a target=xrefwindow id=d28331e1638 href="https://doi.org/10.1182/blood.V19.6.702.702%0A">Publisher Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d28331e1647 class=n-a></a>Abkowitz JL, Robinson AE, Kale S, <i> et al.</i>: Mobilization of hematopoietic stem cells during homeostasis and after cytokine exposure. <i>Blood.</i> 2003; <b>102</b>(4): 1249–53. <a target=xrefwindow id=d28331e1658 href="http://www.ncbi.nlm.nih.gov/pubmed/12714498">PubMed Abstract </a> | <a target=xrefwindow id=d28331e1661 href="https://doi.org/10.1182/blood-2003-01-0318">Publisher Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d28331e1670 class=n-a></a>Méndez-Ferrer S, Chow A, Merad M, <i> et al.</i>: Circadian rhythms influence hematopoietic stem cells. <i>Curr Opin Hematol.</i> 2009; <b>16</b>(4): 235–42. <a target=xrefwindow id=d28331e1681 href="http://www.ncbi.nlm.nih.gov/pubmed/19417648">PubMed Abstract </a> | <a target=xrefwindow id=d28331e1684 href="https://doi.org/10.1097/MOH.0b013e32832bd0f5">Publisher Full Text </a> | <a target=xrefwindow id=d28331e1688 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4117204">Free Full Text </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1102317"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28331e1697 class=n-a></a>Méndez-Ferrer S, Lucas D, Battista M, <i> et al.</i>: Haematopoietic stem cell release is regulated by circadian oscillations. <i>Nature.</i> 2008; <b>452</b>(7186): 442–7. <a target=xrefwindow id=d28331e1708 href="http://www.ncbi.nlm.nih.gov/pubmed/18256599">PubMed Abstract </a> | <a target=xrefwindow id=d28331e1711 href="https://doi.org/10.1038/nature06685">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1102317">F1000 Recommendation</a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717955333"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28331e1725 class=n-a></a>Scheiermann C, Kunisaki Y, Lucas D, <i> et al.</i>: Adrenergic nerves govern circadian leukocyte recruitment to tissues. <i>Immunity.</i> 2012; <b>37</b>(2): 290–301. <a target=xrefwindow id=d28331e1736 href="http://www.ncbi.nlm.nih.gov/pubmed/22863835">PubMed Abstract </a> | <a target=xrefwindow id=d28331e1739 href="https://doi.org/10.1016/j.immuni.2012.05.021">Publisher Full Text </a> | <a target=xrefwindow id=d28331e1743 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3428436">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717955333">F1000 Recommendation</a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a name=d28331e1756 class=n-a></a>Briddell RA, Hartley CA, Smith KA, <i> et al.</i>: Recombinant rat stem cell factor synergizes with recombinant human granulocyte colony-stimulating factor <i>in vivo</i> in mice to mobilize peripheral blood progenitor cells that have enhanced repopulating potential. <i>Blood.</i> 1993; <b>82</b>(6): 1720–3. <a target=xrefwindow id=d28331e1770 href="http://www.ncbi.nlm.nih.gov/pubmed/7691233">PubMed Abstract </a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a name=d28331e1779 class=n-a></a>McNiece IK, Briddell RA, Yan XQ, <i> et al.</i>: The role of stem cell factor in mobilization of peripheral blood progenitor cells. <i>Leuk Lymphoma.</i> 1994; <b>15</b>(5–6): 405–9. <a target=xrefwindow id=d28331e1790 href="http://www.ncbi.nlm.nih.gov/pubmed/7533017">PubMed Abstract </a> | <a target=xrefwindow id=d28331e1793 href="https://doi.org/10.3109/10428199409049743">Publisher Full Text </a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d28331e1802 class=n-a></a>Vadhan-Raj S, Murray LJ, Bueso-Ramos C, <i> et al.</i>: Stimulation of megakaryocyte and platelet production by a single dose of recombinant human thrombopoietin in patients with cancer. <i>Ann Intern Med.</i> 1997; <b>126</b>(9): 673–81. <a target=xrefwindow id=d28331e1813 href="http://www.ncbi.nlm.nih.gov/pubmed/9139552">PubMed Abstract </a> | <a target=xrefwindow id=d28331e1816 href="https://doi.org/10.7326/0003-4819-126-9-199705010-00001">Publisher Full Text </a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d28331e1825 class=n-a></a>Murray LJ, Luens KM, Estrada MF, <i> et al.</i>: Thrombopoietin mobilizes CD34+ cell subsets into peripheral blood and expands multilineage progenitors in bone marrow of cancer patients with normal hematopoiesis. <i>Exp Hematol.</i> 1998; <b>26</b>(3): 207–16. <a target=xrefwindow id=d28331e1836 href="http://www.ncbi.nlm.nih.gov/pubmed/9502616">PubMed Abstract </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a name=d28331e1845 class=n-a></a>Nervi B, Link DC, Dipersio JF: Cytokines and hematopoietic stem cell mobilization. <i>J Cell Biochem.</i> 2006; <b>99</b>(3): 690–705. <a target=xrefwindow id=d28331e1853 href="http://www.ncbi.nlm.nih.gov/pubmed/16888804">PubMed Abstract </a> | <a target=xrefwindow id=d28331e1856 href="https://doi.org/10.1002/jcb.21043">Publisher Full Text </a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d28331e1866 class=n-a></a>Morstyn G, Brown S, Gordon M, <i> et al.</i>: Stem cell factor is a potent synergistic factor in hematopoiesis. <i>Oncology.</i> 1994; <b>51</b>(2): 205–14. <a target=xrefwindow id=d28331e1877 href="http://www.ncbi.nlm.nih.gov/pubmed/7515171">PubMed Abstract </a> | <a target=xrefwindow id=d28331e1880 href="https://doi.org/10.1159/000227335">Publisher Full Text </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d28331e1889 class=n-a></a>Matsunaga T, Sakamaki S, Kohgo Y, <i> et al.</i>: Recombinant human granulocyte colony-stimulating factor can mobilize sufficient amounts of peripheral blood stem cells in healthy volunteers for allogeneic transplantation. <i>Bone Marrow Transplant.</i> 1993; <b>11</b>(2): 103–8. <a target=xrefwindow id=d28331e1900 href="http://www.ncbi.nlm.nih.gov/pubmed/7679596">PubMed Abstract </a> | <a target=xrefwindow id=d28331e1903 href="https://doi.org/10.11501/3101317">Publisher Full Text </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d28331e1912 class=n-a></a>Mayer P, Lam C, Obenaus H, <i> et al.</i>: Recombinant human GM-CSF induces leukocytosis and activates peripheral blood polymorphonuclear neutrophils in nonhuman primates. <i>Blood.</i> 1987; <b>70</b>(1): 206–13. <a target=xrefwindow id=d28331e1923 href="http://www.ncbi.nlm.nih.gov/pubmed/3496133">PubMed Abstract </a> | <a target=xrefwindow id=d28331e1926 href="https://doi.org/10.1182/blood.V70.1.206.206%0A">Publisher Full Text </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d28331e1935 class=n-a></a>To LB, Haylock DN, Kimber RJ, <i> et al.</i>: High levels of circulating haemopoietic stem cells in very early remission from acute non-lymphoblastic leukaemia and their collection and cryopreservation. <i>Br J Haematol.</i> 1984; <b>58</b>(3): 399–410. <a target=xrefwindow id=d28331e1946 href="http://www.ncbi.nlm.nih.gov/pubmed/6498099">PubMed Abstract </a> | <a target=xrefwindow id=d28331e1949 href="https://doi.org/10.1111/j.1365-2141.1984.tb03987.x">Publisher Full Text </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a name=d28331e1958 class=n-a></a>Stiff PJ, Murgo AJ, Wittes RE, <i> et al.</i>: Quantification of the peripheral blood colony forming unit-culture rise following chemotherapy. Could leukocytaphereses replace bone marrow for autologous transplantation? <i>Transfusion.</i> 1983; <b>23</b>(6): 500–3. <a target=xrefwindow id=d28331e1969 href="http://www.ncbi.nlm.nih.gov/pubmed/6316590">PubMed Abstract </a> | <a target=xrefwindow id=d28331e1972 href="https://doi.org/10.1046/j.1537-2995.1983.23684074271.x">Publisher Full Text </a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d28331e1981 class=n-a></a>To LB, Davy ML, Haylock DN, <i> et al.</i>: Autotransplantation using peripheral blood stem cells mobilized by cyclophosphamide. <i>Bone Marrow Transplant.</i> 1989; <b>4</b>(5): 595–6. <a target=xrefwindow id=d28331e1992 href="http://www.ncbi.nlm.nih.gov/pubmed/2571378">PubMed Abstract </a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d28331e2002 class=n-a></a>Laterveer L, Lindley IJ, Heemskerk DP, <i> et al.</i>: Rapid mobilization of hematopoietic progenitor cells in rhesus monkeys by a single intravenous injection of interleukin-8. <i>Blood.</i> 1996; <b>87</b>(2): 781–8. <a target=xrefwindow id=d28331e2013 href="http://www.ncbi.nlm.nih.gov/pubmed/8555503">PubMed Abstract </a> | <a target=xrefwindow id=d28331e2016 href="https://doi.org/10.1182/blood.V87.2.781.bloodjournal872781">Publisher Full Text </a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a name=d28331e2025 class=n-a></a>Laterveer L, Lindley IJ, Hamilton MS, <i> et al.</i>: Interleukin-8 induces rapid mobilization of hematopoietic stem cells with radioprotective capacity and long-term myelolymphoid repopulating ability. <i>Blood.</i> 1995; <b>85</b>(8): 2269–75. <a target=xrefwindow id=d28331e2036 href="http://www.ncbi.nlm.nih.gov/pubmed/7718900">PubMed Abstract </a> | <a target=xrefwindow id=d28331e2039 href="https://doi.org/10.1182/blood.V85.8.2269.bloodjournal8582269">Publisher Full Text </a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a name=d28331e2048 class=n-a></a>Fukuda S, Bian H, King AG, <i> et al.</i>: The chemokine GRObeta mobilizes early hematopoietic stem cells characterized by enhanced homing and engraftment. <i>Blood.</i> 2007; <b>110</b>(3): 860–9. <a target=xrefwindow id=d28331e2059 href="http://www.ncbi.nlm.nih.gov/pubmed/17416737">PubMed Abstract </a> | <a target=xrefwindow id=d28331e2062 href="https://doi.org/10.1182/blood-2006-06-031401">Publisher Full Text </a> | <a target=xrefwindow id=d28331e2066 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1924764">Free Full Text </a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a name=d28331e2075 class=n-a></a>Pelus LM, Bian H, Fukuda S, <i> et al.</i>: The CXCR4 agonist peptide, CTCE-0021, rapidly mobilizes polymorphonuclear neutrophils and hematopoietic progenitor cells into peripheral blood and synergizes with granulocyte colony-stimulating factor. <i>Exp Hematol.</i> 2005; <b>33</b>(3): 295–307. <a target=xrefwindow id=d28331e2086 href="http://www.ncbi.nlm.nih.gov/pubmed/15730853">PubMed Abstract </a> | <a target=xrefwindow id=d28331e2089 href="https://doi.org/10.1016/j.exphem.2004.11.008">Publisher Full Text </a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a name=d28331e2098 class=n-a></a>Bonig H, Watts KL, Chang KH, <i> et al.</i>: Concurrent blockade of alpha4-integrin and CXCR4 in hematopoietic stem/progenitor cell mobilization. <i>Stem Cells.</i> 2009; <b>27</b>(4): 836–7. <a target=xrefwindow id=d28331e2109 href="http://www.ncbi.nlm.nih.gov/pubmed/19350684">PubMed Abstract </a> | <a target=xrefwindow id=d28331e2112 href="https://doi.org/10.1002/stem.9">Publisher Full Text </a> | <a target=xrefwindow id=d28331e2116 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2892056">Free Full Text </a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a name=d28331e2125 class=n-a></a>Ramirez P, Rettig MP, Uy GL, <i> et al.</i>: BIO5192, a small molecule inhibitor of VLA-4, mobilizes hematopoietic stem and progenitor cells. <i>Blood.</i> 2009; <b>114</b>(7): 1340–3. <a target=xrefwindow id=d28331e2136 href="http://www.ncbi.nlm.nih.gov/pubmed/19571319">PubMed Abstract </a> | <a target=xrefwindow id=d28331e2139 href="https://doi.org/10.1182/blood-2008-10-184721">Publisher Full Text </a> | <a target=xrefwindow id=d28331e2143 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2727418">Free Full Text </a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a name=d28331e2153 class=n-a></a>Papayannopoulou T, Nakamoto B: Peripheralization of hemopoietic progenitors in primates treated with anti-VLA4 integrin. <i>Proc Natl Acad Sci U S A.</i> 1993; <b>90</b>(20): 9374–8. <a target=xrefwindow id=d28331e2161 href="http://www.ncbi.nlm.nih.gov/pubmed/7692447">PubMed Abstract </a> | <a target=xrefwindow id=d28331e2164 href="https://doi.org/10.1073/pnas.90.20.9374">Publisher Full Text </a> | <a target=xrefwindow id=d28331e2167 href="http://www.ncbi.nlm.nih.gov/pmc/articles/47570">Free Full Text </a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a name=d28331e2176 class=n-a></a>Craddock CF, Nakamoto B, Andrews RG, <i> et al.</i>: Antibodies to VLA4 integrin mobilize long-term repopulating cells and augment cytokine-induced mobilization in primates and mice. <i>Blood.</i> 1997; <b>90</b>(12): 4779–88. <a target=xrefwindow id=d28331e2187 href="http://www.ncbi.nlm.nih.gov/pubmed/9389694">PubMed Abstract </a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a name=d28331e2196 class=n-a></a>Juarez JG, Harun N, Thien M, <i> et al.</i>: Sphingosine-1-phosphate facilitates trafficking of hematopoietic stem cells and their mobilization by CXCR4 antagonists in mice. <i>Blood.</i> 2012; <b>119</b>(3): 707–16. <a target=xrefwindow id=d28331e2207 href="http://www.ncbi.nlm.nih.gov/pubmed/22049516">PubMed Abstract </a> | <a target=xrefwindow id=d28331e2210 href="https://doi.org/10.1182/blood-2011-04-348904">Publisher Full Text </a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727147298"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28331e2219 class=n-a></a>Ogle ME, Olingy CE, Awojoodu AO, <i> et al.</i>: Sphingosine-1-Phosphate Receptor-3 Supports Hematopoietic Stem and Progenitor Cell Residence Within the Bone Marrow Niche. <i>Stem Cells.</i> 2017; <b>35</b>(4): 1040–52. <a target=xrefwindow id=d28331e2230 href="http://www.ncbi.nlm.nih.gov/pubmed/28026131">PubMed Abstract </a> | <a target=xrefwindow id=d28331e2233 href="https://doi.org/10.1002/stem.2556">Publisher Full Text </a> | <a target=xrefwindow id=d28331e2237 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5367957">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727147298">F1000 Recommendation</a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a name=d28331e2250 class=n-a></a>Zaldivar F, Eliakim A, Radom-Aizik S, <i> et al.</i>: The effect of brief exercise on circulating CD34<sup>+</sup> stem cells in early and late pubertal boys. <i>Pediatr Res.</i> 2007; <b>61</b>(4): 491–5. <a target=xrefwindow id=d28331e2264 href="http://www.ncbi.nlm.nih.gov/pubmed/17515877">PubMed Abstract </a> | <a target=xrefwindow id=d28331e2268 href="https://doi.org/10.1203/pdr.0b013e3180332d36">Publisher Full Text </a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a name=d28331e2277 class=n-a></a>Barrett AJ, Longhurst P, Sneath P, <i> et al.</i>: Mobilization of CFU-C by exercise and ACTH induced stress in man. <i>Exp Hematol.</i> 1978; <b>6</b>(7): 590–4. <a target=xrefwindow id=d28331e2288 href="http://www.ncbi.nlm.nih.gov/pubmed/211045">PubMed Abstract </a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d28331e2298 class=n-a></a>Cline MJ, Golde DW: Mobilization of hematopoietic stem cells (CFU-C) into the peripheral blood of man by endotoxin. <i>Exp Hematol.</i> 1977; <b>5</b>(3): 186–90. <a target=xrefwindow id=d28331e2306 href="http://www.ncbi.nlm.nih.gov/pubmed/872907">PubMed Abstract </a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d28331e2315 class=n-a></a>Benner R, Rijnbeek AM, Molendijk W, <i> et al.</i>: Genetic control of lipopolysaccharide-induced mobilization of CFUs. Dissociation between early and delayed mobilization of CFUs in complement C5-deficient mice and LPS non-responder mice. <i>Cell Tissue Kinet.</i> 1981; <b>14</b>(2): 143–51. <a target=xrefwindow id=d28331e2326 href="http://www.ncbi.nlm.nih.gov/pubmed/7471163">PubMed Abstract </a> | <a target=xrefwindow id=d28331e2329 href="https://doi.org/10.1111/j.1365-2184.1981.tb00519.x">Publisher Full Text </a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a name=d28331e2338 class=n-a></a>Welte K, Bonilla MA, Gillio AP, <i> et al.</i>: Recombinant human granulocyte colony-stimulating factor. Effects on hematopoiesis in normal and cyclophosphamide-treated primates. <i>J Exp Med.</i> 1987; <b>165</b>(4): 941–8. <a target=xrefwindow id=d28331e2349 href="http://www.ncbi.nlm.nih.gov/pubmed/3494094">PubMed Abstract </a> | <a target=xrefwindow id=d28331e2352 href="https://doi.org/10.1084/jem.165.4.941">Publisher Full Text </a> | <a target=xrefwindow id=d28331e2356 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2188574">Free Full Text </a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d28331e2365 class=n-a></a>Nakamura Y, Tajima F, Ishiga K, <i> et al.</i>: Soluble c-kit receptor mobilizes hematopoietic stem cells to peripheral blood in mice. <i>Exp Hematol.</i> 2004; <b>32</b>(4): 390–6. <a target=xrefwindow id=d28331e2376 href="http://www.ncbi.nlm.nih.gov/pubmed/15050750">PubMed Abstract </a> | <a target=xrefwindow id=d28331e2379 href="https://doi.org/10.1016/j.exphem.2004.01.004">Publisher Full Text </a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a name=d28331e2388 class=n-a></a>Luens KM, Travis MA, Chen BP, <i> et al.</i>: Thrombopoietin, kit ligand, and flk2/flt3 ligand together induce increased numbers of primitive hematopoietic progenitors from human CD34<sup>+</sup>Thy-1<sup>+</sup>Lin<sup>-</sup> cells with preserved ability to engraft SCID-hu bone. <i>Blood.</i> 1998; <b>91</b>(4): 1206–15. <a target=xrefwindow id=d28331e2409 href="http://www.ncbi.nlm.nih.gov/pubmed/9454750">PubMed Abstract </a> | <a target=xrefwindow id=d28331e2412 href="https://doi.org/10.1182/blood.V91.4.1206">Publisher Full Text </a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a name=d28331e2421 class=n-a></a>He S, Chu J, Vasu S, <i> et al.</i>: FLT3L and plerixafor combination increases hematopoietic stem cell mobilization and leads to improved transplantation outcome. <i>Biol Blood Marrow Transplant.</i> 2014; <b>20</b>(3): 309–13. <a target=xrefwindow id=d28331e2432 href="http://www.ncbi.nlm.nih.gov/pubmed/24365795">PubMed Abstract </a> | <a target=xrefwindow id=d28331e2435 href="https://doi.org/10.1016/j.bbmt.2013.11.024">Publisher Full Text </a> | <a target=xrefwindow id=d28331e2439 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3943635">Free Full Text </a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a name=d28331e2449 class=n-a></a>Urdziková L, Likavčanová-Mašínová K, Vaněček V, <i> et al.</i>: Flt3 ligand synergizes with granulocyte-colony-stimulating factor in bone marrow mobilization to improve functional outcome after spinal cord injury in the rat. <i>Cytotherapy.</i> 2011; <b>13</b>(9): 1090–104. <a target=xrefwindow id=d28331e2460 href="http://www.ncbi.nlm.nih.gov/pubmed/21539498">PubMed Abstract </a> | <a target=xrefwindow id=d28331e2463 href="https://doi.org/10.3109/14653249.2011.575355">Publisher Full Text </a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a name=d28331e2472 class=n-a></a>Hattori K, Dias S, Heissig B, <i> et al.</i>: Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells. <i>J Exp Med.</i> 2001; <b>193</b>(9): 1005–14. <a target=xrefwindow id=d28331e2483 href="http://www.ncbi.nlm.nih.gov/pubmed/11342585">PubMed Abstract </a> | <a target=xrefwindow id=d28331e2486 href="https://doi.org/10.1084/jem.193.9.1005">Publisher Full Text </a> | <a target=xrefwindow id=d28331e2490 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2193424">Free Full Text </a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/13409092"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28331e2499 class=n-a></a>Moore MA, Hattori K, Heissig B, <i> et al.</i>: Mobilization of endothelial and hematopoietic stem and progenitor cells by adenovector-mediated elevation of serum levels of SDF-1, VEGF, and angiopoietin-1. <i>Ann N Y Acad Sci.</i> 2001; <b>938</b>: 36–45. <a target=xrefwindow id=d28331e2510 href="http://www.ncbi.nlm.nih.gov/pubmed/11458524">PubMed Abstract </a> | <a target=xrefwindow id=d28331e2513 href="https://doi.org/10.1111/j.1749-6632.2001.tb03572.x">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/13409092">F1000 Recommendation</a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a name=d28331e2527 class=n-a></a>Rafii S, Heissig B, Hattori K: Efficient mobilization and recruitment of marrow-derived endothelial and hematopoietic stem cells by adenoviral vectors expressing angiogenic factors. <i>Gene Ther.</i> 2002; <b>9</b>(10): 631–41. <a target=xrefwindow id=d28331e2535 href="http://www.ncbi.nlm.nih.gov/pubmed/12032709">PubMed Abstract </a> | <a target=xrefwindow id=d28331e2538 href="https://doi.org/10.1038/sj.gt.3301723">Publisher Full Text </a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a name=d28331e2547 class=n-a></a>Pruijt JF, van Kooyk Y, Figdor CG, <i> et al.</i>: Anti-LFA-1 blocking antibodies prevent mobilization of hematopoietic progenitor cells induced by interleukin-8. <i>Blood.</i> 1998; <b>91</b>(11): 4099–105. <a target=xrefwindow id=d28331e2558 href="http://www.ncbi.nlm.nih.gov/pubmed/9596655">PubMed Abstract </a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d28331e2567 class=n-a></a>Down JD, Awwad M, Kurilla-Mahon B, <i> et al.</i>: Increases in autologous hematopoietic progenitors in the blood of baboons following irradiation and treatment with porcine stem cell factor and interleukin-3. <i>Transplant Proc.</i> 2000; <b>32</b>(5): 1045–6. <a target=xrefwindow id=d28331e2578 href="http://www.ncbi.nlm.nih.gov/pubmed/10936345">PubMed Abstract </a> | <a target=xrefwindow id=d28331e2581 href="https://doi.org/10.1016/s0041-1345(00)01111-8">Publisher Full Text </a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d28331e2591 class=n-a></a>MacVittie TJ, Farese AM, Davis TA, <i> et al.</i>: Myelopoietin, a chimeric agonist of human interleukin 3 and granulocyte colony-stimulating factor receptors, mobilizes CD34<sup>+</sup> cells that rapidly engraft lethally x-irradiated nonhuman primates. <i>Exp Hematol.</i> 1999; <b>27</b>(10): 1557–68. <a target=xrefwindow id=d28331e2605 href="http://www.ncbi.nlm.nih.gov/pubmed/10517498">PubMed Abstract </a> | <a target=xrefwindow id=d28331e2609 href="https://doi.org/10.1016/s0301-472x(99)00092-2">Publisher Full Text </a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a name=d28331e2618 class=n-a></a>Pettengell R, Luft T, de Wynter E, <i> et al.</i>: Effects of interleukin-6 on mobilization of primitive haemopoietic cells into the circulation. <i>Br J Haematol.</i> 1995; <b>89</b>(2): 237–42. <a target=xrefwindow id=d28331e2629 href="http://www.ncbi.nlm.nih.gov/pubmed/7873372">PubMed Abstract </a> | <a target=xrefwindow id=d28331e2632 href="https://doi.org/10.1111/j.1365-2141.1995.tb03295.x">Publisher Full Text </a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a name=d28331e2641 class=n-a></a>Grzegorzewski KJ, Komschlies KL, Jacobsen SE, <i> et al.</i>: Mobilization of long-term reconstituting hematopoietic stem cells in mice by recombinant human interleukin 7. <i>J Exp Med.</i> 1995; <b>181</b>(1): 369–74. <a target=xrefwindow id=d28331e2652 href="http://www.ncbi.nlm.nih.gov/pubmed/7807018">PubMed Abstract </a> | <a target=xrefwindow id=d28331e2655 href="https://doi.org/10.1084/jem.181.1.369">Publisher Full Text </a> | <a target=xrefwindow id=d28331e2659 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2191845">Free Full Text </a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a name=d28331e2668 class=n-a></a>Jackson JD, Yan Y, Brunda MJ, <i> et al.</i>: Interleukin-12 enhances peripheral hematopoiesis <i>in vivo</i>. <i>Blood.</i> 1995; <b>85</b>(9): 2371–6. <a target=xrefwindow id=d28331e2682 href="http://www.ncbi.nlm.nih.gov/pubmed/7727771">PubMed Abstract </a> | <a target=xrefwindow id=d28331e2686 href="https://doi.org/10.1182/blood.V85.9.2371.bloodjournal8592371">Publisher Full Text </a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a name=d28331e2695 class=n-a></a>Schwarzenberger P, Huang W, Oliver P, <i> et al.</i>: Il-17 mobilizes peripheral blood stem cells with short- and long-term repopulating ability in mice. <i>J Immunol.</i> 2001; <b>167</b>: 2081–6. <a target=xrefwindow id=d28331e2706 href="http://www.ncbi.nlm.nih.gov/pubmed/11489991">PubMed Abstract </a> | <a target=xrefwindow id=d28331e2709 href="https://doi.org/10.4049/jimmunol.167.4.2081">Publisher Full Text </a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a name=d28331e2718 class=n-a></a>Kim J, Kim W, Le HT, <i> et al.</i>: IL-33-induced hematopoietic stem and progenitor cell mobilization depends upon CCR2. <i>J Immunol.</i> 2014; <b>193</b>(7): 3792–802. <a target=xrefwindow id=d28331e2729 href="http://www.ncbi.nlm.nih.gov/pubmed/25143444">PubMed Abstract </a> | <a target=xrefwindow id=d28331e2732 href="https://doi.org/10.4049/jimmunol.1400176">Publisher Full Text </a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/735908176"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28331e2742 class=n-a></a>Alt C, Yuan S, Wu F, <i> et al.</i>: Long-Acting IL-33 Mobilizes High-Quality Hematopoietic Stem and Progenitor Cells More Efficiently Than Granulocyte Colony-Stimulating Factor or AMD3100. <i>Biol Blood Marrow Transplant.</i> 2019; <b>25</b>(8): 1475–85. <a target=xrefwindow id=d28331e2753 href="http://www.ncbi.nlm.nih.gov/pubmed/31163266">PubMed Abstract </a> | <a target=xrefwindow id=d28331e2756 href="https://doi.org/10.1016/j.bbmt.2019.05.030">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/735908176">F1000 Recommendation</a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a name=d28331e2769 class=n-a></a>Green DJ, Bensinger WI, Holmberg LA, <i> et al.</i>: Bendamustine, etoposide and dexamethasone to mobilize peripheral blood hematopoietic stem cells for autologous transplantation in patients with multiple myeloma. <i>Bone Marrow Transplant.</i> 2016; <b>51</b>(10): 1330–6. <a target=xrefwindow id=d28331e2780 href="http://www.ncbi.nlm.nih.gov/pubmed/27214069">PubMed Abstract </a> | <a target=xrefwindow id=d28331e2783 href="https://doi.org/10.1038/bmt.2016.123">Publisher Full Text </a> | <a target=xrefwindow id=d28331e2787 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5052091">Free Full Text </a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a name=d28331e2796 class=n-a></a>Hattori K, Heissig B, Tashiro K, <i> et al.</i>: Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells. <i>Blood.</i> 2001; <b>97</b>(11): 3354–60. <a target=xrefwindow id=d28331e2807 href="http://www.ncbi.nlm.nih.gov/pubmed/11369624">PubMed Abstract </a> | <a target=xrefwindow id=d28331e2810 href="https://doi.org/10.1182/blood.v97.11.3354">Publisher Full Text </a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a name=d28331e2819 class=n-a></a>Karpova D, Rettig MP, Ritchey J, <i> et al.</i>: Targeting VLA4 integrin and CXCR2 mobilizes serially repopulating hematopoietic stem cells. <i>J Clin Invest.</i> 2019; <b>129</b>(7): 2745–59. <a target=xrefwindow id=d28331e2830 href="http://www.ncbi.nlm.nih.gov/pubmed/31085833">PubMed Abstract </a> | <a target=xrefwindow id=d28331e2833 href="https://doi.org/10.1172/JCI124738">Publisher Full Text </a> | <a target=xrefwindow id=d28331e2837 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6597242">Free Full Text </a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732451017"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28331e2846 class=n-a></a>Hoggatt J, Singh P, Tate TA, <i> et al.</i>: Rapid Mobilization Reveals a Highly Engraftable Hematopoietic Stem Cell. <i>Cell.</i> 2018; <b>172</b>(1–2): 191–204.e10. <a target=xrefwindow id=d28331e2857 href="http://www.ncbi.nlm.nih.gov/pubmed/29224778">PubMed Abstract </a> | <a target=xrefwindow id=d28331e2860 href="https://doi.org/10.1016/j.cell.2017.11.003">Publisher Full Text </a> | <a target=xrefwindow id=d28331e2864 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5812290">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732451017">F1000 Recommendation</a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a name=d28331e2877 class=n-a></a>Pelus LM, Fukuda S: Peripheral blood stem cell mobilization: the CXCR2 ligand GRObeta rapidly mobilizes hematopoietic stem cells with enhanced engraftment properties. <i>Exp Hematol.</i> 2006; <b>34</b>(8): 1010–20. <a target=xrefwindow id=d28331e2885 href="http://www.ncbi.nlm.nih.gov/pubmed/16863907">PubMed Abstract </a> | <a target=xrefwindow id=d28331e2888 href="https://doi.org/10.1016/j.exphem.2006.04.004">Publisher Full Text </a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a name=d28331e2898 class=n-a></a>Pruijt JF, Fibbe WE, Laterveer L, <i> et al.</i>: Prevention of interleukin-8-induced mobilization of hematopoietic progenitor cells in rhesus monkeys by inhibitory antibodies against the metalloproteinase gelatinase B (MMP-9). <i>Proc Natl Acad Sci U S A.</i> 1999; <b>96</b>(19): 10863–8. <a target=xrefwindow id=d28331e2909 href="http://www.ncbi.nlm.nih.gov/pubmed/10485917">PubMed Abstract </a> | <a target=xrefwindow id=d28331e2912 href="https://doi.org/10.1073/pnas.96.19.10863">Publisher Full Text </a> | <a target=xrefwindow id=d28331e2916 href="http://www.ncbi.nlm.nih.gov/pmc/articles/17974">Free Full Text </a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a name=d28331e2925 class=n-a></a>Broxmeyer HE, Orschell CM, Clapp DW, <i> et al.</i>: Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. <i>J Exp Med.</i> 2005; <b>201</b>(8): 1307–18. <a target=xrefwindow id=d28331e2936 href="http://www.ncbi.nlm.nih.gov/pubmed/15837815">PubMed Abstract </a> | <a target=xrefwindow id=d28331e2939 href="https://doi.org/10.1084/jem.20041385">Publisher Full Text </a> | <a target=xrefwindow id=d28331e2943 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2213145">Free Full Text </a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a name=d28331e2952 class=n-a></a>Bonig H, Chudziak D, Priestley G, <i> et al.</i>: Insights into the biology of mobilized hematopoietic stem/progenitor cells through innovative treatment schedules of the CXCR4 antagonist AMD3100. <i>Exp Hematol.</i> 2009; <b>37</b>(3): 402–15.e1. <a target=xrefwindow id=d28331e2963 href="http://www.ncbi.nlm.nih.gov/pubmed/19157683">PubMed Abstract </a> | <a target=xrefwindow id=d28331e2966 href="https://doi.org/10.1016/j.exphem.2008.10.017">Publisher Full Text </a> | <a target=xrefwindow id=d28331e2970 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2669109">Free Full Text </a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a name=d28331e2979 class=n-a></a>Rettig MP, Ansstas G, DiPersio JF: Mobilization of hematopoietic stem and progenitor cells using inhibitors of CXCR4 and VLA-4. <i>Leukemia.</i> 2012; <b>26</b>(1): 34–53. <a target=xrefwindow id=d28331e2987 href="http://www.ncbi.nlm.nih.gov/pubmed/21886173">PubMed Abstract </a> | <a target=xrefwindow id=d28331e2990 href="https://doi.org/10.1038/leu.2011.197">Publisher Full Text </a> | <a target=xrefwindow id=d28331e2993 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3514440">Free Full Text </a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a name=d28331e3002 class=n-a></a>Cancelas JA, Lee AW, Prabhakar R, <i> et al.</i>: Rac GTPases differentially integrate signals regulating hematopoietic stem cell localization. <i>Nat Med.</i> 2005; <b>11</b>(8): 886–91. <a target=xrefwindow id=d28331e3013 href="http://www.ncbi.nlm.nih.gov/pubmed/16025125">PubMed Abstract </a> | <a target=xrefwindow id=d28331e3016 href="https://doi.org/10.1038/nm1274">Publisher Full Text </a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a name=d28331e3025 class=n-a></a>Ghiaur G, Lee A, Bailey J, <i> et al.</i>: Inhibition of RhoA GTPase activity enhances hematopoietic stem and progenitor cell proliferation and engraftment. <i>Blood.</i> 2006; <b>108</b>(6): 2087–94. <a target=xrefwindow id=d28331e3036 href="http://www.ncbi.nlm.nih.gov/pubmed/16709932">PubMed Abstract </a> | <a target=xrefwindow id=d28331e3039 href="https://doi.org/10.1182/blood-2006-02-001560">Publisher Full Text </a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a name=d28331e3049 class=n-a></a>Karapetyan AV, Klyachkin YM, Selim S, <i> et al.</i>: Bioactive lipids and cationic antimicrobial peptides as new potential regulators for trafficking of bone marrow-derived stem cells in patients with acute myocardial infarction. <i>Stem Cells Dev.</i> 2013; <b>22</b>(11): 1645–56. <a target=xrefwindow id=d28331e3060 href="http://www.ncbi.nlm.nih.gov/pubmed/23282236">PubMed Abstract </a> | <a target=xrefwindow id=d28331e3063 href="https://doi.org/10.1089/scd.2012.0488">Publisher Full Text </a> | <a target=xrefwindow id=d28331e3067 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3657281">Free Full Text </a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a name=d28331e3076 class=n-a></a>Ratajczak MZ, Suszynska M, Borkowska S, <i> et al.</i>: The role of sphingosine-1 phosphate and ceramide-1 phosphate in trafficking of normal stem cells and cancer cells. <i>Expert Opin Ther Targets.</i> 2013; <b>18</b>(1): 95–107. <a target=xrefwindow id=d28331e3087 href="http://www.ncbi.nlm.nih.gov/pubmed/24188167">PubMed Abstract </a> | <a target=xrefwindow id=d28331e3090 href="https://doi.org/10.1517/14728222.2014.851671">Publisher Full Text </a> | <a target=xrefwindow id=d28331e3094 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3991726">Free Full Text </a></span></li><li><a name=ref-68 class=n-a></a><span class=label>68. </span>&nbsp;<span class=citation><a name=d28331e3103 class=n-a></a>Velders GA, Verzaal P, Van Os RP, <i> et al.</i>: Endotoxins serve as cofactors in cytokine induced mobilization of peripheral blood stem cells. <i>Blood.</i> 2000; <b>96</b>. <a target=xrefwindow id=d28331e3114 href="https://lirias.kuleuven.be/1578490?limo=0">Reference Source</a></span></li><li><a name=ref-69 class=n-a></a><span class=label>69. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1019834"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28331e3123 class=n-a></a>Velders GA, van Os R, Hagoort H, <i> et al.</i>: Reduced stem cell mobilization in mice receiving antibiotic modulation of the intestinal flora: Involvement of endotoxins as cofactors in mobilization. <i>Blood.</i> 2004; <b>103</b>(1): 340–6. <a target=xrefwindow id=d28331e3134 href="http://www.ncbi.nlm.nih.gov/pubmed/12969972">PubMed Abstract </a> | <a target=xrefwindow id=d28331e3137 href="https://doi.org/10.1182/blood-2002-07-2270">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1019834">F1000 Recommendation</a></span></li><li><a name=ref-70 class=n-a></a><span class=label>70. </span>&nbsp;<span class=citation><a name=d28331e3150 class=n-a></a>Molendijk WJ, Oudenaren A, Dijk H, <i> et al.</i>: Complement split product C5a mediates the lipopolysaccharide-induced mobilization of CFU-s and haemopoietic progenitor cells, but not the mobilization induced by proteolytic enzymes. <i>Cell Tissue Kinet.</i> 1986; <b>19</b>(4): 407–17. <a target=xrefwindow id=d28331e3161 href="http://www.ncbi.nlm.nih.gov/pubmed/3533267">PubMed Abstract </a> | <a target=xrefwindow id=d28331e3164 href="https://doi.org/10.1111/j.1365-2184.1986.tb00738.x">Publisher Full Text </a></span></li><li><a name=ref-71 class=n-a></a><span class=label>71. </span>&nbsp;<span class=citation><a name=d28331e3173 class=n-a></a>Schneider OD, Weiss AA, Miller WE: Pertussis toxin signals through the TCR to initiate cross-desensitization of the chemokine receptor CXCR4. <i>J Immunol.</i> 2009; <b>182</b>(9): 5730–9. <a target=xrefwindow id=d28331e3181 href="http://www.ncbi.nlm.nih.gov/pubmed/19380820">PubMed Abstract </a> | <a target=xrefwindow id=d28331e3184 href="https://doi.org/10.4049/jimmunol.0803114">Publisher Full Text </a> | <a target=xrefwindow id=d28331e3187 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2766007">Free Full Text </a></span></li><li><a name=ref-72 class=n-a></a><span class=label>72. </span>&nbsp;<span class=citation><a name=d28331e3197 class=n-a></a>Papayannopoulou T, Priestley GV, Bonig H, <i> et al.</i>: The role of G-protein signaling in hematopoietic stem/progenitor cell mobilization. <i>Blood.</i> 2003; <b>101</b>(12): 4739–47. <a target=xrefwindow id=d28331e3208 href="http://www.ncbi.nlm.nih.gov/pubmed/12595315">PubMed Abstract </a> | <a target=xrefwindow id=d28331e3211 href="https://doi.org/10.1182/blood-2002-09-2741">Publisher Full Text </a></span></li><li><a name=ref-73 class=n-a></a><span class=label>73. </span>&nbsp;<span class=citation><a name=d28331e3220 class=n-a></a>Bonig H, Priestley GV, Papayannopoulou T: Hierarchy of molecular-pathway usage in bone marrow homing and its shift by cytokines. <i>Blood.</i> 2006; <b>107</b>(1): 79–86. <a target=xrefwindow id=d28331e3228 href="http://www.ncbi.nlm.nih.gov/pubmed/16141352">PubMed Abstract </a> | <a target=xrefwindow id=d28331e3231 href="https://doi.org/10.1182/blood-2005-05-2023">Publisher Full Text </a> | <a target=xrefwindow id=d28331e3234 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1895342">Free Full Text </a></span></li><li><a name=ref-74 class=n-a></a><span class=label>74. </span>&nbsp;<span class=citation><a name=d28331e3243 class=n-a></a>Bonig H, Priestley GV, Nilsson LM, <i> et al.</i>: PTX-sensitive signals in bone marrow homing of fetal and adult hematopoietic progenitor cells. <i>Blood.</i> 2004; <b>104</b>(8): 2299–306. <a target=xrefwindow id=d28331e3254 href="http://www.ncbi.nlm.nih.gov/pubmed/15217839">PubMed Abstract </a> | <a target=xrefwindow id=d28331e3257 href="https://doi.org/10.1182/blood-2004-04-1605">Publisher Full Text </a></span></li><li><a name=ref-75 class=n-a></a><span class=label>75. </span>&nbsp;<span class=citation><a name=d28331e3265 class=n-a></a>Fehér I, Gidáli J: Mobilizable stem cells: characteristics and replacement of the pool after exhaustion. <i>Exp Hematol.</i> 1982; <b>10</b>(8): 661–7. <a target=xrefwindow id=d28331e3273 href="http://www.ncbi.nlm.nih.gov/pubmed/7140867">PubMed Abstract </a></span></li><li><a name=ref-76 class=n-a></a><span class=label>76. </span>&nbsp;<span class=citation><a name=d28331e3282 class=n-a></a>Pelus LM, Bian H, King AG, <i> et al.</i>: Neutrophil-derived MMP-9 mediates synergistic mobilization of hematopoietic stem and progenitor cells by the combination of G-CSF and the chemokines GRObeta/CXCL2 and GRObetaT/CXCL2delta4. <i>Blood.</i> 2004; <b>103</b>(1): 110–9. <a target=xrefwindow id=d28331e3293 href="http://www.ncbi.nlm.nih.gov/pubmed/12958067">PubMed Abstract </a> | <a target=xrefwindow id=d28331e3296 href="https://doi.org/10.1182/blood-2003-04-1115">Publisher Full Text </a></span></li><li><a name=ref-77 class=n-a></a><span class=label>77. </span>&nbsp;<span class=citation><a name=d28331e3305 class=n-a></a>Christopherson K, Cooper S, Hangoc G, <i> et al.</i>: CD26 is essential for normal G-CSF-induced progenitor cell mobilization as determined by CD26<sup>-/-</sup> mice. <i>Exp Hematol.</i> 2003; <b>31</b>(11): 1126–34. <a target=xrefwindow id=d28331e3319 href="http://www.ncbi.nlm.nih.gov/pubmed/14585379">PubMed Abstract </a> | <a target=xrefwindow id=d28331e3323 href="https://doi.org/10.1016/j.exphem.2003.07.002">Publisher Full Text </a></span></li><li><a name=ref-78 class=n-a></a><span class=label>78. </span>&nbsp;<span class=citation><a name=d28331e3333 class=n-a></a>Christopherson KW 2nd, Cooper S, Broxmeyer HE: Cell surface peptidase CD26/DPPIV mediates G-CSF mobilization of mouse progenitor cells. <i>Blood.</i> 2003; <b>101</b>(12): 4680–6. <a target=xrefwindow id=d28331e3341 href="http://www.ncbi.nlm.nih.gov/pubmed/12576320">PubMed Abstract </a> | <a target=xrefwindow id=d28331e3344 href="https://doi.org/10.1182/blood-2002-12-3893">Publisher Full Text </a></span></li><li><a name=ref-79 class=n-a></a><span class=label>79. </span>&nbsp;<span class=citation><a name=d28331e3353 class=n-a></a>Lévesque JP, Hendy J, Takamatsu Y, <i> et al.</i>: Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. <i>J Clin Invest.</i> 2003; <b>111</b>(2): 187–96. <a target=xrefwindow id=d28331e3364 href="http://www.ncbi.nlm.nih.gov/pubmed/12531874">PubMed Abstract </a> | <a target=xrefwindow id=d28331e3367 href="https://doi.org/10.1172/JCI15994">Publisher Full Text </a> | <a target=xrefwindow id=d28331e3371 href="http://www.ncbi.nlm.nih.gov/pmc/articles/151860">Free Full Text </a></span></li><li><a name=ref-80 class=n-a></a><span class=label>80. </span>&nbsp;<span class=citation><a name=d28331e3380 class=n-a></a>Scalia R, Kochilas L, Campbell B, <i> et al.</i>: Effects of defibrotide on leukocyte-endothelial cell interaction in the rat mesenteric vascular bed: role of P-selectin. <i>Methods Find Exp Clin Pharmacol.</i> 1996; <b>18</b>(10): 669–76. <a target=xrefwindow id=d28331e3391 href="http://www.ncbi.nlm.nih.gov/pubmed/9121223">PubMed Abstract </a></span></li><li><a name=ref-81 class=n-a></a><span class=label>81. </span>&nbsp;<span class=citation><a name=d28331e3400 class=n-a></a>Carlo-Stella C, Di Nicola M, Magni M, <i> et al.</i>: Defibrotide in combination with granulocyte colony-stimulating factor significantly enhances the mobilization of primitive and committed peripheral blood progenitor cells in mice. <i>Cancer Res.</i> 2002; <b>62</b>(21): 6152–7. <a target=xrefwindow id=d28331e3411 href="http://www.ncbi.nlm.nih.gov/pubmed/12414641">PubMed Abstract </a></span></li><li><a name=ref-82 class=n-a></a><span class=label>82. </span>&nbsp;<span class=citation><a name=d28331e3419 class=n-a></a>Vermeulen M, Le Pesteur F, Gagnerault MC, <i> et al.</i>: Role of adhesion molecules in the homing and mobilization of murine hematopoietic stem and progenitor cells. <i>Blood.</i> 1998; <b>92</b>(3): 894–900. <a target=xrefwindow id=d28331e3430 href="http://www.ncbi.nlm.nih.gov/pubmed/9680357">PubMed Abstract </a> | <a target=xrefwindow id=d28331e3433 href="https://doi.org/10.1182/blood.V92.3.894">Publisher Full Text </a></span></li><li><a name=ref-83 class=n-a></a><span class=label>83. </span>&nbsp;<span class=citation><a name=d28331e3442 class=n-a></a>Bonig H, Wundes A, Chang KH, <i> et al.</i>: Increased numbers of circulating hematopoietic stem/progenitor cells are chronically maintained in patients treated with the CD49d blocking antibody natalizumab. <i>Blood.</i> 2008; <b>111</b>(7): 3439–41. <a target=xrefwindow id=d28331e3453 href="http://www.ncbi.nlm.nih.gov/pubmed/18195093">PubMed Abstract </a> | <a target=xrefwindow id=d28331e3456 href="https://doi.org/10.1182/blood-2007-09-112052">Publisher Full Text </a> | <a target=xrefwindow id=d28331e3460 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2275012">Free Full Text </a></span></li><li><a name=ref-84 class=n-a></a><span class=label>84. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726219120"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28331e3470 class=n-a></a>Cao B, Zhang Z, Grassinger J, <i> et al.</i>: Therapeutic targeting and rapid mobilization of endosteal HSC using a small molecule integrin antagonist. <i>Nat Commun.</i> 2016; <b>7</b>: 11007. <a target=xrefwindow id=d28331e3481 href="http://www.ncbi.nlm.nih.gov/pubmed/26975966">PubMed Abstract </a> | <a target=xrefwindow id=d28331e3484 href="https://doi.org/10.1038/ncomms11007">Publisher Full Text </a> | <a target=xrefwindow id=d28331e3488 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4796355">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726219120">F1000 Recommendation</a></span></li><li><a name=ref-85 class=n-a></a><span class=label>85. </span>&nbsp;<span class=citation><a name=d28331e3501 class=n-a></a>Kikuta T, Shimazaki C, Ashihara E, <i> et al.</i>: Mobilization of hematopoietic primitive and committed progenitor cells into blood in mice by anti-vascular adhesion molecule-1 antibody alone or in combination with granulocyte colony-stimulating factor. <i>Exp Hematol.</i> 2000; <b>28</b>(3): 311–7. <a target=xrefwindow id=d28331e3512 href="http://www.ncbi.nlm.nih.gov/pubmed/10720696">PubMed Abstract </a> | <a target=xrefwindow id=d28331e3515 href="https://doi.org/10.1016/s0301-472x(99)00151-4">Publisher Full Text </a></span></li><li><a name=ref-86 class=n-a></a><span class=label>86. </span>&nbsp;<span class=citation><a name=d28331e3524 class=n-a></a>Zoeller M: CD44v10 in hematopoiesis and stem cell mobilization. <i>Leuk Lymphoma.</i> 2000; <b>38</b>(5–6): 463–80. <a target=xrefwindow id=d28331e3532 href="http://www.ncbi.nlm.nih.gov/pubmed/10953967">PubMed Abstract </a> | <a target=xrefwindow id=d28331e3535 href="https://doi.org/10.3109/10428190009059265">Publisher Full Text </a></span></li><li><a name=ref-87 class=n-a></a><span class=label>87. </span>&nbsp;<span class=citation><a name=d28331e3544 class=n-a></a>Rösel M, Khaldoyanidi S, Zawadzki V, <i> et al.</i>: Involvement of CD44 variant isoform v10 in progenitor cell adhesion and maturation. <i>Exp Hematol.</i> 1999; <b>27</b>(4): 698–711. <a target=xrefwindow id=d28331e3555 href="http://www.ncbi.nlm.nih.gov/pubmed/10210328">PubMed Abstract </a> | <a target=xrefwindow id=d28331e3558 href="https://doi.org/10.1016/s0301-472x(98)00082-4">Publisher Full Text </a></span></li><li><a name=ref-88 class=n-a></a><span class=label>88. </span>&nbsp;<span class=citation><a name=d28331e3567 class=n-a></a>Ting MJ, Day BW, Spanevello MD, <i> et al.</i>: Activation of ephrin A proteins influences hematopoietic stem cell adhesion and trafficking patterns. <i>Exp Hematol.</i> 2010; <b>38</b>(11): 1087–98. <a target=xrefwindow id=d28331e3578 href="http://www.ncbi.nlm.nih.gov/pubmed/20655977">PubMed Abstract </a> | <a target=xrefwindow id=d28331e3581 href="https://doi.org/10.1016/j.exphem.2010.07.007">Publisher Full Text </a></span></li><li><a name=ref-89 class=n-a></a><span class=label>89. </span>&nbsp;<span class=citation><a name=d28331e3590 class=n-a></a>Sweeney EA, Priestley GV, Nakamoto B, <i> et al.</i>: Mobilization of stem/progenitor cells by sulfated polysaccharides does not require selectin presence. <i>Proc Natl Acad Sci U S A.</i> 2000; <b>97</b>(12): 6544–9. <a target=xrefwindow id=d28331e3601 href="http://www.ncbi.nlm.nih.gov/pubmed/10841555">PubMed Abstract </a> | <a target=xrefwindow id=d28331e3604 href="https://doi.org/10.1073/pnas.97.12.6544">Publisher Full Text </a> | <a target=xrefwindow id=d28331e3608 href="http://www.ncbi.nlm.nih.gov/pmc/articles/18653">Free Full Text </a></span></li><li><a name=ref-90 class=n-a></a><span class=label>90. </span>&nbsp;<span class=citation><a name=d28331e3618 class=n-a></a>Sweeney EA, Lortat-Jacob H, Priestley GV, <i> et al.</i>: Sulfated polysaccharides increase plasma levels of SDF-1 in monkeys and mice: involvement in mobilization of stem/progenitor cells. <i>Blood.</i> 2002; <b>99</b>(1): 44–51. <a target=xrefwindow id=d28331e3629 href="http://www.ncbi.nlm.nih.gov/pubmed/11756151">PubMed Abstract </a> | <a target=xrefwindow id=d28331e3632 href="https://doi.org/10.1182/blood.v99.1.44">Publisher Full Text </a></span></li><li><a name=ref-91 class=n-a></a><span class=label>91. </span>&nbsp;<span class=citation><a name=d28331e3641 class=n-a></a>Patchen ML, Liang J, Vaudrain T, <i> et al.</i>: Mobilization of peripheral blood progenitor cells by Betafectin PGG-Glucan alone and in combination with granulocyte colony-stimulating factor. <i>Stem Cells.</i> 1998; <b>16</b>(13): 208–17. <a target=xrefwindow id=d28331e3652 href="http://www.ncbi.nlm.nih.gov/pubmed/9617896">PubMed Abstract </a> | <a target=xrefwindow id=d28331e3655 href="https://doi.org/10.1002/stem.160208">Publisher Full Text </a></span></li><li><a name=ref-92 class=n-a></a><span class=label>92. </span>&nbsp;<span class=citation><a name=d28331e3664 class=n-a></a>Albanese P, Caruelle D, Frescaline G, <i> et al.</i>: Glycosaminoglycan mimetics-induced mobilization of hematopoietic progenitors and stem cells into mouse peripheral blood: structure/function insights. <i>Exp Hematol.</i> 2009; <b>37</b>(9): 1072–83. <a target=xrefwindow id=d28331e3675 href="http://www.ncbi.nlm.nih.gov/pubmed/19539688">PubMed Abstract </a> | <a target=xrefwindow id=d28331e3678 href="https://doi.org/10.1016/j.exphem.2009.06.005">Publisher Full Text </a></span></li><li><a name=ref-93 class=n-a></a><span class=label>93. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717989159"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28331e3687 class=n-a></a>Hoggatt J, Mohammad KS, Singh P, <i> et al.</i>: Differential stem- and progenitor-cell trafficking by prostaglandin E<sub>2</sub>. <i>Nature.</i> 2013; <b>495</b>(7441): 365–9. <a target=xrefwindow id=d28331e3701 href="http://www.ncbi.nlm.nih.gov/pubmed/23485965">PubMed Abstract </a> | <a target=xrefwindow id=d28331e3705 href="https://doi.org/10.1038/nature11929">Publisher Full Text </a> | <a target=xrefwindow id=d28331e3708 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3606692">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717989159">F1000 Recommendation</a></span></li><li><a name=ref-94 class=n-a></a><span class=label>94. </span>&nbsp;<span class=citation><a name=d28331e3721 class=n-a></a>Stenzinger M, Karpova D, Unterrainer C, <i> et al.</i>: Hematopoietic-Extrinsic Cues Dictate Circadian Redistribution of Mature and Immature Hematopoietic Cells in Blood and Spleen. <i>Cells.</i> 2019; <b>8</b>(9): pii: E1033. <a target=xrefwindow id=d28331e3732 href="http://www.ncbi.nlm.nih.gov/pubmed/31491915">PubMed Abstract </a> | <a target=xrefwindow id=d28331e3735 href="https://doi.org/10.3390/cells8091033">Publisher Full Text </a> | <a target=xrefwindow id=d28331e3739 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6769956">Free Full Text </a></span></li><li><a name=ref-95 class=n-a></a><span class=label>95. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/734506414"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28331e3748 class=n-a></a>McKim DB, Yin W, Wang Y, <i> et al.</i>: Social Stress Mobilizes Hematopoietic Stem Cells to Establish Persistent Splenic Myelopoiesis. <i>Cell Rep.</i> 2018; <b>25</b>(9): 2552–2562.e3. <a target=xrefwindow id=d28331e3759 href="http://www.ncbi.nlm.nih.gov/pubmed/30485819">PubMed Abstract </a> | <a target=xrefwindow id=d28331e3762 href="https://doi.org/10.1016/j.celrep.2018.10.102">Publisher Full Text </a> | <a target=xrefwindow id=d28331e3766 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6342493">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/734506414">F1000 Recommendation</a></span></li><li><a name=ref-96 class=n-a></a><span class=label>96. </span>&nbsp;<span class=citation><a name=d28331e3780 class=n-a></a>Machaliński B, Paczkowska E, Koziarska D, <i> et al.</i>: Mobilization of human hematopoietic stem/progenitor-enriched CD34+ cells into peripheral blood during stress related to ischemic stroke. <i>Folia Histochem Cytobiol.</i> 2006; <b>44</b>(2): 97–101. <a target=xrefwindow id=d28331e3791 href="http://www.ncbi.nlm.nih.gov/pubmed/16805134">PubMed Abstract </a></span></li><li><a name=ref-97 class=n-a></a><span class=label>97. </span>&nbsp;<span class=citation><a name=d28331e3799 class=n-a></a>Morici G, Zangla D, Santoro A, <i> et al.</i>: Supramaximal exercise mobilizes hematopoietic progenitors and reticulocytes in athletes. <i>Am J Physiol Regul Integr Comp Physiol.</i> 2005; <b>289</b>(5): R1496–503. <a target=xrefwindow id=d28331e3810 href="http://www.ncbi.nlm.nih.gov/pubmed/16020520">PubMed Abstract </a> | <a target=xrefwindow id=d28331e3813 href="https://doi.org/10.1152/ajpregu.00338.2005">Publisher Full Text </a></span></li><li><a name=ref-98 class=n-a></a><span class=label>98. </span>&nbsp;<span class=citation><a name=d28331e3822 class=n-a></a>Sandri M, Adams V, Gielen S, <i> et al.</i>: Effects of exercise and ischemia on mobilization and functional activation of blood-derived progenitor cells in patients with ischemic syndromes: results of 3 randomized studies. <i>Circulation.</i> 2005; <b>111</b>(25): 3391–9. <a target=xrefwindow id=d28331e3833 href="http://www.ncbi.nlm.nih.gov/pubmed/15956121">PubMed Abstract </a> | <a target=xrefwindow id=d28331e3836 href="https://doi.org/10.1161/CIRCULATIONAHA.104.527135">Publisher Full Text </a></span></li><li><a name=ref-99 class=n-a></a><span class=label>99. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726063617"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28331e3845 class=n-a></a>Emmons R, Niemiro GM, Owolabi O, <i> et al.</i>: Acute exercise mobilizes hematopoietic stem and progenitor cells and alters the mesenchymal stromal cell secretome. <i>J Appl Physiol (1985).</i> 2016; <b>120</b>(6): 624–32. <a target=xrefwindow id=d28331e3856 href="http://www.ncbi.nlm.nih.gov/pubmed/26744505">PubMed Abstract </a> | <a target=xrefwindow id=d28331e3859 href="https://doi.org/10.1152/japplphysiol.00925.2015">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726063617">F1000 Recommendation</a></span></li><li><a name=ref-100 class=n-a></a><span class=label>100. </span>&nbsp;<span class=citation><a name=d28331e3872 class=n-a></a>Kroepfl JM, Pekovits K, Stelzer I, <i> et al.</i>: Exercise increases the frequency of circulating hematopoietic progenitor cells, but reduces hematopoietic colony-forming capacity. <i>Stem Cells Dev.</i> 2012; <b>21</b>(16): 2915–25. <a target=xrefwindow id=d28331e3883 href="http://www.ncbi.nlm.nih.gov/pubmed/22616638">PubMed Abstract </a> | <a target=xrefwindow id=d28331e3886 href="https://doi.org/10.1089/scd.2012.0017">Publisher Full Text </a></span></li><li><a name=ref-101 class=n-a></a><span class=label>101. </span>&nbsp;<span class=citation><a name=d28331e3894 class=n-a></a>Grzelak I, Olszewski WL, Zaleska M, <i> et al.</i>: Surgical trauma evokes a rise in the frequency of hematopoietic progenitor cells and cytokine levels in blood circulation. <i>Eur Surg Res.</i> 1998; <b>30</b>(3): 198–204. <a target=xrefwindow id=d28331e3905 href="http://www.ncbi.nlm.nih.gov/pubmed/9627217">PubMed Abstract </a> | <a target=xrefwindow id=d28331e3908 href="https://doi.org/10.1159/000008577">Publisher Full Text </a></span></li><li><a name=ref-102 class=n-a></a><span class=label>102. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/14499"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28331e3918 class=n-a></a>Kollet O, Dar A, Shivtiel S, <i> et al.</i>: Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells. <i>Nat Med.</i> 2006; <b>12</b>(6): 657–64. <a target=xrefwindow id=d28331e3929 href="http://www.ncbi.nlm.nih.gov/pubmed/16715089">PubMed Abstract </a> | <a target=xrefwindow id=d28331e3932 href="https://doi.org/10.1038/nm1417">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/14499">F1000 Recommendation</a></span></li><li><a name=ref-103 class=n-a></a><span class=label>103. </span>&nbsp;<span class=citation><a name=d28331e3945 class=n-a></a>Hennemann B, Ickenstein G, Sauerbruch S, <i> et al.</i>: Mobilization of CD34<sup>+</sup> hematopoietic cells, colony-forming cells and long-term culture-initiating cells into the peripheral blood of patients with an acute cerebral ischemic insult. <i>Cytotherapy.</i> 2008; <b>10</b>(3): 303–11. <a target=xrefwindow id=d28331e3959 href="http://www.ncbi.nlm.nih.gov/pubmed/18418775">PubMed Abstract </a> | <a target=xrefwindow id=d28331e3963 href="https://doi.org/10.1080/14653240801949994">Publisher Full Text </a></span></li><li><a name=ref-104 class=n-a></a><span class=label>104. </span>&nbsp;<span class=citation><a name=d28331e3972 class=n-a></a>Burberry A, Zeng MY, Ding L, <i> et al.</i>: Infection mobilizes hematopoietic stem cells through cooperative NOD-like receptor and Toll-like receptor signaling. <i>Cell Host Microbe.</i> 2014; <b>15</b>(6): 779–91. <a target=xrefwindow id=d28331e3983 href="http://www.ncbi.nlm.nih.gov/pubmed/24882704">PubMed Abstract </a> | <a target=xrefwindow id=d28331e3986 href="https://doi.org/10.1016/j.chom.2014.05.004">Publisher Full Text </a> | <a target=xrefwindow id=d28331e3990 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4085166">Free Full Text </a></span></li><li><a name=ref-105 class=n-a></a><span class=label>105. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732792335"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28331e3999 class=n-a></a>Ratajczak MZ, Adamiak M, Plonka M, <i> et al.</i>: Mobilization of hematopoietic stem cells as a result of innate immunity-mediated sterile inflammation in the bone marrow microenvironment-the involvement of extracellular nucleotides and purinergic signaling. <i>Leukemia.</i> 2018; <b>32</b>(5): 1116–23. <a target=xrefwindow id=d28331e4010 href="http://www.ncbi.nlm.nih.gov/pubmed/29556022">PubMed Abstract </a> | <a target=xrefwindow id=d28331e4013 href="https://doi.org/10.1038/s41375-018-0087-z">Publisher Full Text </a> | <a target=xrefwindow id=d28331e4017 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5940655">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732792335">F1000 Recommendation</a></span></li><li><a name=ref-106 class=n-a></a><span class=label>106. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733234553"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28331e4030 class=n-a></a>Adamiak M, Bujko K, Cymer M, <i> et al.</i>: Novel evidence that extracellular nucleotides and purinergic signaling induce innate immunity-mediated mobilization of hematopoietic stem/progenitor cells. <i>Leukemia.</i> 2018; <b>32</b>(9): 1920–31. <a target=xrefwindow id=d28331e4041 href="http://www.ncbi.nlm.nih.gov/pubmed/29725032">PubMed Abstract </a> | <a target=xrefwindow id=d28331e4044 href="https://doi.org/10.1038/s41375-018-0122-0">Publisher Full Text </a> | <a target=xrefwindow id=d28331e4048 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6127086">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733234553">F1000 Recommendation</a></span></li><li><a name=ref-107 class=n-a></a><span class=label>107. </span>&nbsp;<span class=citation><a name=d28331e4061 class=n-a></a>Tjwa M, Sidenius N, Moura R, <i> et al.</i>: Membrane-anchored uPAR regulates the proliferation, marrow pool size, engraftment, and mobilization of mouse hematopoietic stem/progenitor cells. <i>J Clin Invest.</i> 2009; <b>119</b>(4): 1008–18. <a target=xrefwindow id=d28331e4072 href="http://www.ncbi.nlm.nih.gov/pubmed/19273908">PubMed Abstract </a> | <a target=xrefwindow id=d28331e4075 href="https://doi.org/10.1172/JCI36010">Publisher Full Text </a> | <a target=xrefwindow id=d28331e4079 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2662545">Free Full Text </a></span></li><li><a name=ref-108 class=n-a></a><span class=label>108. </span>&nbsp;<span class=citation><a name=d28331e4089 class=n-a></a>Tjwa <i>et al.</i> Plasmin therapy enhances mobilization of HPCs after G-CSF. Blood. 2008;112:4048–4050. <i>Blood.</i> 2009; <b>113</b>(21): 5368. <a target=xrefwindow id=d28331e4100 href="https://doi.org/10.1182/blood-2009-02-206284">Publisher Full Text </a></span></li><li><a name=ref-109 class=n-a></a><span class=label>109. </span>&nbsp;<span class=citation><a name=d28331e4109 class=n-a></a>Tjwa M, Janssens S, Carmeliet P: Plasmin therapy enhances mobilization of HPCs after G-CSF. <i>Blood.</i> 2008; <b>112</b>(10): 4048–50. <a target=xrefwindow id=d28331e4117 href="http://www.ncbi.nlm.nih.gov/pubmed/18723692">PubMed Abstract </a> | <a target=xrefwindow id=d28331e4120 href="https://doi.org/10.1182/blood-2008-07-166587">Publisher Full Text </a> | <a target=xrefwindow id=d28331e4123 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2581978">Free Full Text </a></span></li><li><a name=ref-110 class=n-a></a><span class=label>110. </span>&nbsp;<span class=citation><a name=d28331e4132 class=n-a></a>Janowska-Wieczorek A, Marquez-Curtis LA, Shirvaikar N, <i> et al.</i>: The role of complement in the trafficking of hematopoietic stem/progenitor cells. <i>Transfusion.</i> 2012; <b>52</b>(12): 2706–16. <a target=xrefwindow id=d28331e4143 href="http://www.ncbi.nlm.nih.gov/pubmed/22486360">PubMed Abstract </a> | <a target=xrefwindow id=d28331e4146 href="https://doi.org/10.1111/j.1537-2995.2012.03636.x">Publisher Full Text </a> | <a target=xrefwindow id=d28331e4150 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3402689">Free Full Text </a></span></li><li><a name=ref-111 class=n-a></a><span class=label>111. </span>&nbsp;<span class=citation><a name=d28331e4159 class=n-a></a>Borkowska S, Suszynska M, Mierzejewska K, <i> et al.</i>: Novel evidence that crosstalk between the complement, coagulation and fibrinolysis proteolytic cascades is involved in mobilization of hematopoietic stem/progenitor cells (HSPCs). <i>Leukemia.</i> 2014; <b>28</b>(11): 2148–54. <a target=xrefwindow id=d28331e4170 href="http://www.ncbi.nlm.nih.gov/pubmed/24667943">PubMed Abstract </a> | <a target=xrefwindow id=d28331e4173 href="https://doi.org/10.1038/leu.2014.115">Publisher Full Text </a> | <a target=xrefwindow id=d28331e4177 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4177021">Free Full Text </a></span></li><li><a name=ref-112 class=n-a></a><span class=label>112. </span>&nbsp;<span class=citation><a name=d28331e4186 class=n-a></a>Borkowska S, Suszynska M, Wysoczynski M, <i> et al.</i>: Mobilization studies in C3-deficient mice unravel the involvement of a novel crosstalk between the coagulation and complement cascades in mobilization of hematopoietic stem/progenitor cells. <i>Leukemia.</i> 2013; <b>27</b>(9): 1928–30. <a target=xrefwindow id=d28331e4197 href="http://www.ncbi.nlm.nih.gov/pubmed/23511127">PubMed Abstract </a> | <a target=xrefwindow id=d28331e4200 href="https://doi.org/10.1038/leu.2013.84">Publisher Full Text </a> | <a target=xrefwindow id=d28331e4204 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5542053">Free Full Text </a></span></li><li><a name=ref-113 class=n-a></a><span class=label>113. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727174870"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28331e4213 class=n-a></a>Adamiak M, Abdelbaset-Ismail A, Suszynska M, <i> et al.</i>: Novel evidence that the mannan-binding lectin pathway of complement activation plays a pivotal role in triggering mobilization of hematopoietic stem/progenitor cells by activation of both the complement and coagulation cascades. <i>Leukemia.</i> 2017; <b>31</b>(1): 262–5. <a target=xrefwindow id=d28331e4224 href="http://www.ncbi.nlm.nih.gov/pubmed/27733776">PubMed Abstract </a> | <a target=xrefwindow id=d28331e4227 href="https://doi.org/10.1038/leu.2016.278">Publisher Full Text </a> | <a target=xrefwindow id=d28331e4231 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5214582">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727174870">F1000 Recommendation</a></span></li><li><a name=ref-114 class=n-a></a><span class=label>114. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727307706"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28331e4245 class=n-a></a>Pierce H, Zhang D, Magnon C, <i> et al.</i>: Cholinergic Signals from the CNS Regulate G-CSF-Mediated HSC Mobilization from Bone Marrow via a Glucocorticoid Signaling Relay. <i>Cell Stem Cell.</i> 2017; <b>20</b>(5): 648–658.e4. <a target=xrefwindow id=d28331e4256 href="http://www.ncbi.nlm.nih.gov/pubmed/28196601">PubMed Abstract </a> | <a target=xrefwindow id=d28331e4259 href="https://doi.org/10.1016/j.stem.2017.01.002">Publisher Full Text </a> | <a target=xrefwindow id=d28331e4263 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5467872">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727307706">F1000 Recommendation</a></span></li><li><a name=ref-115 class=n-a></a><span class=label>115. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1030778"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28331e4276 class=n-a></a>Katayama Y, Battista M, Kao WM, <i> et al.</i>: Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow. <i>Cell.</i> 2006; <b>124</b>(2): 407–21. <a target=xrefwindow id=d28331e4287 href="http://www.ncbi.nlm.nih.gov/pubmed/16439213">PubMed Abstract </a> | <a target=xrefwindow id=d28331e4290 href="https://doi.org/10.1016/j.cell.2005.10.041">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1030778">F1000 Recommendation</a></span></li><li><a name=ref-116 class=n-a></a><span class=label>116. </span>&nbsp;<span class=citation><a name=d28331e4303 class=n-a></a>Weaver CH, Hazelton B, Birch R, <i> et al.</i>: An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. <i>Blood.</i> 1995; <b>86</b>(10): 3961–9. <a target=xrefwindow id=d28331e4314 href="http://www.ncbi.nlm.nih.gov/pubmed/7579367">PubMed Abstract </a> | <a target=xrefwindow id=d28331e4317 href="https://doi.org/10.1182/blood.V86.10.3961.bloodjournal86103961">Publisher Full Text </a></span></li><li><a name=ref-117 class=n-a></a><span class=label>117. </span>&nbsp;<span class=citation><a name=d28331e4326 class=n-a></a>Bensinger W, Appelbaum F, Rowley S, <i> et al.</i>: Factors that influence collection and engraftment of autologous peripheral-blood stem cells. <i>J Clin Oncol.</i> 1995; <b>13</b>(10): 2547–55. <a target=xrefwindow id=d28331e4337 href="http://www.ncbi.nlm.nih.gov/pubmed/7595706">PubMed Abstract </a> | <a target=xrefwindow id=d28331e4340 href="https://doi.org/10.1200/JCO.1995.13.10.2547">Publisher Full Text </a></span></li><li><a name=ref-118 class=n-a></a><span class=label>118. </span>&nbsp;<span class=citation><a name=d28331e4349 class=n-a></a>Benedetti G, Patoia L, Giglietti A, <i> et al.</i>: Very large amounts of peripheral blood progenitor cells eliminate severe thrombocytopenia after high-dose melphalan in advanced breast cancer patients. <i>Bone Marrow Transplant.</i> 1999; <b>24</b>(9): 971–9. <a target=xrefwindow id=d28331e4360 href="http://www.ncbi.nlm.nih.gov/pubmed/10556956">PubMed Abstract </a> | <a target=xrefwindow id=d28331e4363 href="https://doi.org/10.1038/sj.bmt.1702008">Publisher Full Text </a></span></li><li><a name=ref-119 class=n-a></a><span class=label>119. </span>&nbsp;<span class=citation><a name=d28331e4372 class=n-a></a>Russell NH, Hunter A, Rogers S, <i> et al.</i>: Peripheral blood stem cells as an alternative to marrow for allogeneic transplantation. <i>Lancet.</i> 1993; <b>341</b>(8858): 1482. <a target=xrefwindow id=d28331e4383 href="http://www.ncbi.nlm.nih.gov/pubmed/8099182">PubMed Abstract </a> | <a target=xrefwindow id=d28331e4386 href="https://doi.org/10.1016/0140-6736(93)90929-b">Publisher Full Text </a></span></li><li><a name=ref-120 class=n-a></a><span class=label>120. </span>&nbsp;<span class=citation><a name=d28331e4396 class=n-a></a>van Besien K, Shore T, Cushing M: Peripheral-blood versus bone marrow stem cells. <i>N Engl J Med.</i> 2013; <b>368</b>(3): 287–8. <a target=xrefwindow id=d28331e4404 href="http://www.ncbi.nlm.nih.gov/pubmed/23323912 ">PubMed Abstract </a> | <a target=xrefwindow id=d28331e4407 href="https://doi.org/10.1056/NEJMc1214025">Publisher Full Text </a></span></li><li><a name=ref-121 class=n-a></a><span class=label>121. </span>&nbsp;<span class=citation><a name=d28331e4416 class=n-a></a>Mueller MM, Bialleck H, Bomke B, <i> et al.</i>: Safety and efficacy of healthy volunteer stem cell mobilization with filgrastim G-CSF and mobilized stem cell apheresis: results of a prospective longitudinal 5-year follow-up study. <i>Vox Sang.</i> 2013; <b>104</b>(1): 46–54. <a target=xrefwindow id=d28331e4427 href="http://www.ncbi.nlm.nih.gov/pubmed/22827736">PubMed Abstract </a> | <a target=xrefwindow id=d28331e4430 href="https://doi.org/10.1111/j.1423-0410.2012.01632.x">Publisher Full Text </a></span></li><li><a name=ref-122 class=n-a></a><span class=label>122. </span>&nbsp;<span class=citation><a name=d28331e4439 class=n-a></a>Hölig K, Kramer M, Kroschinsky F, <i> et al.</i>: Safety and efficacy of hematopoietic stem cell collection from mobilized peripheral blood in unrelated volunteers: 12 years of single-center experience in 3928 donors. <i>Blood.</i> 2009; <b>114</b>(18): 3757–63. <a target=xrefwindow id=d28331e4450 href="http://www.ncbi.nlm.nih.gov/pubmed/19666868">PubMed Abstract </a> | <a target=xrefwindow id=d28331e4453 href="https://doi.org/10.1182/blood-2009-04-218651">Publisher Full Text </a></span></li><li><a name=ref-123 class=n-a></a><span class=label>123. </span>&nbsp;<span class=citation><a name=d28331e4462 class=n-a></a>Salvucci O, Jiang K, Gasperini P, <i> et al.</i>: MicroRNA126 contributes to granulocyte colony-stimulating factor-induced hematopoietic progenitor cell mobilization by reducing the expression of vascular cell adhesion molecule 1. <i>Haematologica.</i> 2012; <b>97</b>(6): 818–26. <a target=xrefwindow id=d28331e4473 href="http://www.ncbi.nlm.nih.gov/pubmed/22271895">PubMed Abstract </a> | <a target=xrefwindow id=d28331e4476 href="https://doi.org/10.3324/haematol.2011.056945">Publisher Full Text </a> | <a target=xrefwindow id=d28331e4480 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3366645">Free Full Text </a></span></li><li><a name=ref-124 class=n-a></a><span class=label>124. </span>&nbsp;<span class=citation><a name=d28331e4489 class=n-a></a>Semerad CL, Christopher MJ, Liu F, <i> et al.</i>: G-CSF potently inhibits osteoblast activity and <i>CXCL12</i> mRNA expression in the bone marrow. <i>Blood.</i> 2005; <b>106</b>(9): 3020–7. <a target=xrefwindow id=d28331e4503 href="http://www.ncbi.nlm.nih.gov/pubmed/16037394">PubMed Abstract </a> | <a target=xrefwindow id=d28331e4507 href="https://doi.org/10.1182/blood-2004-01-0272">Publisher Full Text </a> | <a target=xrefwindow id=d28331e4510 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1895331">Free Full Text </a></span></li><li><a name=ref-125 class=n-a></a><span class=label>125. </span>&nbsp;<span class=citation><a name=d28331e4519 class=n-a></a>Winkler IG, Hendy J, Coughlin P, <i> et al.</i>: Serine protease inhibitors serpina1 and serpina3 are down-regulated in bone marrow during hematopoietic progenitor mobilization. <i>J Exp Med.</i> 2005; <b>201</b>(7): 1077–88. <a target=xrefwindow id=d28331e4530 href="http://www.ncbi.nlm.nih.gov/pubmed/15795238">PubMed Abstract </a> | <a target=xrefwindow id=d28331e4533 href="https://doi.org/10.1084/jem.20042299">Publisher Full Text </a> | <a target=xrefwindow id=d28331e4537 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2213124">Free Full Text </a></span></li><li><a name=ref-126 class=n-a></a><span class=label>126. </span>&nbsp;<span class=citation><a name=d28331e4547 class=n-a></a>Lévesque JP, Hendy J, Takamatsu Y, <i> et al.</i>: Mobilization by either cyclophosphamide or granulocyte colony-stimulating factor transforms the bone marrow into a highly proteolytic environment. <i>Exp Hematol.</i> 2002; <b>30</b>(5): 440–9. <a target=xrefwindow id=d28331e4558 href="http://www.ncbi.nlm.nih.gov/pubmed/12031650">PubMed Abstract </a> | <a target=xrefwindow id=d28331e4561 href="https://doi.org/10.1016/s0301-472x(02)00788-9">Publisher Full Text </a></span></li><li><a name=ref-127 class=n-a></a><span class=label>127. </span>&nbsp;<span class=citation><a name=d28331e4570 class=n-a></a>Lévesque JP, Hendy J, Winkler IG, <i> et al.</i>: Granulocyte colony-stimulating factor induces the release in the bone marrow of proteases that cleave c-KIT receptor (CD117) from the surface of hematopoietic progenitor cells. <i>Exp Hematol.</i> 2003; <b>31</b>(2): 109–17. <a target=xrefwindow id=d28331e4581 href="http://www.ncbi.nlm.nih.gov/pubmed/12591275">PubMed Abstract </a> | <a target=xrefwindow id=d28331e4584 href="https://doi.org/10.1016/s0301-472x(02)01028-7">Publisher Full Text </a></span></li><li><a name=ref-128 class=n-a></a><span class=label>128. </span>&nbsp;<span class=citation><a name=d28331e4593 class=n-a></a>Levesque JP, Liu F, Simmons PJ, <i> et al.</i>: Characterization of hematopoietic progenitor mobilization in protease-deficient mice. <i>Blood.</i> 2004; <b>104</b>(1): 65–72. <a target=xrefwindow id=d28331e4604 href="http://www.ncbi.nlm.nih.gov/pubmed/15010367">PubMed Abstract </a> | <a target=xrefwindow id=d28331e4607 href="https://doi.org/10.1182/blood-2003-05-1589">Publisher Full Text </a></span></li><li><a name=ref-129 class=n-a></a><span class=label>129. </span>&nbsp;<span class=citation><a name=d28331e4616 class=n-a></a>Greenbaum AM, Link DC: Mechanisms of G-CSF-mediated hematopoietic stem and progenitor mobilization. <i>Leukemia.</i> 2011; <b>25</b>(2): 211–7. <a target=xrefwindow id=d28331e4624 href="http://www.ncbi.nlm.nih.gov/pubmed/21079612">PubMed Abstract </a> | <a target=xrefwindow id=d28331e4627 href="https://doi.org/10.1038/leu.2010.248">Publisher Full Text </a></span></li><li><a name=ref-130 class=n-a></a><span class=label>130. </span>&nbsp;<span class=citation><a name=d28331e4636 class=n-a></a>Anderlini P, Przepiorka D, Huh Y, <i> et al.</i>: Duration of filgrastim mobilization and apheresis yield of CD34<sup>+</sup> progenitor cells and lymphoid subsets in normal donors for allogeneic transplantation. <i>Br J Haematol.</i> 1996; <b>93</b>(4): 940–2. <a target=xrefwindow id=d28331e4650 href="http://www.ncbi.nlm.nih.gov/pubmed/8703830">PubMed Abstract </a> | <a target=xrefwindow id=d28331e4654 href="https://doi.org/10.1046/j.1365-2141.1996.d01-1747.x">Publisher Full Text </a></span></li><li><a name=ref-131 class=n-a></a><span class=label>131. </span>&nbsp;<span class=citation><a name=d28331e4663 class=n-a></a>Anderlini P, Przepiorka D, Champlin R, <i> et al.</i>: Biologic and clinical effects of granulocyte colony-stimulating factor in normal individuals. <i>Blood.</i> 1996; <b>88</b>(8): 2819–25. <a target=xrefwindow id=d28331e4674 href="http://www.ncbi.nlm.nih.gov/pubmed/8874177">PubMed Abstract </a> | <a target=xrefwindow id=d28331e4677 href="https://doi.org/10.1182/blood.V88.8.2819.bloodjournal8882819">Publisher Full Text </a></span></li><li><a name=ref-132 class=n-a></a><span class=label>132. </span>&nbsp;<span class=citation><a name=d28331e4687 class=n-a></a>Anderlini P, Champlin RE: Biologic and molecular effects of granulocyte colony-stimulating factor in healthy individuals: recent findings and current challenges. <i>Blood.</i> 2008; <b>111</b>(4): 1767–72. <a target=xrefwindow id=d28331e4695 href="http://www.ncbi.nlm.nih.gov/pubmed/18057230">PubMed Abstract </a> | <a target=xrefwindow id=d28331e4698 href="https://doi.org/10.1182/blood-2007-07-097543">Publisher Full Text </a></span></li><li><a name=ref-133 class=n-a></a><span class=label>133. </span>&nbsp;<span class=citation><a name=d28331e4707 class=n-a></a>Karpova D, Wiercinska E, Bönig H: Mobilisierung hämatopoietischer Stammzellen. <i>Transfusionsmedizin.</i> 2013; <b>3</b>(3): 127–39. <a target=xrefwindow id=d28331e4715 href="https://doi.org/ 10.1055/s-0032-1325071">Publisher Full Text </a></span></li><li><a name=ref-134 class=n-a></a><span class=label>134. </span>&nbsp;<span class=citation><a name=d28331e4724 class=n-a></a>DiPersio JF, Micallef IN, Stiff PJ, <i> et al.</i>: Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantation for patients with non-Hodgkin's lymphoma. <i>J Clin Oncol.</i> 2009; <b>27</b>(28): 4767–73. <a target=xrefwindow id=d28331e4735 href="http://www.ncbi.nlm.nih.gov/pubmed/19720922">PubMed Abstract </a> | <a target=xrefwindow id=d28331e4738 href="https://doi.org/10.1200/JCO.2008.20.7209">Publisher Full Text </a></span></li><li><a name=ref-135 class=n-a></a><span class=label>135. </span>&nbsp;<span class=citation><a name=d28331e4747 class=n-a></a>DiPersio JF, Stadtmauer EA, Nademanee A, <i> et al.</i>: Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma. <i>Blood.</i> 2009; <b>113</b>(23): 5720–6. <a target=xrefwindow id=d28331e4758 href="http://www.ncbi.nlm.nih.gov/pubmed/19363221">PubMed Abstract </a> | <a target=xrefwindow id=d28331e4761 href="https://doi.org/10.1182/blood-2008-08-174946">Publisher Full Text </a></span></li><li><a name=ref-136 class=n-a></a><span class=label>136. </span>&nbsp;<span class=citation><a name=d28331e4770 class=n-a></a>Kymes SM, Pusic I, Lambert DL, <i> et al.</i>: Economic evaluation of plerixafor for stem cell mobilization. <i>Am J Manag Care.</i> 2012; <b>18</b>(1): 33–41. <a target=xrefwindow id=d28331e4781 href="http://www.ncbi.nlm.nih.gov/pubmed/22435747">PubMed Abstract </a> | <a target=xrefwindow id=d28331e4784 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3650087">Free Full Text </a></span></li><li><a name=ref-137 class=n-a></a><span class=label>137. </span>&nbsp;<span class=citation><a name=d28331e4793 class=n-a></a>Hosing C, Smith V, Rhodes B, <i> et al.</i>: Assessing the charges associated with hematopoietic stem cell mobilization and remobilization in patients with lymphoma and multiple myeloma undergoing autologous hematopoietic peripheral blood stem cell transplantation. <i>Transfusion.</i> 2011; <b>51</b>(6): 1300–13. <a target=xrefwindow id=d28331e4804 href="http://www.ncbi.nlm.nih.gov/pubmed/21575005">PubMed Abstract </a> | <a target=xrefwindow id=d28331e4807 href="https://doi.org/10.1111/j.1537-2995.2011.03176.x">Publisher Full Text </a></span></li><li><a name=ref-138 class=n-a></a><span class=label>138. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1120060"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28331e4817 class=n-a></a>Devine SM, Vij R, Rettig M, <i> et al.</i>: Rapid mobilization of functional donor hematopoietic cells without G-CSF using AMD3100, an antagonist of the CXCR4/SDF-1 interaction. <i>Blood.</i> 2008; <b>112</b>(4): 990–8. <a target=xrefwindow id=d28331e4828 href="http://www.ncbi.nlm.nih.gov/pubmed/18426988">PubMed Abstract </a> | <a target=xrefwindow id=d28331e4831 href="https://doi.org/10.1182/blood-2007-12-130179">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1120060">F1000 Recommendation</a></span></li><li><a name=ref-139 class=n-a></a><span class=label>139. </span>&nbsp;<span class=citation><a name=d28331e4844 class=n-a></a>Karpova D, Dauber K, Spohn G, <i> et al.</i>: The novel CXCR4 antagonist POL5551 mobilizes hematopoietic stem and progenitor cells with greater efficiency than Plerixafor. <i>Leukemia.</i> 2013; <b>27</b>(12): 2322–31. <a target=xrefwindow id=d28331e4855 href="http://www.ncbi.nlm.nih.gov/pubmed/24072044">PubMed Abstract </a> | <a target=xrefwindow id=d28331e4858 href="https://doi.org/10.1038/leu.2013.266">Publisher Full Text </a> | <a target=xrefwindow id=d28331e4862 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3865534">Free Full Text </a></span></li><li><a name=ref-140 class=n-a></a><span class=label>140. </span>&nbsp;<span class=citation><a name=d28331e4871 class=n-a></a>Karpova D, Bräuninger S, Wiercinska E, <i> et al.</i>: Mobilization of hematopoietic stem cells with the novel CXCR4 antagonist POL6326 (balixafortide) in healthy volunteers-results of a dose escalation trial. <i>J Transl Med.</i> 2017; <b>15</b>(1): 2. <a target=xrefwindow id=d28331e4882 href="http://www.ncbi.nlm.nih.gov/pubmed/28049490">PubMed Abstract </a> | <a target=xrefwindow id=d28331e4885 href="https://doi.org/10.1186/s12967-016-1107-2">Publisher Full Text </a> | <a target=xrefwindow id=d28331e4889 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5209880">Free Full Text </a></span></li><li><a name=ref-141 class=n-a></a><span class=label>141. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/13834960"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28331e4898 class=n-a></a>Winkler IG, Pettit AR, Raggatt LJ, <i> et al.</i>: Hematopoietic stem cell mobilizing agents G-CSF, cyclophosphamide or AMD3100 have distinct mechanisms of action on bone marrow HSC niches and bone formation. <i>Leukemia.</i> 2012; <b>26</b>(7): 1594–601. <a target=xrefwindow id=d28331e4909 href="http://www.ncbi.nlm.nih.gov/pubmed/22266913">PubMed Abstract </a> | <a target=xrefwindow id=d28331e4912 href="https://doi.org/10.1038/leu.2012.17">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/13834960">F1000 Recommendation</a></span></li><li><a name=ref-142 class=n-a></a><span class=label>142. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/11493958"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28331e4925 class=n-a></a>Chow A, Lucas D, Hidalgo A, <i> et al.</i>: Bone marrow CD169<sup>+</sup> macrophages promote the retention of hematopoietic stem and progenitor cells in the mesenchymal stem cell niche. <i>J Exp Med.</i> 2011; <b>208</b>(2): 261–71. <a target=xrefwindow id=d28331e4939 href="http://www.ncbi.nlm.nih.gov/pubmed/21282381">PubMed Abstract </a> | <a target=xrefwindow id=d28331e4943 href="https://doi.org/10.1084/jem.20101688">Publisher Full Text </a> | <a target=xrefwindow id=d28331e4946 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3039855">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/11493958">F1000 Recommendation</a></span></li><li><a name=ref-143 class=n-a></a><span class=label>143. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/9758956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28331e4959 class=n-a></a>Christopher MJ, Rao M, Liu F, <i> et al.</i>: Expression of the G-CSF receptor in monocytic cells is sufficient to mediate hematopoietic progenitor mobilization by G-CSF in mice. <i>J Exp Med.</i> 2011; <b>208</b>(2): 251–60. <a target=xrefwindow id=d28331e4970 href="http://www.ncbi.nlm.nih.gov/pubmed/21282380">PubMed Abstract </a> | <a target=xrefwindow id=d28331e4973 href="https://doi.org/10.1084/jem.20101700">Publisher Full Text </a> | <a target=xrefwindow id=d28331e4977 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3039862">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/9758956">F1000 Recommendation</a></span></li><li><a name=ref-144 class=n-a></a><span class=label>144. </span>&nbsp;<span class=citation><a name=d28331e4991 class=n-a></a>Liu F, Poursine-Laurent J, Link DC: Expression of the G-CSF receptor on hematopoietic progenitor cells is not required for their mobilization by G-CSF. <i>Blood.</i> 2000; <b>95</b>(10): 3025–31. <a target=xrefwindow id=d28331e4999 href="http://www.ncbi.nlm.nih.gov/pubmed/10807765">PubMed Abstract </a> | <a target=xrefwindow id=d28331e5002 href="https://doi.org/10.1182/blood.V95.10.3025">Publisher Full Text </a></span></li><li><a name=ref-145 class=n-a></a><span class=label>145. </span>&nbsp;<span class=citation><a name=d28331e5011 class=n-a></a>Albiero M, Poncina N, Ciciliot S, <i> et al.</i>: Bone Marrow Macrophages Contribute to Diabetic Stem Cell Mobilopathy by Producing Oncostatin M. <i>Diabetes.</i> 2015; <b>64</b>(8): 2957–68. <a target=xrefwindow id=d28331e5022 href="http://www.ncbi.nlm.nih.gov/pubmed/25804939">PubMed Abstract </a> | <a target=xrefwindow id=d28331e5025 href="https://doi.org/10.2337/db14-1473">Publisher Full Text </a></span></li><li><a name=ref-146 class=n-a></a><span class=label>146. </span>&nbsp;<span class=citation><a name=d28331e5034 class=n-a></a>Winkler IG, Sims NA, Pettit AR, <i> et al.</i>: Bone marrow macrophages maintain hematopoietic stem cell (HSC) niches and their depletion mobilizes HSCs. <i>Blood.</i> 2010; <b>116</b>(23): 4815–28. <a target=xrefwindow id=d28331e5045 href="http://www.ncbi.nlm.nih.gov/pubmed/20713966">PubMed Abstract </a> | <a target=xrefwindow id=d28331e5048 href="https://doi.org/10.1182/blood-2009-11-253534">Publisher Full Text </a></span></li><li><a name=ref-147 class=n-a></a><span class=label>147. </span>&nbsp;<span class=citation><a name=d28331e5057 class=n-a></a>Barbier V, Winkler IG, Lévesque JP: Mobilization of hematopoietic stem cells by depleting bone marrow macrophages. <i>Methods Mol Biol.</i> 2012; <b>904</b>: 117–38. <a target=xrefwindow id=d28331e5065 href="http://www.ncbi.nlm.nih.gov/pubmed/22890928">PubMed Abstract </a> | <a target=xrefwindow id=d28331e5068 href="https://doi.org/10.1007/978-1-61779-943-3_11">Publisher Full Text </a></span></li><li><a name=ref-148 class=n-a></a><span class=label>148. </span>&nbsp;<span class=citation><a name=d28331e5077 class=n-a></a>Minehata K, Takeuchi M, Hirabayashi Y, <i> et al.</i>: Oncostatin m maintains the hematopoietic microenvironment and retains hematopoietic progenitors in the bone marrow. <i>Int J Hematol.</i> 2006; <b>84</b>(4): 319–27. <a target=xrefwindow id=d28331e5088 href="http://www.ncbi.nlm.nih.gov/pubmed/17118758">PubMed Abstract </a> | <a target=xrefwindow id=d28331e5091 href="https://doi.org/10.1532/IJH97.06090">Publisher Full Text </a></span></li><li><a name=ref-149 class=n-a></a><span class=label>149. </span>&nbsp;<span class=citation><a name=d28331e5100 class=n-a></a>Pruijt JF, Verzaal P, van Os R, <i> et al.</i>: Neutrophils are indispensable for hematopoietic stem cell mobilization induced by interleukin-8 in mice. <i>Proc Natl Acad Sci U S A.</i> 2002; <b>99</b>(9): 6228–33. <a target=xrefwindow id=d28331e5111 href="http://www.ncbi.nlm.nih.gov/pubmed/11983913">PubMed Abstract </a> | <a target=xrefwindow id=d28331e5114 href="https://doi.org/10.1073/pnas.092112999">Publisher Full Text </a> | <a target=xrefwindow id=d28331e5118 href="http://www.ncbi.nlm.nih.gov/pmc/articles/122931">Free Full Text </a></span></li><li><a name=ref-150 class=n-a></a><span class=label>150. </span>&nbsp;<span class=citation><a name=d28331e5128 class=n-a></a>Fibbe WE, Pruijt JF, Velders GA, <i> et al.</i>: Biology of IL-8-induced stem cell mobilization. <i>Ann N Y Acad Sci.</i> 1999; <b>872</b>: 71–82. <a target=xrefwindow id=d28331e5139 href="http://www.ncbi.nlm.nih.gov/pubmed/10372112">PubMed Abstract </a> | <a target=xrefwindow id=d28331e5142 href="https://doi.org/10.1111/j.1749-6632.1999.tb08454.x">Publisher Full Text </a></span></li><li><a name=ref-151 class=n-a></a><span class=label>151. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/735646170"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28331e5151 class=n-a></a>Zhang J, Supakorndej T, Krambs JR, <i> et al.</i>: Bone marrow dendritic cells regulate hematopoietic stem/progenitor cell trafficking. <i>J Clin Invest.</i> 2019; <b>129</b>(7): 2920–31. <a target=xrefwindow id=d28331e5162 href="http://www.ncbi.nlm.nih.gov/pubmed/31039135">PubMed Abstract </a> | <a target=xrefwindow id=d28331e5165 href="https://doi.org/10.1172/JCI124829">Publisher Full Text </a> | <a target=xrefwindow id=d28331e5169 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6597218">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/735646170">F1000 Recommendation</a></span></li><li><a name=ref-152 class=n-a></a><span class=label>152. </span>&nbsp;<span class=citation><a name=d28331e5182 class=n-a></a>Rettig MP, McFarland K, Ritchey J, <i> et al.</i>: Preferential Mobilization of CD34+ Plasmacytoid Dendritic Cell Precursors by Plerixafor. <i>Blood.</i> 2009; <b>114</b>(22): 32. <a target=xrefwindow id=d28331e5193 href="https://doi.org/10.1182/blood.V114.22.32.32">Publisher Full Text </a></span></li><li><a name=ref-153 class=n-a></a><span class=label>153. </span>&nbsp;<span class=citation><a name=d28331e5202 class=n-a></a>Schroeder MA, Rettig MP, Lopez S, <i> et al.</i>: Mobilization of allogeneic peripheral blood stem cell donors with intravenous plerixafor mobilizes a unique graft. <i>Blood.</i> 2017; <b>129</b>(19): 2680–92. <a target=xrefwindow id=d28331e5213 href="http://www.ncbi.nlm.nih.gov/pubmed/28292947">PubMed Abstract </a> | <a target=xrefwindow id=d28331e5216 href="https://doi.org/10.1182/blood-2016-09-739722">Publisher Full Text </a> | <a target=xrefwindow id=d28331e5220 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5428459">Free Full Text </a></span></li><li><a name=ref-154 class=n-a></a><span class=label>154. </span>&nbsp;<span class=citation><a name=d28331e5229 class=n-a></a>Morris ES, MacDonald KP, Rowe V, <i> et al.</i>: Donor treatment with pegylated G-CSF augments the generation of IL-10-producing regulatory T cells and promotes transplantation tolerance. <i>Blood.</i> 2004; <b>103</b>(9): 3573–81. <a target=xrefwindow id=d28331e5240 href="http://www.ncbi.nlm.nih.gov/pubmed/14726406">PubMed Abstract </a> | <a target=xrefwindow id=d28331e5243 href="https://doi.org/10.1182/blood-2003-08-2864">Publisher Full Text </a></span></li><li><a name=ref-155 class=n-a></a><span class=label>155. </span>&nbsp;<span class=citation><a name=d28331e5252 class=n-a></a>Banovic T, MacDonald KP, Markey KA, <i> et al.</i>: Donor treatment with a multipegylated G-CSF maximizes graft-versus-leukemia effects. <i>Biol Blood Marrow Transplant.</i> 2009; <b>15</b>(1): 126–30. <a target=xrefwindow id=d28331e5263 href="http://www.ncbi.nlm.nih.gov/pubmed/19135951">PubMed Abstract </a> | <a target=xrefwindow id=d28331e5266 href="https://doi.org/10.1016/j.bbmt.2008.11.019">Publisher Full Text </a></span></li><li><a name=ref-156 class=n-a></a><span class=label>156. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/735844660"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28331e5276 class=n-a></a>Wilkinson AC, Ishida R, Kikuchi M, <i> et al.</i>: Long-term <i>ex vivo</i> haematopoietic-stem-cell expansion allows nonconditioned transplantation. <i>Nature.</i> 2019; <b>571</b>(7763): 117–21. <a target=xrefwindow id=d28331e5290 href="http://www.ncbi.nlm.nih.gov/pubmed/31142833">PubMed Abstract </a> | <a target=xrefwindow id=d28331e5294 href="https://doi.org/10.1038/s41586-019-1244-x">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/735844660">F1000 Recommendation</a></span></li><li><a name=ref-157 class=n-a></a><span class=label>157. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1164246"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28331e5307 class=n-a></a>Christopher MJ, Liu F, Hilton MJ, <i> et al.</i>: Suppression of CXCL12 production by bone marrow osteoblasts is a common and critical pathway for cytokine-induced mobilization. <i>Blood.</i> 2009; <b>114</b>(7): 1331–9. <a target=xrefwindow id=d28331e5318 href="http://www.ncbi.nlm.nih.gov/pubmed/19141863">PubMed Abstract </a> | <a target=xrefwindow id=d28331e5321 href="https://doi.org/10.1182/blood-2008-10-184754">Publisher Full Text </a> | <a target=xrefwindow id=d28331e5325 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2727413">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1164246">F1000 Recommendation</a></span></li><li><a name=ref-158 class=n-a></a><span class=label>158. </span>&nbsp;<span class=citation><a name=d28331e5338 class=n-a></a>Karpova D, Ritchey JK, Holt MS, <i> et al.</i>: Continuous blockade of CXCR4 results in dramatic mobilization and expansion of hematopoietic stem and progenitor cells. <i>Blood.</i> 2017; <b>129</b>(21): 2939–49. <a target=xrefwindow id=d28331e5349 href="http://www.ncbi.nlm.nih.gov/pubmed/28400375">PubMed Abstract </a> | <a target=xrefwindow id=d28331e5352 href="https://doi.org/10.1182/blood-2016-10-746909">Publisher Full Text </a> | <a target=xrefwindow id=d28331e5356 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5445573">Free Full Text </a></span></li><li><a name=ref-159 class=n-a></a><span class=label>159. </span>&nbsp;<span class=citation><a name=d28331e5365 class=n-a></a>Zhang J, Ren X, Shi W, <i> et al.</i>: Small molecule Me6TREN mobilizes hematopoietic stem/progenitor cells by activating MMP-9 expression and disrupting SDF-1/CXCR4 axis. <i>Blood.</i> 2014; <b>123</b>(3): 428–41. <a target=xrefwindow id=d28331e5376 href="http://www.ncbi.nlm.nih.gov/pubmed/24196072">PubMed Abstract </a> | <a target=xrefwindow id=d28331e5379 href="https://doi.org/10.1182/blood-2013-04-498535">Publisher Full Text </a></span></li><li><a name=ref-160 class=n-a></a><span class=label>160. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/736733072"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28331e5388 class=n-a></a>Smith-Berdan S, Bercasio A, Rajendiran S, <i> et al.</i>: Viagra Enables Efficient, Single-Day Hematopoietic Stem Cell Mobilization. <i>Stem Cell Reports.</i> 2019; <b>13</b>(5): 787–92. <a target=xrefwindow id=d28331e5399 href="http://www.ncbi.nlm.nih.gov/pubmed/31607567">PubMed Abstract </a> | <a target=xrefwindow id=d28331e5402 href="https://doi.org/10.1016/j.stemcr.2019.09.004">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/736733072">F1000 Recommendation</a></span></li><li><a name=ref-161 class=n-a></a><span class=label>161. </span>&nbsp;<span class=citation><a name=d28331e5415 class=n-a></a>Handgretinger R: New approaches to graft engineering for haploidentical bone marrow transplantation. <i>Semin Oncol.</i> 2012; <b>39</b>(6): 664–73. <a target=xrefwindow id=d28331e5423 href="http://www.ncbi.nlm.nih.gov/pubmed/23206843">PubMed Abstract </a> | <a target=xrefwindow id=d28331e5426 href="https://doi.org/10.1053/j.seminoncol.2012.09.007">Publisher Full Text </a></span></li><li><a name=ref-162 class=n-a></a><span class=label>162. </span>&nbsp;<span class=citation><a name=d28331e5436 class=n-a></a>Handgretinger R: Negative depletion of CD3(+) and TcRαβ(+) T cells. <i>Curr Opin Hematol.</i> 2012; <b>19</b>(6): 434–9. <a target=xrefwindow id=d28331e5444 href="http://www.ncbi.nlm.nih.gov/pubmed/22914586">PubMed Abstract </a> | <a target=xrefwindow id=d28331e5447 href="https://doi.org/10.1097/MOH.0b013e3283582340">Publisher Full Text </a></span></li><li><a name=ref-163 class=n-a></a><span class=label>163. </span>&nbsp;<span class=citation><a name=d28331e5456 class=n-a></a>Bethge WA, Haegele M, Faul C, <i> et al.</i>: Haploidentical allogeneic hematopoietic cell transplantation in adults with reduced-intensity conditioning and CD3/CD19 depletion: fast engraftment and low toxicity. <i>Exp Hematol.</i> 2006; <b>34</b>(12): 1746–52. <a target=xrefwindow id=d28331e5467 href="http://www.ncbi.nlm.nih.gov/pubmed/17157172">PubMed Abstract </a> | <a target=xrefwindow id=d28331e5470 href="https://doi.org/10.1016/j.exphem.2006.08.009">Publisher Full Text </a></span></li><li><a name=ref-164 class=n-a></a><span class=label>164. </span>&nbsp;<span class=citation><a name=d28331e5479 class=n-a></a>Spohn G, Wiercinska E, Karpova D, <i> et al.</i>: Automated CD34+ cell isolation of peripheral blood stem cell apheresis product. <i>Cytotherapy.</i> 2015; <b>17</b>(10): 1465–71. <a target=xrefwindow id=d28331e5490 href="http://www.ncbi.nlm.nih.gov/pubmed/25981397">PubMed Abstract </a> | <a target=xrefwindow id=d28331e5493 href="https://doi.org/10.1016/j.jcyt.2015.04.005">Publisher Full Text </a></span></li><li><a name=ref-165 class=n-a></a><span class=label>165. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/728378853"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28331e5502 class=n-a></a>Kumar S, Geiger H: HSC Niche Biology and HSC Expansion <i>Ex Vivo</i>. <i>Trends Mol Med.</i> 2017; <b>23</b>(9): 799–819. <a target=xrefwindow id=d28331e5513 href="http://www.ncbi.nlm.nih.gov/pubmed/28801069">PubMed Abstract </a> | <a target=xrefwindow id=d28331e5516 href="https://doi.org/10.1016/j.molmed.2017.07.003">Publisher Full Text </a> | <a target=xrefwindow id=d28331e5520 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5600322">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/728378853">F1000 Recommendation</a></span></li><li><a name=ref-166 class=n-a></a><span class=label>166. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725387501"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28331e5533 class=n-a></a>Eaves CJ: Hematopoietic stem cells: concepts, definitions, and the new reality. <i>Blood.</i> 2015; <b>125</b>(17): 2605–13. <a target=xrefwindow id=d28331e5541 href="http://www.ncbi.nlm.nih.gov/pubmed/25762175">PubMed Abstract </a> | <a target=xrefwindow id=d28331e5544 href="https://doi.org/10.1182/blood-2014-12-570200">Publisher Full Text </a> | <a target=xrefwindow id=d28331e5547 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4440889">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725387501">F1000 Recommendation</a></span></li><li><a name=ref-167 class=n-a></a><span class=label>167. </span>&nbsp;<span class=citation><a name=d28331e5560 class=n-a></a>Lane SW, Scadden DT, Gilliland DG: The leukemic stem cell niche: current concepts and therapeutic opportunities. <i>Blood.</i> 2009; <b>114</b>(6): 1150–7. <a target=xrefwindow id=d28331e5568 href="http://www.ncbi.nlm.nih.gov/pubmed/19401558">PubMed Abstract </a> | <a target=xrefwindow id=d28331e5571 href="https://doi.org/10.1182/blood-2009-01-202606">Publisher Full Text </a> | <a target=xrefwindow id=d28331e5574 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2723012">Free Full Text </a></span></li><li><a name=ref-168 class=n-a></a><span class=label>168. </span>&nbsp;<span class=citation><a name=d28331e5584 class=n-a></a>Schroeder MA, DiPersio JF: Mobilization of hematopoietic stem and leukemia cells. <i>J Leukoc Biol.</i> 2012; <b>91</b>(1): 47–57. <a target=xrefwindow id=d28331e5592 href="http://www.ncbi.nlm.nih.gov/pubmed/22028335">PubMed Abstract </a> | <a target=xrefwindow id=d28331e5595 href="https://doi.org/10.1189/jlb.0210085">Publisher Full Text </a></span></li><li><a name=ref-169 class=n-a></a><span class=label>169. </span>&nbsp;<span class=citation><a name=d28331e5604 class=n-a></a>Konopleva M, Tabe Y, Zeng Z, <i> et al.</i>: Therapeutic targeting of microenvironmental interactions in leukemia: mechanisms and approaches. <i>Drug Resist Updat.</i> 2009; <b>12</b>(4–5): 103–13. <a target=xrefwindow id=d28331e5615 href="http://www.ncbi.nlm.nih.gov/pubmed/19632887">PubMed Abstract </a> | <a target=xrefwindow id=d28331e5618 href="https://doi.org/10.1016/j.drup.2009.06.001">Publisher Full Text </a> | <a target=xrefwindow id=d28331e5622 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3640296">Free Full Text </a></span></li><li><a name=ref-170 class=n-a></a><span class=label>170. </span>&nbsp;<span class=citation><a name=d28331e5631 class=n-a></a>Nervi B, Ramirez P, Rettig MP, <i> et al.</i>: Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100. <i>Blood.</i> 2009; <b>113</b>(24): 6206–14. <a target=xrefwindow id=d28331e5642 href="http://www.ncbi.nlm.nih.gov/pubmed/19050309">PubMed Abstract </a> | <a target=xrefwindow id=d28331e5645 href="https://doi.org/10.1182/blood-2008-06-162123">Publisher Full Text </a> | <a target=xrefwindow id=d28331e5649 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2699239">Free Full Text </a></span></li><li><a name=ref-171 class=n-a></a><span class=label>171. </span>&nbsp;<span class=citation><a name=d28331e5658 class=n-a></a>Nervi B, Holt M, Rettig MP, <i> et al.</i>: AMD3100 Mobilizes Acute Promyelocytic Leukemia Cells from the Bone Marrow into the Peripheral Blood and Sensitizes Leukemia Cells to Chemotherapy. ASH Annu Meet Abstr. 2005. <a target=xrefwindow id=d28331e5663 href="https://ashpublications.org/blood/article/106/11/246/121023/AMD3100-Mobilizes-Acute-Promyelocytic-Leukemia">Reference Source</a></span></li><li><a name=ref-172 class=n-a></a><span class=label>172. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/5218956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28331e5672 class=n-a></a>Zeng Z, Shi YX, Samudio IJ, <i> et al.</i>: Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML. <i>Blood.</i> 2009; <b>113</b>(24): 6215–24. <a target=xrefwindow id=d28331e5683 href="http://www.ncbi.nlm.nih.gov/pubmed/18955566">PubMed Abstract </a> | <a target=xrefwindow id=d28331e5686 href="https://doi.org/10.1182/blood-2008-05-158311">Publisher Full Text </a> | <a target=xrefwindow id=d28331e5690 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2699240">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/5218956">F1000 Recommendation</a></span></li><li><a name=ref-173 class=n-a></a><span class=label>173. </span>&nbsp;<span class=citation><a name=d28331e5703 class=n-a></a>Matsunaga T, Takemoto N, Sato T, <i> et al.</i>: Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia. <i>Nat Med.</i> 2003; <b>9</b>(9): 1158–65. <a target=xrefwindow id=d28331e5714 href="http://www.ncbi.nlm.nih.gov/pubmed/12897778">PubMed Abstract </a> | <a target=xrefwindow id=d28331e5717 href="https://doi.org/10.1038/nm909">Publisher Full Text </a></span></li><li><a name=ref-174 class=n-a></a><span class=label>174. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/10982956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28331e5727 class=n-a></a>Parameswaran R, Yu M, Lim M, <i> et al.</i>: Combination of drug therapy in acute lymphoblastic leukemia with a CXCR4 antagonist. <i>Leukemia.</i> 2011; <b>25</b>(8): 1314–23. <a target=xrefwindow id=d28331e5738 href="http://www.ncbi.nlm.nih.gov/pubmed/21483439">PubMed Abstract </a> | <a target=xrefwindow id=d28331e5741 href="https://doi.org/10.1038/leu.2011.76">Publisher Full Text </a> | <a target=xrefwindow id=d28331e5745 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3135709">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/10982956">F1000 Recommendation</a></span></li><li><a name=ref-175 class=n-a></a><span class=label>175. </span>&nbsp;<span class=citation><a name=d28331e5758 class=n-a></a>Hsieh YT, Gang EJ, Geng H, <i> et al.</i>: Integrin alpha4 blockade sensitizes drug resistant pre-B acute lymphoblastic leukemia to chemotherapy. <i>Blood.</i> 2013; <b>121</b>(10): 1814–8. <a target=xrefwindow id=d28331e5769 href="http://www.ncbi.nlm.nih.gov/pubmed/23319569">PubMed Abstract </a> | <a target=xrefwindow id=d28331e5772 href="https://doi.org/10.1182/blood-2012-01-406272">Publisher Full Text </a> | <a target=xrefwindow id=d28331e5776 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3591800">Free Full Text </a></span></li><li><a name=ref-176 class=n-a></a><span class=label>176. </span>&nbsp;<span class=citation><a name=d28331e5785 class=n-a></a>Burger M, Hartmann T, Krome M, <i> et al.</i>: Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells. <i>Blood.</i> 2005; <b>106</b>(5): 1824–30. <a target=xrefwindow id=d28331e5796 href="http://www.ncbi.nlm.nih.gov/pubmed/15905192">PubMed Abstract </a> | <a target=xrefwindow id=d28331e5799 href="https://doi.org/10.1182/blood-2004-12-4918">Publisher Full Text </a></span></li><li><a name=ref-177 class=n-a></a><span class=label>177. </span>&nbsp;<span class=citation><a name=d28331e5808 class=n-a></a>Azab AK, Runnels JM, Pitsillides C, <i> et al.</i>: CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy. <i>Blood.</i> 2009; <b>113</b>(18): 4341–51. <a target=xrefwindow id=d28331e5819 href="http://www.ncbi.nlm.nih.gov/pubmed/19139079">PubMed Abstract </a> | <a target=xrefwindow id=d28331e5822 href="https://doi.org/10.1182/blood-2008-10-186668">Publisher Full Text </a> | <a target=xrefwindow id=d28331e5826 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2676090">Free Full Text </a></span></li><li><a name=ref-178 class=n-a></a><span class=label>178. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717847964"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28331e5835 class=n-a></a>Uy GL, Rettig MP, Motabi IH, <i> et al.</i>: A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia. <i>Blood.</i> 2012; <b>119</b>(17): 3917–24. <a target=xrefwindow id=d28331e5846 href="http://www.ncbi.nlm.nih.gov/pubmed/22308295">PubMed Abstract </a> | <a target=xrefwindow id=d28331e5849 href="https://doi.org/10.1182/blood-2011-10-383406">Publisher Full Text </a> | <a target=xrefwindow id=d28331e5853 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3350358">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717847964">F1000 Recommendation</a></span></li><li><a name=ref-179 class=n-a></a><span class=label>179. </span>&nbsp;<span class=citation><a name=d28331e5866 class=n-a></a>Uy GL, Rettig MP, Stone RM, <i> et al.</i>: A phase 1/2 study of chemosensitization with plerixafor plus G-CSF in relapsed or refractory acute myeloid leukemia. <i>Blood Cancer J.</i> 2017; <b>7</b>(3): e542. <a target=xrefwindow id=d28331e5877 href="http://www.ncbi.nlm.nih.gov/pubmed/28282031">PubMed Abstract </a> | <a target=xrefwindow id=d28331e5880 href="https://doi.org/10.1038/bcj.2017.21">Publisher Full Text </a> | <a target=xrefwindow id=d28331e5884 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5380905">Free Full Text </a></span></li><li><a name=ref-180 class=n-a></a><span class=label>180. </span>&nbsp;<span class=citation><a name=d28331e5894 class=n-a></a>Beider K, Begin M, Abraham M, <i> et al.</i>: CXCR4 antagonist 4F-benzoyl-TN14003 inhibits leukemia and multiple myeloma tumor growth. <i>Exp Hematol.</i> 2011; <b>39</b>(3): 282–92. <a target=xrefwindow id=d28331e5905 href="http://www.ncbi.nlm.nih.gov/pubmed/21138752">PubMed Abstract </a> | <a target=xrefwindow id=d28331e5908 href="https://doi.org/10.1016/j.exphem.2010.11.010">Publisher Full Text </a></span></li><li><a name=ref-181 class=n-a></a><span class=label>181. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1040702"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28331e5917 class=n-a></a>Chen J, Larochelle A, Fricker S, <i> et al.</i>: Mobilization as a preparative regimen for hematopoietic stem cell transplantation. <i>Blood.</i> 2006; <b>107</b>(9): 3764–71. <a target=xrefwindow id=d28331e5928 href="http://www.ncbi.nlm.nih.gov/pubmed/16439683">PubMed Abstract </a> | <a target=xrefwindow id=d28331e5931 href="https://doi.org/10.1182/blood-2005-09-3593">Publisher Full Text </a> | <a target=xrefwindow id=d28331e5935 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1895779">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1040702">F1000 Recommendation</a></span></li><li><a name=ref-182 class=n-a></a><span class=label>182. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726406351"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28331e5948 class=n-a></a>Palchaudhuri R, Saez B, Hoggatt J, <i> et al.</i>: Non-genotoxic conditioning for hematopoietic stem cell transplantation using a hematopoietic-cell-specific internalizing immunotoxin. <i>Nat Biotechnol.</i> 2016; <b>34</b>(7): 738–45. <a target=xrefwindow id=d28331e5959 href="http://www.ncbi.nlm.nih.gov/pubmed/27272386">PubMed Abstract </a> | <a target=xrefwindow id=d28331e5962 href="https://doi.org/10.1038/nbt.3584">Publisher Full Text </a> | <a target=xrefwindow id=d28331e5966 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5179034">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726406351">F1000 Recommendation</a></span></li><li><a name=ref-183 class=n-a></a><span class=label>183. </span>&nbsp;<span class=citation><a name=d28331e5979 class=n-a></a>Pang WW, Czechowicz A, Poyser J, <i> et al.</i>: Anti-Human CD117 Antibodies Mediate Clearance of Myelodysplastic Syndrome Hematopoietic Stem Cells and Facilitate Establishment of Normal Hematopoiesis in Transplantation. <i>Biol Blood Marrow Transplant.</i> 2018; <b>24</b>(3): S230–S231. <a target=xrefwindow id=d28331e5990 href="https://doi.org/10.1016/j.bbmt.2017.12.211">Publisher Full Text </a></span></li><li><a name=ref-184 class=n-a></a><span class=label>184. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1098140"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28331e5999 class=n-a></a>Czechowicz A, Kraft D, Weissman IL, <i> et al.</i>: Efficient transplantation via antibody-based clearance of hematopoietic stem cell niches. <i>Science.</i> 2007; <b>318</b>(5854): 1296–9. <a target=xrefwindow id=d28331e6010 href="http://www.ncbi.nlm.nih.gov/pubmed/18033883">PubMed Abstract </a> | <a target=xrefwindow id=d28331e6013 href="https://doi.org/10.1126/science.1149726">Publisher Full Text </a> | <a target=xrefwindow id=d28331e6017 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2527021">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1098140">F1000 Recommendation</a></span></li><li><a name=ref-185 class=n-a></a><span class=label>185. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/735034391"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28331e6030 class=n-a></a>Czechowicz A, Palchaudhuri R, Scheck A, <i> et al.</i>: Selective hematopoietic stem cell ablation using CD117-antibody-drug-conjugates enables safe and effective transplantation with immunity preservation. <i>Nat Commun.</i> 2019; <b>10</b>(1): 617. <a target=xrefwindow id=d28331e6041 href="http://www.ncbi.nlm.nih.gov/pubmed/30728354">PubMed Abstract </a> | <a target=xrefwindow id=d28331e6044 href="https://doi.org/10.1038/s41467-018-08201-x">Publisher Full Text </a> | <a target=xrefwindow id=d28331e6048 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6365495">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/735034391">F1000 Recommendation</a></span></li><li><a name=ref-186 class=n-a></a><span class=label>186. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/735980719"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28331e6062 class=n-a></a>George BM, Kao KS, Kwon HS, <i> et al.</i>: Antibody Conditioning Enables MHC-Mismatched Hematopoietic Stem Cell Transplants and Organ Graft Tolerance. <i>Cell Stem Cell.</i> 2019; <b>25</b>(2): 185–192.e3. <a target=xrefwindow id=d28331e6073 href="http://www.ncbi.nlm.nih.gov/pubmed/31204177">PubMed Abstract </a> | <a target=xrefwindow id=d28331e6076 href="https://doi.org/10.1016/j.stem.2019.05.018">Publisher Full Text </a> | <a target=xrefwindow id=d28331e6080 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6679784">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/735980719">F1000 Recommendation</a></span></li><li><a name=ref-187 class=n-a></a><span class=label>187. </span>&nbsp;<span class=citation><a name=d28331e6093 class=n-a></a>Kim AG, Vrecenak JD, Boelig MM, <i> et al.</i>: Enhanced <i>in utero</i> allogeneic engraftment in mice after mobilizing fetal HSCs by α4β1/7 inhibition. <i>Blood.</i> 2016; <b>128</b>(20): 2457–61. <a target=xrefwindow id=d28331e6107 href="http://www.ncbi.nlm.nih.gov/pubmed/27650329 ">PubMed Abstract </a> | <a target=xrefwindow id=d28331e6111 href="https://doi.org/10.1182/blood-2016-06-723981">Publisher Full Text </a> | <a target=xrefwindow id=d28331e6114 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5114489">Free Full Text </a></span></li><li><a name=ref-188 class=n-a></a><span class=label>188. </span>&nbsp;<span class=citation><a name=d28331e6123 class=n-a></a>Byrne SM, Mali P, Church GM: Genome editing in human stem cells. <i>Meth Enzymol.</i> 2014; <b>546</b>: 119–38. <a target=xrefwindow id=d28331e6131 href="http://www.ncbi.nlm.nih.gov/pubmed/25398338">PubMed Abstract </a> | <a target=xrefwindow id=d28331e6134 href="https://doi.org/10.1016/B978-0-12-801185-0.00006-4">Publisher Full Text </a> | <a target=xrefwindow id=d28331e6137 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4408990">Free Full Text </a></span></li><li><a name=ref-189 class=n-a></a><span class=label>189. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726606529"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28331e6146 class=n-a></a>Yu KR, Natanson H, Dunbar CE: Gene Editing of Human Hematopoietic Stem and Progenitor Cells: Promise and Potential Hurdles. <i>Hum Gene Ther.</i> 2016; <b>27</b>(10): 729–40. <a target=xrefwindow id=d28331e6154 href="http://www.ncbi.nlm.nih.gov/pubmed/27483988">PubMed Abstract </a> | <a target=xrefwindow id=d28331e6157 href="https://doi.org/10.1089/hum.2016.107">Publisher Full Text </a> | <a target=xrefwindow id=d28331e6160 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5035911">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726606529">F1000 Recommendation</a></span></li><li><a name=ref-190 class=n-a></a><span class=label>190. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732568497"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28331e6173 class=n-a></a>Bak RO, Dever DP, Porteus MH: CRISPR/Cas9 genome editing in human hematopoietic stem cells. <i>Nat Protoc.</i> 2018; <b>13</b>(2): 358–76. <a target=xrefwindow id=d28331e6181 href="http://www.ncbi.nlm.nih.gov/pubmed/29370156">PubMed Abstract </a> | <a target=xrefwindow id=d28331e6184 href="https://doi.org/10.1038/nprot.2017.143">Publisher Full Text </a> | <a target=xrefwindow id=d28331e6187 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5826598">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732568497">F1000 Recommendation</a></span></li><li><a name=ref-191 class=n-a></a><span class=label>191. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733321342"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28331e6200 class=n-a></a>Kuo CY, Long JD, Campo-Fernandez B, <i> et al.</i>: Site-Specific Gene Editing of Human Hematopoietic Stem Cells for X-Linked Hyper-IgM Syndrome. <i>Cell Rep.</i> 2018; <b>23</b>(9): 2606–16. <a target=xrefwindow id=d28331e6211 href="http://www.ncbi.nlm.nih.gov/pubmed/29847792">PubMed Abstract </a> | <a target=xrefwindow id=d28331e6214 href="https://doi.org/10.1016/j.celrep.2018.04.103">Publisher Full Text </a> | <a target=xrefwindow id=d28331e6218 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6181643">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733321342">F1000 Recommendation</a></span></li><li><a name=ref-192 class=n-a></a><span class=label>192. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/735294742"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28331e6232 class=n-a></a>Cavazzana M, Bushman FD, Miccio A, <i> et al.</i>: Gene therapy targeting haematopoietic stem cells for inherited diseases: progress and challenges. <i>Nat Rev Drug Discov.</i> 2019; <b>18</b>(6): 447–62. <a target=xrefwindow id=d28331e6243 href="http://www.ncbi.nlm.nih.gov/pubmed/30858502">PubMed Abstract </a> | <a target=xrefwindow id=d28331e6246 href="https://doi.org/10.1038/s41573-019-0020-9">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/735294742">F1000 Recommendation</a></span></li><li><a name=ref-193 class=n-a></a><span class=label>193. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/734898392"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28331e6259 class=n-a></a>Naldini L: Genetic engineering of hematopoiesis: current stage of clinical translation and future perspectives. <i>EMBO Mol Med.</i> 2019; <b>11</b>(3): pii: e9958. <a target=xrefwindow id=d28331e6267 href="http://www.ncbi.nlm.nih.gov/pubmed/30670463">PubMed Abstract </a> | <a target=xrefwindow id=d28331e6270 href="https://doi.org/10.15252/emmm.201809958">Publisher Full Text </a> | <a target=xrefwindow id=d28331e6273 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6404113">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/734898392">F1000 Recommendation</a></span></li><li><a name=ref-194 class=n-a></a><span class=label>194. </span>&nbsp;<span class=citation><a name=d28331e6286 class=n-a></a>Yannaki E, Karponi G, Zervou F, <i> et al.</i>: Hematopoietic stem cell mobilization for gene therapy: superior mobilization by the combination of granulocyte-colony stimulating factor plus plerixafor in patients with β-thalassemia major. <i>Hum Gene Ther.</i> 2013; <b>24</b>(10): 852–60. <a target=xrefwindow id=d28331e6297 href="http://www.ncbi.nlm.nih.gov/pubmed/24001178">PubMed Abstract </a> | <a target=xrefwindow id=d28331e6300 href="https://doi.org/10.1089/hum.2013.163">Publisher Full Text </a> | <a target=xrefwindow id=d28331e6304 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3787462">Free Full Text </a></span></li><li><a name=ref-195 class=n-a></a><span class=label>195. </span>&nbsp;<span class=citation><a name=d28331e6313 class=n-a></a>Yannaki E, Papayannopoulou T, Jonlin E, <i> et al.</i>: Hematopoietic stem cell mobilization for gene therapy of adult patients with severe β-thalassemia: results of clinical trials using G-CSF or plerixafor in splenectomized and nonsplenectomized subjects. <i>Mol Ther.</i> 2012; <b>20</b>(1): 230–8. <a target=xrefwindow id=d28331e6324 href="http://www.ncbi.nlm.nih.gov/pubmed/21952171">PubMed Abstract </a> | <a target=xrefwindow id=d28331e6327 href="https://doi.org/10.1038/mt.2011.195">Publisher Full Text </a> | <a target=xrefwindow id=d28331e6331 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3255592">Free Full Text </a></span></li><li><a name=ref-196 class=n-a></a><span class=label>196. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726669175"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28331e6340 class=n-a></a>Richter M, Saydaminova K, Yumul R, <i> et al.</i>: <i>In vivo</i> transduction of primitive mobilized hematopoietic stem cells after intravenous injection of integrating adenovirus vectors. <i>Blood.</i> 2016; <b>128</b>(18): 2206–17. <a target=xrefwindow id=d28331e6354 href="http://www.ncbi.nlm.nih.gov/pubmed/27554082">PubMed Abstract </a> | <a target=xrefwindow id=d28331e6358 href="https://doi.org/10.1182/blood-2016-04-711580">Publisher Full Text </a> | <a target=xrefwindow id=d28331e6361 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5095755">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726669175">F1000 Recommendation</a></span></li><li><a name=ref-197 class=n-a></a><span class=label>197. </span>&nbsp;<span class=citation><a name=d28331e6374 class=n-a></a>Casanova-Acebes M, Pitaval C, Weiss LA, <i> et al.</i>: Rhythmic modulation of the hematopoietic niche through neutrophil clearance. <i>Cell.</i> 2013; <b>153</b>(5): 1025–35. <a target=xrefwindow id=d28331e6385 href="http://www.ncbi.nlm.nih.gov/pubmed/23706740">PubMed Abstract </a> | <a target=xrefwindow id=d28331e6388 href="https://doi.org/10.1016/j.cell.2013.04.040">Publisher Full Text </a> | <a target=xrefwindow id=d28331e6392 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4128329">Free Full Text </a></span></li><li><a name=ref-198 class=n-a></a><span class=label>198. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1129819"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28331e6402 class=n-a></a>Lucas D, Battista M, Shi PA, <i> et al.</i>: Mobilized hematopoietic stem cell yield depends on species-specific circadian timing. <i>Cell Stem Cell.</i> 2008; <b>3</b>(4): 364–6. <a target=xrefwindow id=d28331e6413 href="http://www.ncbi.nlm.nih.gov/pubmed/18940728">PubMed Abstract </a> | <a target=xrefwindow id=d28331e6416 href="https://doi.org/10.1016/j.stem.2008.09.004">Publisher Full Text </a> | <a target=xrefwindow id=d28331e6420 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4089094">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1129819">F1000 Recommendation</a></span></li><li><a name=ref-199 class=n-a></a><span class=label>199. </span>&nbsp;<span class=citation><a name=d28331e6433 class=n-a></a>Harris JE, Ford CE, Barnes DW, <i> et al.</i>: Evidence from Parabiosis for an Afferent Stream of Cells. <i>Nature.</i> 1964; <b>201</b>: 886–7. <a target=xrefwindow id=d28331e6444 href="http://www.ncbi.nlm.nih.gov/pubmed/14132780">PubMed Abstract </a> | <a target=xrefwindow id=d28331e6447 href="https://doi.org/10.1038/201886a0">Publisher Full Text </a></span></li><li><a name=ref-200 class=n-a></a><span class=label>200. </span>&nbsp;<span class=citation><a name=d28331e6456 class=n-a></a>McBride RA, Simonsen M: Cellular and Humoral Phenomena during the Inductive Phase of Parabiosis Tolerance. <i>Transplantation.</i> 1965; <b>3</b>: 140–54. <a target=xrefwindow id=d28331e6464 href="http://www.ncbi.nlm.nih.gov/pubmed/14265491">PubMed Abstract </a> | <a target=xrefwindow id=d28331e6467 href="https://doi.org/10.1097/00007890-196503000-00002">Publisher Full Text </a></span></li><li><a name=ref-201 class=n-a></a><span class=label>201. </span>&nbsp;<span class=citation><a name=d28331e6476 class=n-a></a>Croizat H, Frindel E, Tubiana M: The effect of partial body irradiation on haemopoietic stem cell migration. <i>Cell Tissue Kinet.</i> 1980; <b>13</b>(3): 319–25. <a target=xrefwindow id=d28331e6484 href="http://www.ncbi.nlm.nih.gov/pubmed/7371068">PubMed Abstract </a> | <a target=xrefwindow id=d28331e6487 href="https://doi.org/10.1111/j.1365-2184.1980.tb00470.x">Publisher Full Text </a></span></li><li><a name=ref-202 class=n-a></a><span class=label>202. </span>&nbsp;<span class=citation><a name=d28331e6496 class=n-a></a>Murate T, Utsumi M, Hotta T, <i> et al.</i>: Hematopoietic stem cell migration and proliferation after partial body irradiation: Significant role of the spleen in hematopoietic recovery. <i>Nippon Ketsueki Gakkai Zasshi.</i> 1983; <b>46</b>(4): 867–75. <a target=xrefwindow id=d28331e6507 href="http://www.ncbi.nlm.nih.gov/pubmed/6637341">PubMed Abstract </a></span></li><li><a name=ref-203 class=n-a></a><span class=label>203. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1097167"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28331e6516 class=n-a></a>Massberg S, Schaerli P, Knezevic-Maramica I, <i> et al.</i>: Immunosurveillance by Hematopoietic Progenitor Cells Trafficking through Blood, Lymph, and Peripheral Tissues. <i>Cell.</i> 2007; <b>131</b>(5): 994–1008. <a target=xrefwindow id=d28331e6527 href="http://www.ncbi.nlm.nih.gov/pubmed/18045540">PubMed Abstract </a> | <a target=xrefwindow id=d28331e6530 href="https://doi.org/10.1016/j.cell.2007.09.047">Publisher Full Text </a> | <a target=xrefwindow id=d28331e6534 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2330270">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1097167">F1000 Recommendation</a></span></li><li><a name=ref-204 class=n-a></a><span class=label>204. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/734520032"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28331e6548 class=n-a></a>Fu J, Zuber J, Martinez M, <i> et al.</i>: Human Intestinal Allografts Contain Functional Hematopoietic Stem and Progenitor Cells that Are Maintained by a Circulating Pool. <i>Cell Stem Cell.</i> 2019; <b>24</b>(2): 227–239.e8. <a target=xrefwindow id=d28331e6559 href="http://www.ncbi.nlm.nih.gov/pubmed/30503142">PubMed Abstract </a> | <a target=xrefwindow id=d28331e6562 href="https://doi.org/10.1016/j.stem.2018.11.007">Publisher Full Text </a> | <a target=xrefwindow id=d28331e6566 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6398344">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/734520032">F1000 Recommendation</a></span></li><li><a name=ref-205 class=n-a></a><span class=label>205. </span>&nbsp;<span class=citation><a name=d28331e6579 class=n-a></a>Bettinotti MP, Lucas DP, Ghiaur G, <i> et al.</i>: HLA-Class I and II Antigens are Expressed in CD34+ Cells: Implications for HLA Mismatched Bone Marrow Transplantation (BMT). <i>Biol Blood Marrow Transplant.</i> 2018; <b>24</b>(3): S420–S421. <a target=xrefwindow id=d28331e6590 href="https://doi.org/10.1016/j.bbmt.2017.12.431">Publisher Full Text </a></span></li><li><a name=ref-206 class=n-a></a><span class=label>206. </span>&nbsp;<span class=citation><a name=d28331e6599 class=n-a></a>Greinix HT, Storb R, Bartelmez SH: Specific growth inhibition of primitive hematopoietic progenitor cells mediated through monoclonal antibody binding to major histocompatibility class II molecules. <i>Blood.</i> 1992; <b>80</b>(8): 1950–6. <a target=xrefwindow id=d28331e6607 href="http://www.ncbi.nlm.nih.gov/pubmed/1382714">PubMed Abstract </a></span></li><li><a name=ref-207 class=n-a></a><span class=label>207. </span>&nbsp;<span class=citation><a name=d28331e6616 class=n-a></a>Roberts AW, Foote S, Alexander WS, <i> et al.</i>: Genetic Influences Determining Progenitor Cell Mobilization and Leukocytosis Induced by Granulocyte Colony-Stimulating Factor. <i>Blood.</i> 1997; <b>89</b>(8): 2736–44. <a target=xrefwindow id=d28331e6627 href="http://www.ncbi.nlm.nih.gov/pubmed/9108391">PubMed Abstract </a> | <a target=xrefwindow id=d28331e6630 href="https://doi.org/10.1182/blood.V89.8.2736">Publisher Full Text </a></span></li><li><a name=ref-208 class=n-a></a><span class=label>208. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/5666969"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28331e6639 class=n-a></a>Ryan MA, Nattamai KJ, Xing E, <i> et al.</i>: Pharmacological inhibition of EGFR signaling enhances G-CSF-induced hematopoietic stem cell mobilization. <i>Nat Med.</i> 2010; <b>16</b>(10): 1141–6. <a target=xrefwindow id=d28331e6650 href="http://www.ncbi.nlm.nih.gov/pubmed/20871610">PubMed Abstract </a> | <a target=xrefwindow id=d28331e6653 href="https://doi.org/10.1038/nm.2217">Publisher Full Text </a> | <a target=xrefwindow id=d28331e6657 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4464748">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/5666969">F1000 Recommendation</a></span></li><li><a name=ref-209 class=n-a></a><span class=label>209. </span>&nbsp;<span class=citation><a name=d28331e6670 class=n-a></a>Cohen KS, Cheng S, Larson MG, <i> et al.</i>: Circulating CD34<sup>+</sup> progenitor cell frequency is associated with clinical and genetic factors. <i>Blood.</i> 2013; <b>121</b>(8): e50–e56. <a target=xrefwindow id=d28331e6684 href="http://www.ncbi.nlm.nih.gov/pubmed/23287867">PubMed Abstract </a> | <a target=xrefwindow id=d28331e6688 href="https://doi.org/10.1182/blood-2012-05-424846">Publisher Full Text </a> | <a target=xrefwindow id=d28331e6691 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3578962">Free Full Text </a></span></li><li><a name=ref-210 class=n-a></a><span class=label>210. </span>&nbsp;<span class=citation><a name=d28331e6701 class=n-a></a>Bogunia-Kubik K, Gieryng A, Dlubek D, <i> et al.</i>: The CXCL12-3'A allele is associated with a higher mobilization yield of CD34 progenitors to the peripheral blood of healthy donors for allogeneic transplantation. <i>Bone Marrow Transplant.</i> 2009; <b>44</b>(5): 273–8. <a target=xrefwindow id=d28331e6712 href="http://www.ncbi.nlm.nih.gov/pubmed/19252530">PubMed Abstract </a> | <a target=xrefwindow id=d28331e6715 href="https://doi.org/10.1038/bmt.2009.30">Publisher Full Text </a></span></li><li><a name=ref-211 class=n-a></a><span class=label>211. </span>&nbsp;<span class=citation><a name=d28331e6724 class=n-a></a>B MA, M C, A B, <i> et al.</i>: VCAM1 RS1041163 polymorphism influences G-CSF mobilization of CD34+ cells. <i>Haematologica.</i> 2010. </span></li><li><a name=ref-212 class=n-a></a><span class=label>212. </span>&nbsp;<span class=citation><a name=d28331e6739 class=n-a></a>Martin-Antonio B, Carmona M, Falantes J, <i> et al.</i>: Impact of constitutional polymorphisms in <i>VCAM1</i> and <i>CD44</i> on CD34<sup>+</sup> cell collection yield after administration of granulocyte colony-stimulating factor to healthy donors. <i>Haematologica.</i> 2011; <b>96</b>(1): 102–9. <a target=xrefwindow id=d28331e6760 href="http://www.ncbi.nlm.nih.gov/pubmed/20851866">PubMed Abstract </a> | <a target=xrefwindow id=d28331e6763 href="https://doi.org/10.3324/haematol.2010.026401">Publisher Full Text </a> | <a target=xrefwindow id=d28331e6766 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3012773">Free Full Text </a></span></li><li><a name=ref-213 class=n-a></a><span class=label>213. </span>&nbsp;<span class=citation><a name=d28331e6775 class=n-a></a>Szmigielska-Kaplon A, Szemraj J, Hamara K, <i> et al.</i>: Polymorphism of CD44 influences the efficacy of CD34<sup>+</sup> cells mobilization in patients with hematological malignancies. <i>Biol Blood Marrow Transplant.</i> 2014; <b>20</b>(7): 986–91. <a target=xrefwindow id=d28331e6789 href="http://www.ncbi.nlm.nih.gov/pubmed/24680978">PubMed Abstract </a> | <a target=xrefwindow id=d28331e6793 href="https://doi.org/10.1016/j.bbmt.2014.03.019">Publisher Full Text </a></span></li><li><a name=ref-214 class=n-a></a><span class=label>214. </span>&nbsp;<span class=citation><a name=d28331e6802 class=n-a></a>Schulz M, Karpova D, Spohn G, <i> et al.</i>: Variant rs1801157 in the 3’UTR of SDF-1ß Does Not Explain Variability of Healthy-Donor G-CSF Responsiveness. <i>PLoS One.</i> 2015; <b>10</b>(3): e0121859. <a target=xrefwindow id=d28331e6813 href="http://www.ncbi.nlm.nih.gov/pubmed/25803672">PubMed Abstract </a> | <a target=xrefwindow id=d28331e6816 href="https://doi.org/10.1371/journal.pone.0121859">Publisher Full Text </a> | <a target=xrefwindow id=d28331e6820 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4372333">Free Full Text </a></span></li><li><a name=ref-215 class=n-a></a><span class=label>215. </span>&nbsp;<span class=citation><a name=d28331e6829 class=n-a></a>Schroeder MA, Rettig MP, Uy GL, <i> et al.</i>: Cxcl12 G801A Polymorphisms Do Not Predict Response to Mobilization by Plerixafor in Normal Allogeneic Stem Cell Donors. <i>Biol Blood Marrow Transplant.</i> 2012; <b>18</b>(2): S261. <a target=xrefwindow id=d28331e6840 href="https://doi.org/10.1016/j.bbmt.2011.12.169">Publisher Full Text </a></span></li><li><a name=ref-216 class=n-a></a><span class=label>216. </span>&nbsp;<span class=citation><a name=d28331e6850 class=n-a></a>To LB, Levesque JP, Herbert KE: How I treat patients who mobilize hematopoietic stem cells poorly. <i>Blood.</i> 2011; <b>118</b>(17): 4530–40. <a target=xrefwindow id=d28331e6858 href="http://www.ncbi.nlm.nih.gov/pubmed/21832280">PubMed Abstract </a> | <a target=xrefwindow id=d28331e6861 href="https://doi.org/10.1182/blood-2011-06-318220">Publisher Full Text </a></span></li><li><a name=ref-217 class=n-a></a><span class=label>217. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732456096"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28331e6870 class=n-a></a>Olivieri J, Attolico I, Nuccorini R, <i> et al.</i>: Predicting failure of hematopoietic stem cell mobilization before it starts: The predicted poor mobilizer (pPM) score. <i>Bone Marrow Transplant.</i> 2018; <b>53</b>(4): 461–73. <a target=xrefwindow id=d28331e6881 href="http://www.ncbi.nlm.nih.gov/pubmed/29330395">PubMed Abstract </a> | <a target=xrefwindow id=d28331e6884 href="https://doi.org/10.1038/s41409-017-0051-y">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732456096">F1000 Recommendation</a></span></li><li><a name=ref-218 class=n-a></a><span class=label>218. </span>&nbsp;<span class=citation><a name=d28331e6897 class=n-a></a>Bhamidipati P, Wang S, Sturgill T, <i> et al.</i>: Predicting autologous stem cell mobilization failure in hematologic malignancies. <i>Blood.</i> 2013; <b>122</b>(21): 2034. <a target=xrefwindow id=d28331e6908 href="https://doi.org/10.1182/blood.V122.21.2034.2034">Publisher Full Text </a></span></li><li><a name=ref-219 class=n-a></a><span class=label>219. </span>&nbsp;<span class=citation><a name=d28331e6917 class=n-a></a>Duong HK, Bolwell BJ, Rybicki L, <i> et al.</i>: Predicting hematopoietic stem cell mobilization failure in patients with multiple myeloma: a simple method using day 1 CD34+ cell yield. <i>J Clin Apher.</i> 2011; <b>26</b>(3): 111–5. <a target=xrefwindow id=d28331e6928 href="http://www.ncbi.nlm.nih.gov/pubmed/21647951">PubMed Abstract </a> | <a target=xrefwindow id=d28331e6931 href="https://doi.org/10.1002/jca.20278">Publisher Full Text </a></span></li><li><a name=ref-220 class=n-a></a><span class=label>220. </span>&nbsp;<span class=citation><a name=d28331e6940 class=n-a></a>Kuittinen T, Nousiainen T, Halonen P, <i> et al.</i>: Prediction of mobilisation failure in patients with non-Hodgkin's lymphoma. <i>Bone Marrow Transplant.</i> 2004; <b>33</b>(9): 907–12. <a target=xrefwindow id=d28331e6951 href="http://www.ncbi.nlm.nih.gov/pubmed/15034543">PubMed Abstract </a> | <a target=xrefwindow id=d28331e6954 href="https://doi.org/10.1038/sj.bmt.1704466">Publisher Full Text </a></span></li><li><a name=ref-221 class=n-a></a><span class=label>221. </span>&nbsp;<span class=citation><a name=d28331e6963 class=n-a></a>Giralt S, Costa L, Schriber J, <i> et al.</i>: Optimizing Autologous Stem Cell Mobilization Strategies to Improve Patient Outcomes: Consensus Guidelines and Recommendations. <i>Biol Blood Marrow Transplant.</i> 2014; <b>20</b>(3): 295–308. <a target=xrefwindow id=d28331e6974 href="http://www.ncbi.nlm.nih.gov/pubmed/24141007">PubMed Abstract </a> | <a target=xrefwindow id=d28331e6977 href="https://doi.org/10.1016/j.bbmt.2013.10.013">Publisher Full Text </a></span></li><li><a name=ref-222 class=n-a></a><span class=label>222. </span>&nbsp;<span class=citation><a name=d28331e6987 class=n-a></a>Jiang L, Malik S, Litzow M, <i> et al.</i>: Hematopoietic stem cells from poor and good mobilizers are qualitatively equivalent. <i>Transfusion.</i> 2012; <b>52</b>(3): 542–8. <a target=xrefwindow id=d28331e6998 href="http://www.ncbi.nlm.nih.gov/pubmed/21827503">PubMed Abstract </a> | <a target=xrefwindow id=d28331e7001 href="https://doi.org/10.1111/j.1537-2995.2011.03286.x">Publisher Full Text </a> | <a target=xrefwindow id=d28331e7005 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3214250">Free Full Text </a></span></li><li><a name=ref-223 class=n-a></a><span class=label>223. </span>&nbsp;<span class=citation><a name=d28331e7014 class=n-a></a>Papayannopoulou T, Nakamoto B, Andrews RG, <i> et al.</i>: <i>In vivo</i> effects of Flt3/Flk2 ligand on mobilization of hematopoietic progenitors in primates and potent synergistic enhancement with granulocyte colony-stimulating factor. <i>Blood.</i> 1997; <b>90</b>(2): 620–9. <a target=xrefwindow id=d28331e7028 href="http://www.ncbi.nlm.nih.gov/pubmed/9226162">PubMed Abstract </a> | <a target=xrefwindow id=d28331e7032 href="https://doi.org/10.1182/blood.V90.2.620">Publisher Full Text </a></span></li><li><a name=ref-224 class=n-a></a><span class=label>224. </span>&nbsp;<span class=citation><a name=d28331e7041 class=n-a></a>Anandasabapathy N, Breton G, Hurley A, <i> et al.</i>: Efficacy and safety of CDX-301, recombinant human Flt3L, at expanding dendritic cells and hematopoietic stem cells in healthy human volunteers. <i>Bone Marrow Transplant.</i> 2015; <b>50</b>(7): 924–30. <a target=xrefwindow id=d28331e7052 href="http://www.ncbi.nlm.nih.gov/pubmed/25915810">PubMed Abstract </a> | <a target=xrefwindow id=d28331e7055 href="https://doi.org/10.1038/bmt.2015.74">Publisher Full Text </a> | <a target=xrefwindow id=d28331e7059 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4532305">Free Full Text </a></span></li><li><a name=ref-225 class=n-a></a><span class=label>225. </span>&nbsp;<span class=citation><a name=d28331e7068 class=n-a></a>Brasel K, McKenna HJ, Morrissey PJ, <i> et al.</i>: Hematologic effects of flt3 ligand <i>in vivo</i> in mice. <i>Blood.</i> 1996; <b>88</b>(6): 2004–12. <a target=xrefwindow id=d28331e7082 href="http://www.ncbi.nlm.nih.gov/pubmed/8822919">PubMed Abstract </a> | <a target=xrefwindow id=d28331e7086 href="https://doi.org/10.1182/blood.V88.6.2004.bloodjournal8862004">Publisher Full Text </a></span></li><li><a name=ref-226 class=n-a></a><span class=label>226. </span>&nbsp;<span class=citation><a name=d28331e7095 class=n-a></a>Donahue RE, Jin P, Bonifacino AC, <i> et al.</i>: Plerixafor (AMD3100) and granulocyte colony-stimulating factor (G-CSF) mobilize different CD34<sup>+</sup> cell populations based on global gene and microRNA expression signatures. <i>Blood.</i> 2009; <b>114</b>(12): 2530–41. <a target=xrefwindow id=d28331e7109 href="http://www.ncbi.nlm.nih.gov/pubmed/19602709">PubMed Abstract </a> | <a target=xrefwindow id=d28331e7113 href="https://doi.org/10.1182/blood-2009-04-214403">Publisher Full Text </a> | <a target=xrefwindow id=d28331e7116 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2746476">Free Full Text </a></span></li><li><a name=ref-227 class=n-a></a><span class=label>227. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732901785"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28331e7125 class=n-a></a>Ziegenhain C, Vieth B, Parekh S, <i> et al.</i>: Quantitative single-cell transcriptomics. <i>Brief Funct Genomics.</i> 2018; <b>17</b>(4): 220–32. <a target=xrefwindow id=d28331e7136 href="http://www.ncbi.nlm.nih.gov/pubmed/29579145">PubMed Abstract </a> | <a target=xrefwindow id=d28331e7139 href="https://doi.org/10.1093/bfgp/ely009">Publisher Full Text </a> | <a target=xrefwindow id=d28331e7143 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6063296">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732901785">F1000 Recommendation</a></span></li><li><a name=ref-228 class=n-a></a><span class=label>228. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/735077925"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28331e7157 class=n-a></a>Rodriguez-Meira A, Buck G, Clark SA, <i> et al.</i>: Unravelling Intratumoral Heterogeneity through High-Sensitivity Single-Cell Mutational Analysis and Parallel RNA Sequencing. <i>Mol Cell.</i> 2019; <b>73</b>(6): 1292–1305.e8. <a target=xrefwindow id=d28331e7168 href="http://www.ncbi.nlm.nih.gov/pubmed/30765193">PubMed Abstract </a> | <a target=xrefwindow id=d28331e7171 href="https://doi.org/10.1016/j.molcel.2019.01.009">Publisher Full Text </a> | <a target=xrefwindow id=d28331e7175 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6436961">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/735077925">F1000 Recommendation</a></span></li><li><a name=ref-229 class=n-a></a><span class=label>229. </span>&nbsp;<span class=citation><a name=d28331e7188 class=n-a></a>Petti AA, Williams SR, Miller CA, <i> et al.</i>: Mutation detection in thousands of acute myeloid leukemia cells using single cell RNA-sequencing. <i>bioRxiv</i> 2018. <a target=xrefwindow id=d28331e7196 href="https://doi.org/10.1101/434746">Publisher Full Text </a></span></li><li><a name=ref-230 class=n-a></a><span class=label>230. </span>&nbsp;<span class=citation><a name=d28331e7204 class=n-a></a>Nam AS, Kim KT, Chaligne R, <i> et al.</i>: High throughput droplet single-cell Genotyping of Transcriptomes (GoT) reveals the cell identity dependency of the impact of somatic mutations. <i>bioRxiv</i> 2018. <a target=xrefwindow id=d28331e7212 href="https://doi.org/10.1101/444687">Publisher Full Text </a></span></li><li><a name=ref-231 class=n-a></a><span class=label>231. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/735810574"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28331e7221 class=n-a></a>Baryawno N, Przybylski D, Kowalczyk MS, <i> et al.</i>: A Cellular Taxonomy of the Bone Marrow Stroma in Homeostasis and Leukemia. <i>Cell.</i> 2019; <b>177</b>(7): 1915–1932.e16. <a target=xrefwindow id=d28331e7232 href="http://www.ncbi.nlm.nih.gov/pubmed/31130381">PubMed Abstract </a> | <a target=xrefwindow id=d28331e7235 href="https://doi.org/10.1016/j.cell.2019.04.040">Publisher Full Text </a> | <a target=xrefwindow id=d28331e7239 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6570562">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/735810574">F1000 Recommendation</a></span></li><li><a name=ref-232 class=n-a></a><span class=label>232. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/736146209"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28331e7252 class=n-a></a>Severe N, Karabacak NM, Gustafsson K, <i> et al.</i>: Stress-Induced Changes in Bone Marrow Stromal Cell Populations Revealed through Single-Cell Protein Expression Mapping. <i>Cell Stem Cell.</i> 2019; <b>25</b>(4): 570–583.e7. <a target=xrefwindow id=d28331e7263 href="http://www.ncbi.nlm.nih.gov/pubmed/31279774">PubMed Abstract </a> | <a target=xrefwindow id=d28331e7266 href="https://doi.org/10.1016/j.stem.2019.06.003">Publisher Full Text </a> | <a target=xrefwindow id=d28331e7270 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6778015">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/736146209">F1000 Recommendation</a></span></li><li><a name=ref-233 class=n-a></a><span class=label>233. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/735522296"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28331e7283 class=n-a></a>Tikhonova AN, Dolgalev I, Hu H, <i> et al.</i>: The bone marrow microenvironment at single-cell resolution. <i>Nature.</i> 2019; <b>569</b>(7755): 222–8. <a target=xrefwindow id=d28331e7294 href="http://www.ncbi.nlm.nih.gov/pubmed/30971824">PubMed Abstract </a> | <a target=xrefwindow id=d28331e7297 href="https://doi.org/10.1038/s41586-019-1104-8">Publisher Full Text </a> | <a target=xrefwindow id=d28331e7301 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6607432">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/735522296">F1000 Recommendation</a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 20 Dec 2019</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/8-2125.html&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/8-2125.html&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, 69120, Germany<br/> <sup>2</sup> Division of Oncology, Department of Medicine, Washington University School of Medicine,, St. Louis, Missouri, 63110, USA<br/> <p> <div class=margin-bottom> Darja Karpova <br/> <span>Roles: </span> Conceptualization, Writing – Original Draft Preparation </div> <div class=margin-bottom> Michael P. Rettig <br/> <span>Roles: </span> Supervision, Writing – Review & Editing </div> <div class=margin-bottom> John F. DiPersio <br/> <span>Roles: </span> Supervision, Writing – Review & Editing </div> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/8-2125/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 20 Dec 2019, 8:2125 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.21129.1">https://doi.org/10.12688/f1000research.21129.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> © 2019 Karpova D <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=23258 data-id=21129 data-downloads="" data-views="" data-scholar="10.12688/f1000research.21129.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/8-2125/v1/pdf?article_uuid=6d2c0418-1961-4ed8-ab5a-919f02f46244" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.21129.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Karpova D, Rettig MP and DiPersio JF. Mobilized peripheral blood: an updated perspective [version 1; peer review: 2 approved] <i>F1000Research</i> 2019, <b>8</b>(F1000 Faculty Rev):2125 (<a href="https://doi.org/10.12688/f1000research.21129.1" target=_blank>https://doi.org/10.12688/f1000research.21129.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=21129 id=mobile-track-article-signin-21129 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/21129?target=/articles/8-2125.html"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=23258 /> <input name=articleId type=hidden value=21129 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Mariusz Ratajczak</strong>, Stem Cell Program, Department of Medicine, Division of Hematology and Oncology, University of Louisville, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Jean-Pierre Levesque</strong>, Faculty of Medicine, University of Queensland, Australia </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 20 Dec 2019</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/8-2125.html&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/8-2125.html&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=58984-57776></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=61520-57777></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=2><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/8-2125/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>20 Dec 19</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Mariusz Ratajczak</strong>, Stem Cell Program, Department of Medicine, Division of Hematology and Oncology, University of Louisville, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Jean-Pierre Levesque</strong>, Faculty of Medicine, University of Queensland, Australia </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/8-2125.html&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/8-2125/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Mobilized peripheral blood: an updated perspective".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/8-2125/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/8-2125/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/8-2125/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Karpova D et al.');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/8-2125/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/8-2125",
            templates : {
                twitter : "Mobilized peripheral blood: an updated perspective. Karpova D et al., published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/8-2125/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Mobilized peripheral blood: an updated perspective", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Mobilized peripheral blood: an updated perspective", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/21129/23258")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "23258");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "57776": 4,
                           "57777": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "a2e0efa3-ee99-43fd-bc6a-dc2bec5c3f92";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/8-2125.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/8-2125.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/8-2125.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/8-2125.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/8-2125.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>